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INTRODUCTION 
Surgery is the cornerstone of medical treatment of numerous benign conditions such as 
gallstone disease, but also of malignancies such as colorectal and thyroid cancer. Every 
surgical procedure does incorporate a risk for complications.1,2 Part of these complications 
occur during surgery and are caused by incorrect identification of vital anatomical structures. 
For example, with respect to the most frequently performed laparoscopic procedure, 
laparoscopic cholecystectomy, bile duct injury is the most feared complication because of 
its associated significant morbidity and even mortality. Misidentification of the extrahepatic 
bile duct anatomy during the laparoscopic cholecystectomy seems to be the main cause of 
bile duct injury.3 
Another example is iatrogenic injury of the ureter during colorectal or gynecologic 
surgery. In order to prevent such injury during procedures in which the ureter is specifically 
at risk, time is spent to identify the exact location of the ureter. A third example is 
inadvertent resection of parathyroid tissue during thyroid surgery. Preservation of the 
parathyroid glands during thyroid surgery is important to maintain calcium homeostasis. 
These parathyroid glands can be very hard to identify, causing unwilling resection of the 
parathyroid tissue, potentially resulting in hypoparathyroidism, which occurs in 18% of 
thyroidectomy patients.4
Hence in various procedures it is of great importance to be able to distinguish vital 
structures in the surgical field such as bile ducts, parathyroid glands, ureters and arteries. 
An optical tool that can help identify anatomy might facilitate the surgeon in critical 
intraoperative decision-making, thereby improving the safety and outcome for the patients. 
One potential optical tool is near-infrared fluorescence (NIRF) imaging. The use of NIRF 
imaging is based on the administration of an exogenous contrast agent (i.e. a fluorescent 
dye), which can be visualized in the human body using a dedicated imaging system. The dye 
can be excited when exposed to a specific wave length in the near-infrared light spectrum, 
see Figure 1. When excited, the dye becomes fluorescent and can then be visualized and 
detected by using a special filter in front of the camera. 
In Figure 2 a schematic overview of the use of this technique in practice is given. First, a 
fluorescent dye is administered, mostly intravenously. Then, a laser controller shines light in 
the exact right wavelength on this fluorescent dye, making it fluorescent. The fluorescent 
signal can then be detected using a camera which is equipped with a specific filter, only 
allowing the wavelength the fluorescent dye produces. The video-recordings can then 
be seen on the screen, with illuminating caused by the fluorescent dye in the patient’s 
body. When the dye is located in the vascular system, fluorescence angiography can be 
performed using this technique. This opens the possibility to visualize perfusion of the 
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intestines e.g. before and after constructing bowel anastomoses in colorectal surgery. 
When the dye is cleared by the liver, it will be collected in the bile ducts, facilitating the 
visualization of the extra-hepatic biliary anatomy. When cleared by the kidneys, the dye can 
be applied for ureteral delineation during pelvic interventions, e.g. in gynecologic, urologic 
or gastrointestinal surgery.
Figure 1 Wave length of visible and near infrared light 
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In Figure 2 a schematic overview of the use of this technique in practice is given. First, a fluorescent 
dye is administered, mostly intravenously. Then, a laser controller shines light in the exact right 
wavelength on this fluorescent dye, making it fluorescent. The fluorescent signal can then be 
detected using a camera which is equipped with a specific filter, only allowing the wavelength the 
fluorescent dye produces. The video-recordings can then be seen on the screen, with illuminating 
caused by the fluorescent dye in the patient’s body. When the dye is located in the vascular system, 
fluorescence angiography can be performed using this technique. This opens the possibility to 
visualize perfusion of the intestines e.g. before and after constructing bowel anastomoses in 
colorectal surgery. When the dye is cleared by the liver, it will be collected in the bile ducts, 
facilitating the visualization of the extra-hepatic biliary anatomy. When cleared by the kidneys, the 
dye can be applied for ureteral delineation during pelvic interventions, e.g. in gynecologic, urologic or 
gastrointestinal surgery. 
 
 
Figure 2 Schematic overview of the use of NIRF in surgery 
  
 
The great potential of NIRF imaging is that the fluorescent dye can shine through a bile duct wall or 
vascular walls, because of a higher penetration depth (up to 5-10 mm) compared to light in the 
visible light spectrum. Another advantage is that no radiological support is needed, which is for 
example mandatory in conventional x-ray cholangiography. Moreover, the patient is not exposed to 
any ionizing radiation. 
Figure 2 Schematic overview of the use of NIRF in surgery
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The great potential of NIRF imaging is that the fluorescent dye can shine through a bile duct 
wall or vascular walls, because of a higher penetration depth (up to 5-10 mm) compared 
to light in the visible light spectrum. Another advantage is that no radiological support is 
needed, which is for example mandatory in conventional x-ray cholangiography. Moreover, 
the patient is not exposed to any ionizing radiation.
Nowadays, several fluorescent dyes are used. The most commonly used dye, approved for 
clinical use, is indocyanine green (ICG). The use of ICG is reported since 1960 for assessing 
hepatic blood flow.5 In 1969, the use of infrared angiography was first reported to study 
pial vessels in dogs.6 In 1972, the first use of this technique in humans was described.7 
Later, in 1973, Flower and Hochheimer actually report to have performed ICG-fluorescence 
angiography to visualize the choroidal vessels using a fundus camera with filters, showing 
only the exited light from the vessels filled with ICG and blocking the reflection in the 
fundus.8 This application is used to assess the choroidal vessels and thereby assess possible 
pathological choroidal patterns such as in senile macular degeneration, diabetic retinopathy 
and choroidal tumors.9 
ICG binds quickly to albumin after intravenous administration.5 As mentioned, ICG is 
exclusively cleared by the liver. ICG is a small molecule (molecule mass 775 Dalton) and 
the plasma-half-life is short with 1-2 minutes.10 The excitation and emission peaks are 
respectively near 780 and 830 nm.11
Another fluorescent dye approved for human use is methylene blue. Apart from the 
fluorescence, methylene blue is used for its pharmacological properties and as a staining 
agent. The pharmacological properties are used for treatment of methemoglobinemia12, 
treatment of resistant plaque psoriasis13 and as antimalarial medication.14 In very high doses 
it can be used as a vasopressor.15 Methylene blue is cleared by the kidneys and can therefore 
possibly be used to visualize the ureters. The peak excitation of methylene blue is 668nm, 
and peak emission at 688nm.16
New NIRF dyes are being developed but are still at an experimental stage. The IR-Dyes (LI-
COR, Licon, Nebraska) are such agents. FDA approval for in-human use is expected to be 
obtained soon for the dyes IRDye® 800CW, IRDye® 800BK and IRDye® 800NOS.17 The excitation 
and emission peak of these dyes are 775 and 796 nm for IRDYE® 800NOS, 774 and 790nm 
for IRDye® 800BK and 767 and 786nm in IRDye® 800NOS. The advantages of these dyes are 
the similar wavelengths as compared to ICG, enabling the use of the presently available 
commercial systems and its improved hydrophilicity, causing faster biliary secretion and 
thereby earlier illumination of the bile ducts. In addition, these dyes are cleared both by 
the liver and the kidneys, making visualization of both the biliary anatomy as the ureters 
possible. 
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As described, the NIRF imaging technique is not entirely new, as it has already been used for 
almost fifty years in ophthalmology. In surgery, this technique was first used in humans by 
Mitsuhashi in 2008, followed by Ishizawa et al in 2010, both to visualize the biliary anatomy.18,19 
In 2012, the first publication on NIRF imaging during laparoscopic cholecystectomy from 
our research group was published online.20 Hereafter, many more publications from all over 
the world followed. Other applications were described, such as the use of fluorescence 
imaging for assessment of bowel perfusion in anastomotic surgery21, intraoperative ureteral 
visualization22 and real-time parathyroid gland identification.23 In these studies, almost 
exclusively promising results were found. However, the use of NIRF imaging was not yet 
implemented in standard clinical practice at the start of this thesis. 
AIMS AND OUTLINE OF THIS THESIS 
The overall aim of this thesis was to investigate some of the presently possible applications 
of near infrared fluorescence imaging during surgery in order to prevent iatrogenic damage 
due to misrecognition of the anatomy. 
PART I NEAR INFRARED FLUORESCENCE CHOLANGIOGRAPHY
In this part, the use of near infrared fluorescence imaging in visualizing the biliary structures 
during laparoscopic cholecystectomy is described. Chapter 2 contains the protocol of an 
international multicenter international randomized controlled trial to investigate the added 
value of the use of near infrared fluorescence in laparoscopic cholecystectomies. Chapter 3 
presents possible parameters of influence on the obtained intensity of the fluorescence 
signal during laparoscopic cholecystectomies. In Chapter 4, testing of two new fluorescent 
dyes for the visualization of the cystic duct and cystic artery is described. In Chapter 5, the 
objective measurement of fluorescence intensity in current literature is critically evaluated. 
PART II NEAR INFRARED FLUORESCENCE IMAGING IN COLORECTAL SURGERY 
In this part, the use of near infra-red fluorescence imaging in visualizing both the bowel 
perfusion and the ureter during colorectal surgery is described. Chapter 6 presents a 
systematic review investigating the added value of near infrared fluorescence angiography 
in anastomotic colorectal surgery. In Chapter 7, we present a clinical study to investigate 
the relation between fluorescence intensity of the bowel and postoperative inflammatory 
markers characterizing anastomotic leakage in order to explore the value of the intensity 
of the signal in predicting anastomotic healing. In Chapter 8 the use of Methylene Blue as 
a fluorescent dye for visualization of the ureter during colorectal surgery is evaluated. In 
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Chapter 9, two new fluorescent dyes for ureter visualization are tested. In Chapter 10, a 
search for the optimal dose to gain the best fluorescent signal using a new fluorescent dye 
to visualize the ureters is presented. 
PART III NEAR INFRARED FLUORESCENCE IMAGING IN THYROID SURGERY
Chapter 11 describes the use of near infrared fluorescence imaging in 30 thyroid surgeries 
to identify and assess remaining perfusion of the parathyroid glands.
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PART I
NEAR INFRARED FLUORESCENCE 
CHOLANGIOGRAPHY
CHAPTER 22
Near-infrared fluorescence 
cholangiography assisted 
laparoscopic cholecystectomy 
versus conventional laparoscopic 
cholecystectomy (FALCON trial): 
study protocol for a multicenter 
randomized controlled trial
Jacqueline van den Bos, Rutger M. Schols, Misha D. Luyer, Ronald M. van Dam, 
Alexander L. Vahrmeijer, Wilhelmus J. Meijerink, Paul D. Gobardhan,  
Gooitzen M. van Dam, Nicole D. Bouvy, Laurents P.S. Stassen. 
BMJ Open. 2016;6(8):e011668.
FALCON: study protocol
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ABSTRACT 
Introduction
Misidentification of the extrahepatic bile duct anatomy during laparoscopic cholecystectomy 
(LC) is the main cause of bile duct injury. Easier intraoperative recognition of the biliary 
anatomy may be accomplished by using near-infrared fluorescence (NIRF) imaging after 
an intravenous injection of indocyanine green (ICG). Promising results were reported 
for successful intraoperative identification of the extrahepatic bile ducts compared to 
conventional laparoscopic imaging. However, routine use of ICG fluorescence laparoscopy 
has not gained wide clinical acceptance yet due to a lack of high-quality clinical data. 
Therefore, this multicentre randomised clinical study was designed to assess the potential 
added value of the NIRF imaging technique during LC. 
Methods and Analysis
A multicentre, randomized controlled clinical trial will be carried out to assess the use of 
NIRF imaging in LC. In total, 308 patients scheduled for an elective LC will be included. These 
patients will be randomised into a NIRF imaging laparoscopic cholecystectomy (NIRF-LC) 
group and a conventional laparoscopic cholecystectomy (CLC) group. The primary end 
point is time to ‘critical view of safety’ (CVS). Secondary end points are ‘time to identification 
of the cystic duct (CD), of the common bile duct, the transition of CD in the gallbladder and 
the transition of the cystic artery in the gallbladder, these all during dissection of CVS’; ‘total 
surgical time’; ‘intraoperative bile leakage from the gallbladder or cystic duct’; ‘bile duct 
injury’; ‘postoperative length of stay’, ‘complications due to the injected ICG’; ‘conversion to 
open cholecystectomy’; ‘postoperative complications (until 90 days postoperatively)’ and 
‘cost-minimisation’.
Ethics and dissemination
The protocol has been approved by the Medical Ethical Committee of Maastricht University 
Medical Center/Maastricht University; the trial has been registered at ClinicalTrials.gov. The 
findings of this study will be disseminated widely through peer-reviewed publications and 
conference presentations.
FALCON: study protocol | Chapter 2
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INTRODUCTION
Laparoscopic cholecystectomy (LC) is the most commonly performed laparoscopic 
procedure in the Netherlands, with almost 23 000 procedures annually.1 Bile duct injury 
during this procedure is rare with an incidence of 0.3–0.7%.2–5 However, when bile duct injury 
or vascular injury is present, it results in significant clinical relevant morbidity and mortality, 
lower quality of life and extra costs.6–10 Bile duct injury will generally lead to bile leakage and 
abdominal sepsis and can lead to bile duct obstruction with obstructive jaundice eventually 
leading to orthotropic liver transplantation or both.7 Late recognition and management of 
bile duct injuries can lead to severe deterioration in the patient’s condition, progressing 
to biliary peritonitis, sepsis, multiorgan failure and eventually death. Therefore, early 
recognition and treatment is important.7, 11 Misidentification of the extrahepatic bile duct 
anatomy during LC is the main cause of bile duct injury.12
To reduce this risk of bile duct injury, the critical view of safety (CVS) technique was 
introduced by Strasberg in 1995.13 A recent Society of American Gastrointestinal and 
Endoscopic Surgeons (SAGES) expert Delphi consensus deemed the CVS as being the 
most important factor for overall safety,14 in accordance with the current Dutch Surgical 
Society Guideline for Laparoscopic Cholecystectomy.15 To establish CVS, two observation 
windows need to be created: one window between the cystic artery (CA), cystic duct (CD) 
and gallbladder and another between the CA, gallbladder and liver (see Figure 1). The CVS 
technique is especially aimed at mobilising the gallbladder neck from the liver, in order 
to obtain a circumferential identification of the transition of the CD into the gallbladder. 
Nowadays, the CVS technique is the gold standard to perform a safe cholecystectomy with 
identification of the vital structures such as the CD.16–20
According to a Dutch nationwide survey in 2011, 97.6% of the Dutch surgeons use the 
CVS technique.21 However, according to a recent study by Nijssen et al,22 only in 10% of the 
laparoscopic cholecystectomies CVS is actually established. This could mean that it is more 
difficult to establish CVS than thought before, thus resulting in more bile duct injury than 
necessary.
Nowadays, there are several imaging techniques, such as intraoperative cholangiography 
(IOC) and near infrared fluorescence (NIRF) imaging, to identify the relevant anatomical 
structures easier. IOC has been advised to reduce the risk of bile duct injury.2, 16, 23
However, this radiological imaging of the biliary tree is not adopted worldwide 
in standard LC, as the procedure takes time, involves radiation exposure and requires 
additional equipment and manpower. Moreover, the interpretation of an intraoperative 
cholangiogram with potentially distorted anatomy clearly depends on the expertise of the 
surgeon. Therefore, worldwide consensus about implementation of IOC is still lacking.24
NIRF imaging after intravenous injection of indocyanine green (ICG) is a promising new 
technique for easier intraoperative recognition of the biliary anatomy.25, 26 ICG is cleared 
Chapter 2 | FALCON: study protocol
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quickly and exclusively by the liver after intravenous administration and has a very well-
known pharmacokinetic and safety profile. Neither radiological support nor additional 
intervention such as opening the cystic or common bile duct (CBD) is required, making it 
an easy, real-time and flexible technique to use during surgery. By real-time identification of 
the vital structures being the CD and CBD within the already adapted CVS technique, it may 
improve the outcome of LC.16, 27, 28 NIRF imaging using ICG has been evaluated in various animal 
models29–31 and in open, laparoscopic and single-incision laparoscopic cholecystectomies.30, 
32–34 Promising results were presented for safe and successful intraoperative identification 
of the CBD and the CD, compared to conventional laparoscopic imaging. Furthermore, a 
clinical study (n=30) showed that the NIRF imaging technique provided significantly earlier 
identification of the extrahepatic bile ducts during the CVS dissection phase: up to 10 min 
earlier identification of the CD and CBD could be obtained.35 Real-time imaging of the 
hepatic and cystic arteries was also achieved when a repeated dose of ICG was given.35–37
Despite these encouraging results derived from clinical feasibility studies, the routine 
use of ICG fluorescence laparoscopy has not gained wide clinical acceptance yet due to a 
lack of high-quality clinical data.
Therefore, a multicentre randomised clinical study was designed to assess the added 
value of the NIRF imaging technique during LC. The ultimate goal of this technique is to 
perform a safer procedure leading to a reduction in vascular and bile duct injuries. The 
primary objective of the present study is to evaluate whether earlier establishment of CVS 
can be obtained using the NIRF imaging technique during LC.
METHODS AND ANALYSIS
Primary aim 
The main objective of the study is to evaluate whether earlier establishment of the CVS can 
be obtained using the NIRF imaging technique during elective LC, by applying NIRF imaging 
as an adjunct to conventional laparoscopic imaging versus conventional laparoscopic 
imaging alone.
Hypothesis
It is hypothesised that standard application of NIRF imaging during LC will result in 
establishment of CVS at least 5 min earlier and with more certainty regarding visualisation 
of biliary anatomy when compared to conventional laparoscopic imaging alone.
Study design 
This multicentre randomised controlled clinical trial includes two randomisation arms: a 
NIRF-LC (laparoscopic cholecystectomy) group—this group of patients will undergo NIRF 
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cholangiography assisted laparoscopic cholecystectomy and a conventional laparoscopic 
cholecystectomy (CLC) control group—this group will undergo CLC.
Setting 
In the FALCON trial, a total of 308 patients will be included at the Departments of Surgery of 
the participating centres. The centres will be supported by the trial coordinator (JvdB) and 
by the Clinical Trial Center Maastricht (CTCM) (see also under the ‘data monitoring’ section). 
Further, no additional strategies for achieving adequate participant enrolment to reach the 
target sample size are considered necessary, as LC is a commonly performed surgery.
Sample size calculation 
The number of 308 participants is based on pilot data,35, 38 where the identification of 
the CD and CBD was established, respectively, 11 and 10 min earlier using fluorescence 
laparoscopic imaging compared to conventional laparoscopic imaging. A sample size 
of 131 for each randomisation arm has been calculated to detect a reduction in ‘time to 
establishment of CVS’ of at least 5 min with a power of 80% and an α of 0.05 (95% CI). 
Assuming a withdrawal rate of 15% (due to usual reasons for dropout in combination with 
 - 17 - 
identification of the extrahepatic bile ducts during the CVS dissection phase: up to 10 min earlier 
identification of the CD and CBD could be obtained.35 Real-time imaging of the hepatic and cystic 
arteries was also achieved when a repeated dose of ICG was given.35–37 
Despite these encouraging results derived from clinical feasibility studies, the routine use of ICG 
fluorescence laparoscopy has not gained wide clinical acceptance yet due to a lack of high-quality 
clinical data. 
Therefore, a multicentre randomised clinical study was designed to assess the added value of the 
NIRF imaging technique during LC. The ultimate goal of this technique is to perform a safer 
procedure leading to a reduction in vascular and bile duct injuries. The primary objective of the 
present study is to evaluate whether earlier establishment of CVS can be obtained using the NIRF 
imaging technique during LC. 
 
 
Figure 1a Anterior view of CVS    Figure 1b Posterior view of CVS 
 
 
 
 
  
Window of CVS between cystic artery, cystic duct and gallbladder 
 
Window of CVS between cystic artery, gallbladder and liver  
 
Gallbladder bed where detached from liver  
Figure 1a Anterior view of CVS Figure 1b Posterior view of CVS
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technical difficulties concerning the video recordings) during the trial, we will require a total 
of 308 (n=2×131+15%).
All patients (age >18 years) scheduled for an elective LC and meeting the inclusion 
criteria will be suitable for inclusion.
Inclusion criteria 
The inclusion criteria are as follows: male and female patients, aged 18 years and above, 
scheduled for elective LC, with normal liver and renal function, no hypersensitivity for 
iodine or ICG, able to understand the nature of the study procedures, willing to participate 
and give written informed consent and Physical Status Classification of ASA I/ASA II.
Exclusion criteria 
The exclusion criteria are as follows: age <18 years, liver or renal insufficiency, known iodine 
or ICG hypersensitivity, pregnancy or breastfeeding, not able to understand the nature of 
the study procedure and a Physical Status Classification of ASA III and above.
Participants can leave the study at any time for any reason if they wish to do so without any 
consequences.
The investigator can decide to withdraw a participant from the study for urgent medical 
reasons. Conversion to open cholecystectomy, before CVS is established, is a reason for 
study withdrawal. Furthermore, if the video recordings of the laparoscopic procedure were 
not successful, the procedure will be unsuitable for analysis of all predefined end points. 
There are no other specific criteria for withdrawal. In case of withdrawal, participants will 
be replaced to achieve the calculated sample size. All inclusions will be analysed on an 
intention-to-treat basis.
Randomisation
All included patients will be randomised centrally using block randomisation with sealed 
envelopes and stratification per participating centre. After signing the informed consent 
form, the next sealed envelope in line will be opened by the coordinating investigator. 
There will be no blinding of patients or surgeons.
Intervention 
The CLC group will undergo conventional laparoscopic cholecystectomy. The NIRF-LC 
group will undergo near infrared fluorescence cholangiography using a laparoscopic NIRF 
imaging system (Karl Storz GmbH, Tuttlingen, Germany). To obtain fluorescence imaging 
of the biliary tract and CA, a NIRF contrast agent will be administered. Directly after the 
induction of anaesthesia, 2.5 mg of ICG (2.5 mg/mL; Diagnostic Green, Aschheim, Germany) 
will be given intravenously. A repeat injection of 2.5 mg will be administered for concomitant 
arterial and biliary fluorescence delineation after achievement of CVS.
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Outcome measures 
The primary outcome measure is time to identification of CVS. This end point is used as a 
surrogate for bile duct identification without surgical exploration. CVS is established if the 
following three criteria are met:
1. Mobilisation of the gallbladder infundibulum for one-third of the length of the 
gallbladder from the liver bed.
2. Circumferential exposure of the CD and confirmation of its transition in the 
gallbladder.
3. Circumferential exposure of the CA and confirmation of its transition in the 
gallbladder.
Secondary outcome measures are listed in Table 1.
Data collection 
Intraoperatively, a case report form will be filled in. A structure is scored as ‘identified’ if its 
localisation is confirmed with great certainty by the experienced surgeon. The attending 
surgeon will be consulted to decide whether he believes CVS is established.
In accordance with regular care, all laparoscopic surgical procedures will be digitally 
recorded. An expert panel, consisting of three highly experienced laparoscopic surgeons, 
will analyse the data using video recordings: time until identification of the CD and of its 
transition into the gallbladder; time until identification of the CA and its transition into the 
gallbladder during dissection of CVS and when and whether CVS is established. Eventually, 
all five observers (the surgeon or surgical trainee, PhD researcher or local researcher during 
the operation and the three postoperative observers) will individually assess the above-
mentioned end points. The mean values of these five assessments will be used for each of 
the end points. All clinical data are prospectively registered in a database.
OsiriX V.5.5.1. Imaging Software (Prixmeo, Geneva, Switzerland) will be used for objective 
assessment of the degree of fluorescence illumination in the extrahepatic bile ducts. The 
fluorescence images will be analysed by determining the target-to-background ratio (TBR). 
TBR is defined as the mean fluorescence intensity (FI) of two-point regions of interest (ROIs) 
in the target (ie, CBD, CD or CA) minus the mean FI of two background (BG) ROIs in the liver 
hilum, divided by the mean FI of the two background ROIs in the liver hilum; that is TBR = (FI 
of target−FI of BG)/FI of BG.
The costs made in the two groups will be compared, resulting in a cost-minimisation 
analysis. This analysis will include the costs made by using the operation theatre in terms 
of fluorescence laparoscopy equipment, the fluorescent dye ICG, morbidity, mortality and 
postoperative hospital stay.
In Figure 2, flow charts of the study procedure for the CLC-group and the NIRF-LC group 
are presented.
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Data validation and management 
Patient data will be anonymously registered and analysed by comparing NIRF-LC with CLC. 
Only the investigators will have access to the patient data after informed consent is given.
Table 1 Secondary outcome measures 
Outcome measure Definition 
Time until identification of the cystic duct (CD) Time in minutes
Time until identification of common bile duct Time in minutes
Time until identification of the transition of CD 
into the gallbladder
Time in minutes
Time until identification of the transition of the 
cystic artery (CA) into the gallbladder
Time in minutes
Total Surgical time Time in minutes from skin incision to the end of 
skin closure
Visualization of CVS and visualization of the 
transition of the cystic duct and cystic artery into 
the gallbladder
Time in minutes
Intraoperative bile leakage from the gallbladder 
or cystic duct
 Visualized bile leakage or spill during surgery. 
Bile duct injury Any injury to the main biliary tree; will be 
classified using the Strasberg Classification 
System13
Type A: Injury to the cystic duct or from minor 
hepatic ducts draining the liver bed.
Type B: Occlusion of biliary tree, commonly 
aberrant right hepatic duct(s).
Type C: Transection without ligation of aberrant 
right hepatic duct(s).
Type D: Lateral injury to a major bile duct.
Type E: Injury to the main hepatic duct; classified 
according to level of injury. 
Postoperative length of hospital stay Duration from date of admission (included) to 
date of discharge (included)
Complications due to injected contrast agent  Any complication potentially caused by injected 
ICG
Conversion to open cholecystectomy Laparoscopic approach converted to an
open operation, or in which an abdominal 
incision to assist the procedure was needed. 
90-day all-cause postoperative complications Any complication, up to 90 days, described by 
the Clavien-Dindo classification of postoperative 
complications39
Specific attention to bile leak, CBD injury, wound 
infection, intra-abdominal collection, pancreatitis, 
CBD stones, ICU/HDU readmissions; prospectively 
assessed during admission; thereafter 
immediately to be reported to study coordinator
Cost Minimization Difference in costs (in Euros) between 
conventional LC and NIRF LC
CA: cystic artery; CBD: common bile duct; CD: cystic duct; CVS: critical view of safety; LC: laparoscopic cholecystectomy; NIRF: near-
infrared fluorescence.
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Study timeline 
In Figure 3, the study timeline is presented. From January 2016 until January 2018, data will 
be collected; in September 2016, March 2017, September 2017 and March 2018, the expert 
panel will evaluate the video material for end points; around July 2018, data analysis is 
expected to be complete. 
Participants will be informed about the study during their preoperative visit to the 
outpatient clinic. Thereafter, patients have at least a week to consider participation in the 
Figure 3 Study timeline 
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individually assess the above-mentioned end points. The mean values of these five assessments will 
be used for each of the end points. All clinical data are prospectively registered in a database. 
OsiriX V.5.5.1. Imaging Software (Prixmeo, Geneva, Switzerland) will be used for objective 
assessment of the degree of fluorescence illumination in the extrahepatic bile ducts. The 
fluorescence images will be analysed by determining the target-to-background ratio (TBR). TBR is 
defined as the mean fluorescence intensity (FI) of two-point regions of interest (ROIs) in the target 
(ie, CBD, CD or CA) minus the mean FI of two background (BG) ROIs in the liver hilum, divided by the 
mean FI of the two background ROIs in the liver hilum; that is TBR = (FI of target−FI of BG)/FI of BG. 
The costs made in the two groups will be compared, resulting in a cost-minimisation analysis. This 
analysis will include the costs made by using the operation theatre in terms of fluorescence 
laparoscopy equipment, the fluorescent dye ICG, morbidity, mortality and postoperative hospital 
stay. 
In Figure 2, flow charts of the study procedure for the CLC-group and the NIRF-LC group are 
presented. 
 
Figure 2a Flow chart of study procedures: conventional laparoscopic cholecystectomy (CLC) group  
 
 
  
Figure 2a Flow chart of study procedures: conventional laparoscopic cholecystectomy (CLC) group 
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Data validation and management  
Patient data will be anonymously registered and analysed by comparing NIRF-LC with CLC. Only the 
investigators will have access to the patient data after informed consent is given. 
 
Study timeline  
In Figure 3, the study timeline is presented. From January 2016 until January 2018, data will be 
collected; in September 2016, March 2017, September 2017 and March 2018, the expert panel will 
evaluate the video material for end points; around July 2018, data analysis is expected to be 
complete.  
Participants will be informed about the study during their preoperative visit to the outpatient clinic. 
Thereafter, patients have at least a week to consider participation in the study. During their elective 
surgery, the near-infrared fluorescence laparoscopy will be used if the patient is randomised in the 
NIRF-LC group. After surgery, a 90-day follow-up period follows, and then possible complications will 
be evaluated. 
 
 
Figure 3 Study timeline  
 
 
 
Statistical analysis 
For statistical analysis, the ost recent version of SPSS (IBM, Armonk, New York, USA) will be used. 
Baseline characteristics such as patient clinical history (including previous surgery), age, body mass 
index and indication for the procedure will be recorded and compare  between the intervention 
(NIRF-LC) and control groups (CLC). Categorical baseline variables will be compared using a χ2 test, 
while numerical variables will be compared by the independent sample t-test or the Mann-Whitney 
U test, depending on the distribution. 
The primary outcome measure, namely, time until establishment of CVS, will be given in minutes, 
with a mean and SD. A linear regression analysis will be applied for determination of possible 
significant differences between the time measurements, therewith comparing the NIRF-LC group to 
the CLC group. This will be conducted to determine whether a reduction in time can in fact be 
achieved using the NIRF imaging technique compared to CLC. 
All numerical secondary outcomes such as time until visualisation of CD and CA will be analysed using 
a linear regression model. In case of missing values, a Cox regression analysis will be performed. 
Missing values can occur especially in the postoperative analysis by the expert panel, when the panel 
concludes that, contrary to the opinion of the operating team, actually no CVS was obtained or that 
the transition of the CD or CA in the gallbladder had actually not been properly identified. All 
Chapter 2 | FALCON: study protocol
30
Figure 2b Flow chart of study procedures: NIRF laparoscopic cholecystectomy (NIRF-LC) group 
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Figure 2b Flow chart of study procedures: NIRF laparoscopic cholecystectomy (NIRF-LC) group  
  
 
 
 
 
 
 
 
study. During their elective surgery, the near-infrared fluorescence laparoscopy will be used 
if the patient is randomised in the NIRF-LC group. After surgery, a 90-day follow-up period 
follows, and then possible complications will be evaluated.
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Statistical analysis
For statistical analysis, the most recent version of SPSS (IBM, Armonk, New York, USA) will be 
used. Baseline characteristics such as patient clinical history (including previous surgery), age, 
body mass index and indication for the procedure will be recorded and compared between 
the intervention (NIRF-LC) and control groups (CLC). Categorical baseline variables will be 
compared using a χ2 test, while numerical variables will be compared by the independent 
sample t-test or the Mann-Whitney U test, depending on the distribution.
The primary outcome measure, namely, time until establishment of CVS, will be given in 
minutes, with a mean and SD. A linear regression analysis will be applied for determination of 
possible significant differences between the time measurements, therewith comparing the 
NIRF-LC group to the CLC group. This will be conducted to determine whether a reduction 
in time can in fact be achieved using the NIRF imaging technique compared to CLC.
All numerical secondary outcomes such as time until visualisation of CD and CA will be 
analysed using a linear regression model. In case of missing values, a Cox regression analysis 
will be performed. Missing values can occur especially in the postoperative analysis by the 
expert panel, when the panel concludes that, contrary to the opinion of the operating team, 
actually no CVS was obtained or that the transition of the CD or CA in the gallbladder had 
actually not been properly identified. All categorical secondary outcomes such as bile duct 
injury and conversion to open surgery will be analysed with a logistic regression model.
Data monitoring 
An independent data monitoring committee will monitor the study procedures and data 
management. This team consists of independent and certified persons from the CTCM. 
No interim analysis will be performed. Adverse events and serious adverse events will be 
centrally reported in the online database, toetsingonline.nl.
ETHICS AND DISSEMINATION 
The proposed study is approved by the Medical Ethics committee of Maastricht University 
Medical
Center/Maastricht University. Possible protocol amendments will be sent to the Medical 
Ethics Committee of Maastricht University Medical Center/Maastricht University. After 
approval, the changes will be communicated on clinicaltrials.gov and to the relevant parties.
Is there scientific and clinical value in conducting this study?
Despite the promising results from previous feasibility studies, a lack of solid clinical data 
precludes wide clinical acceptance of the routine use of ICG fluorescence laparoscopy. This 
multicentre randomised clinical study can provide such data.
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Risk-benefit assessment
There are no additional risks accompanied by the laparoscopic NIRF imaging systems, 
compared to conventional laparoscopic imaging. The gifts of ICG are the only additional 
(minimally) invasive interventions for the patient. ICG preparations can, in very rare cases, 
cause nausea and anaphylactoid or anaphylactic reactions (<1:10 000). Patients with 
terminal renal insufficiency seem to be more prone for such an anaphylactic reaction. 
Estimated death due to anaphylaxis is reported as <1 per 330 000.40–43 Symptoms include 
anxiety, feeling of warmth, pruritus, urticaria, acceleration of heart rate, decrease in blood 
pressure, shortness of breath, bronchospasm, flushing, cardiac arrest, laryngospasm, facial 
oedema and nausea. Together with the anaphylactoid reaction, hyper-eosinophilia may 
occur. If, contrary to expectations, symptoms of anaphylaxis occur, the following measures 
will be taken: stop further administration of ICG, leave injection catheter or cannula in the 
vein, keep airways free, inject 100– 300 mg hydrocortisone or a similar preparation by rapid 
intravenous injection, substitute volume with isotonic electrolyte solution, give oxygen and 
monitor the circulation and slowly administer antihistamines intravenously. In case of an 
anaphylactic shock, the patient will be placed in the recumbent position with legs raised, 
volume will be rapidly substituted with, for example, isotonic electrolyte solution (pressure 
infusion), plasma expanders. Furthermore, 0.1–0.5 mg epinephrine will be administered 
and immediately diluted to 10 mL with 0.9% saline intravenously. If necessary, this will be 
repeated after 10 min.
The benefit for the patients in the NIRF-LC group will possibly include a shorter 
period to the establishment of CVS and the clearer identification of CVS and its anatomical 
components. 
Do the individuals give informed consent?
To each patient, that is, a potential candidate for inclusion, thorough patient information 
will be given. From each individual who is willing to participate, written informed consent 
will be obtained by one of the investigators.
The ethical issues of the trial will be thoroughly explained and discussed, verbally and 
in writing. The basic principles laid down in the Declaration of Helsinki44 will be followed 
throughout the execution of the trial. Accordingly, each participant has the right to withdraw 
from the study at any given moment without having to explain this decision in any way.
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ABSTRACT 
Background 
Though often only brie y described in the literature, there are clearly factors that have an 
influence on the fluorescence intensity, and thereby the usefulness of the technique. This 
article aims to provide an overview of the factors influencing the fluorescence intensity 
of fluorescence imaging with Indocyanine green, primarily focused on NIRF guided 
cholangiography.
Methods
A systematic search was conducted to gain an overview of currently used methods in NIRF 
imaging in laparoscopic cholecystectomies. Relevant literature was searched to gain advice 
on what methods to use. Ex vivo experiments were performed to assess various factors that 
influence fluorescence intensity and whether the found clinical advices can be confirmed.
Results 
ICG is currently the most widely applied fluorescent dye. Optimal ICG concentration lies 
between 0.00195 and 0.025 mg/ml, and this dose should be given as early as achievable—but 
maximum 24h—before surgery. When holding the laparoscope closer and perpendicular 
to the dye, the signal is most intense. In patients with a higher BMI and/or cholecystitis, 
fluorescence intensity is lower, but NIRF seems to be more helpful. There are differences 
between various marketed fluorescence systems. Also, no uniform method to assess 
fluorescence intensity is available yet.
Conclusions
This study identified and discussed several factors that influence the signal of fluorescence 
cholangiography. These factors should be taken into account when using NIRF 
cholangiography. Also, surgeons should be aware of new dyes and clinical systems, in order 
to benefit most from the potential of NIRF imaging.
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INTRODUCTION
The most common laparoscopic procedure in the Nether- lands is laparoscopic cholecystec-
tomy (LC), which is per- formed 23,000 times each year.1 The most feared complication in 
this surgery is bile duct injury. Even though LC is a very common procedure, bile duct injury 
still has an incidence of 0.3–0.7%.2–5 Generally, bile duct injury leads to bile leakage, causing 
abdominal sepsis. It can also lead to obstruction, with obstructive jaundice, eventually 
potentially leading to a need for liver transplantation in the worst case.6 Late recognition 
is common in bile duct injuries, resulting in significant morbidity and mortality, a lower 
quality of life and extra costs.6–9 The main cause for bile duct injury is misidentification of the 
anatomy.10, 11 Therefore, techniques to improve the visualization of the anatomy are desired.
Several imaging techniques to improve recognition of the relevant anatomical 
structures have been proposed. One is intra-operative cholangiography. Although this 
imaging technique is advised to reduce the risk of bile duct injury, there are disadvantages 
such as radiation exposure and need for additional equipment, knowledge and personnel 
to perform this procedure and extra costs.2, 11–13 Because of these disadvantages, there is no 
worldwide consensus about implementation of intra-operative cholangiography.14
Another technique to help identify the relevant anatomical structures is the use of near-
infrared fluorescence (NIRF) imaging. This is a relatively new and promising technique to 
improve recognition of the biliary anatomy by injecting a fluorescent dye.15, 16 The clinically 
used dye is Indocyanine green (ICG), belonging to the family of cyanine dyes.17 ICG is a water-
soluble tricarbocyanine with a molecular weight of 774.96 absorbing excitation light at 
800–835 nm while emitting fluorescent light at 740–793 nm.18–20 Generally, ICG is considered 
safe with a very low incidence of complications, although there is a possibility of an allergic 
reaction to the sodium-iodine in the ICG.21–23 Other dyes are not generally available yet, 
either because they are not excreted in bile or because they are still in a research phase and 
thus not yet available for routine clinical use.24, 25
In addition to this small risk for an allergic reaction, all researchers and surgeons working 
with near-infrared (NIR) fluorescence-imaging experience limitations of the technique. 
Though often only briefly described in the literature, there are clearly factors such as the 
given dose and distance between the laparoscope and the target that have an influence on 
the fluorescence intensity, and thereby the usefulness of the technique. Since this technique 
is nowadays commonly used, it is of importance to obtain more general knowledge about 
the factors that influence the fluorescence intensity. Therefore, this article aims to provide 
an overview of these factors influencing the fluorescence intensity, primarily focused on 
NIRF guided cholangiography during laparoscopic cholecystectomy.
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MATERIALS AND METHODS
To provide an overview of the factors influencing the fluorescence intensity in NIRF-guided 
cholangiography during laparoscopic cholecystectomy, three strategies were combined.
First a systematic review of the literature was performed. Secondly, using free searches, more 
information about specific suspected factors of influence was sought. Thirdly, factors of 
influence identified from the literature were further investigated with ex vivo experiments.
Since no (new) patients are included in this study, IRB approval or patients informed consent 
was not needed for this study.
Literature search 
A Pubmed search on methods used for fluorescence cholangiography and its influencing 
factors was performed by two reviewers through November 2017. Used search terms were 
as follows: ((((((((((((near-infrared imaging) OR fluorescence imaging) OR fluorescent imaging) 
OR near-infrared fluorescence) OR fluorescent dyes) OR fluorescent dye) OR “Fluorescent 
Dyes“[Mesh]) OR ICG) OR infracyanine green) OR indocyanine green) OR “Indocyanine 
Green“[Mesh])) AND ((((((“Cholecystectomy“[Mesh]) OR Cholecystectomy) OR laparoscopic 
cholecystectomy) OR “Cholecystectomy, Laparoscopic“[Mesh]) OR gallbladder removal) OR 
laparoscopic cholecystectomies). No Language restrictions were applied. Studies presenting 
original data on performing near-infrared fluorescence-guided cholecystectomy in human 
subjects were included. Therefore, animal studies, protocol-articles, reviews and case 
reports were excluded. From the included reports, data regarding the used methods and 
outcomes (visibility of anatomical structures) was extracted.
Ex vivo experiments 
In addition, ex vivo experiments were performed to further analyze certain aspects. The 
aim of these experiments was to evaluate whether albumin is needed in the medium used 
for ICG to become fluorescent and to study the influence of the concentration of ICG, the 
distance between the laparoscope and the target, the angle between the laparoscope and 
the target and the penetration depth on the fluorescent signal.
A laparoscopic Near-infrared Fluorescence Imaging System (Karl Storz GmbH, Germany) 
was used, as we use in daily clinical practice. This system includes a D-light P xenon light 
source, an IMAGE 1 camera and a 30-degree 10 mm fluorescence laparoscope (Karl Storz 
GmbH, Germany).
Experiments were performed both with ICG diluted in NaCl 0.9% and with ICG dilution 
in 35 mg/ml albumin in a 0.9% NaCl dilution. This was done as ICG is considered in vivo to 
bind to albumin. The aim was to assess whether such binding ex vivo was necessary in order 
to obtain a signal.
Initially, we used ten different concentrations of ICG, ranging between 10 and 0.125 mg/ml. 
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In these experiments, a lower concentration gave a better signal. To find the optimum, 
eventually twenty-one solutions ranging from 10 to 0.000121875 mg/ml were used. From 
each dilution, 9 times 1 ml of the ICG was placed on a wells plate.
The influence of distance was measured holding the endoscope at distances from 14 
to 1 cm from the surface of the dye. Also, the maximum distance at which the fluorescence 
could still be detected was measured for each concentration.
The influence of angle between the laparoscope and the surface of the dye was 
measured by comparing the middle cup, at which the laparoscope was aimed, with the 
surrounding cups with ICG and by holding the endoscope at different angles.
The penetration depth was evaluated with the use of beeswax plates stacked to 
different thicknesses. This medium was chosen because it approaches the scattering 
behavior and translucent light penetration of human tissue quite well.26 In fact, from the 
renaissance until the early twentieth century, anatomical wax models were used for medical 
education and until today provide an impressive visual display.27 Beeswax plates of exactly 
0.9 mm thickness were one by one progressively stacked on the wells plate to stepwise 
increase the thickness of scattering material on top of the fluorescent dye. In all experiments, 
fluorescence intensity was measured using Osirix (version Lite 8.5.2, Pixmeo). The setup of 
the ex vivo experiment is shown in Figure 1.
Additional information for this article was retrieved by a free search in the PubMed 
database, hand-searches of the retrieved references and personal experience with the 
technique.
RESULTS 
The systematic search was performed to retrieve insight in the currently used methods of 
performing near-infrared fluorescence guided cholangiography and the factors influencing 
its signal intensity. This search resulted initially in 126 articles, of which 80 were excluded 
9 times 1 ml of ICG in a dilution of 0.125 mg/ml in the cups of a Wells plate. Left: in white light. Middle: in NIRF light. 
Right: in NIRF light with one plate (0.9 mm) of beeswax on top of the Wells plate.
Figure 1 Setup of ex vivo experiments 
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based on title and abstract and 18 more after full text assessment. 28 articles were included 
in this review. Figure 2 presents the flowchart of this search.13, 19, 28–53 An overview of the 
included articles and their results is given in Tables 1 and 2 (Supplementary Material), 
respectively.
The results of literature search and the results of the performed experiments will be 
discussed in this section.
Fluorescent dye and concentration 
In all studies, ICG is used as the fluorescent dye. Both Indocyanine green and Infracyanine 
green where used. ICG was administered intravenously, except in the study by Graves et al.29 
and Liu et al.53, who injected the fluorescent dye directly into the gallbladder. Graves et al. 
made a special solution for this intra-gallbladder injection. First, a 0.25 mg/ml solution of 
ICG in sterile water was created. Once the gallbladder fundus was grasped and retracted, a 
needle tipped Kumar cholangiogram catheter (Nashville Surgical Instruments, Springfield, 
TN) was introduced through the 12-mm port and used to puncture the infundibulum of the 
gallbladder. 9 ml of bile was aspirated from the gallbladder through this catheter and mixed 
with the 0.25 mg/ml ICG solution. The new 0.025 mg/ml ICG-bile solution was reinjected 
into the gallbladder. The authors describe an immediately glow-up of the solution with no 
lag time, quickly filling the gallbladder and through the cystic duct the extrahepatic ducts. 
Due to the absence of background fluorescence from the liver, improved visual contrast was 
claimed as compared to intravenous injection.29 Liu et al. used a less complicated method, 
in which the ICG was diluted to a concentration of 0.125 mg/mL. 10 mL of this ICG dilution 
was injected through a gallbladder drain when this was already in situ, or through a Veress 
needle after draining the gallbladder from bile.53 In these patients, although background 
fluorescence was absent, results comparable to intravenous administration were found.
The most commonly used doses of ICG for intravenous administration where a fixed 
dose of 2.5 mg bolus (in 13 of the studies) or a dose adjusted to the patient’s weight of 0.05 
mg/kg (in 6 of the included studies). Other used doses are fixed dosed of 0.25, 3.75, 5, 10 
and 12.5 mg and weight-adjusted doses of 0.1–0.4, 0.2, 0.4 and 0.5 mg/kg (see Table 1 in 
Supplementary Material). When using a 2.5 mg bolus, the cystic duct was visualized in an 
average of 94% patients. When using 0.05 mg/kg, the average percentage of visualization 
of the cystic duct was 98%.
Zarrinpar et al.54 undertook a study with systematic variation of dosing (and timing) of 
injection of ICG. In 37 patients, the given dose varied between 0.02 and 0.25 mg/ kg. With 
an increasing dose, the visualization of the extrahepatic biliary tract improved. No decrease 
at the highest doses was observed. Boogerd et al.30 compared a dose of 5 and 10 mg with 
optimal signal at the lower dose of 5 mg.
The results of our ex vivo experiments are depicted in Figure 3. When ICG was diluted 
in NaCl 0.9%, no fluorescent signal could be obtained. Therefore, all further experiments 
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Legend:  A Maximum distance of visibility fluorescent signal for the tested concentrations
B Fluorescence intensity at 2 cm distance for the tested concentrations
C Maximum penetration depth of fluorescent signal for the tested concentrations
D Fluorescence intensity at increased distance between laparoscope and dye-surface
Figure 3 Results of ex vivo experiments 
Figure 2 Flow chart of search 
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were performed with ICG diluted in 35 mg/ml albumin in a 0.9% NaCl solution. The optimum 
concentration in which the highest measured fluorescence intensity at 2 cm distance was 
between 0.00195 and 0.025 mg/ml. A concentration of 0.0039 mg/ml would be a dose of 
19.5 mg to obtain this ideal concentration in the blood in an average patient with 5L blood, 
which is much higher than current used concentrations. However, when using this technique 
in laparoscopic cholecystectomy, we would want the concentration of 0.0039 mg/ml in the 
cystic duct. With a content of 60 ml of bile in the gallbladder, a dose of 0.234 mg would then 
be desirable assuming all ICG is cleared by the liver.
The used concentration of the administered ICG solution was not clearly described in 
every study. The studies that do provide information on ICG concentration use 2.5 mg/ml.19, 
33, 34, 40, 46, 49–52 In all, except two studies, the fluorescent dye was administered intravenously.
Timing of administration 
The timing of administration differed among the studies and ranged mostly between 1 
and 2 h and 15 min before surgery. Verbeek et al.55 investigated whether a longer period 
between the administration of ICG and the imaging resulted in an improved visibility 
of the biliary anatomy. They found that application 24h prior to surgery does result in a 
significant better signal-to-background ratio.55 This is mainly caused by a lesser fluorescent 
signal coming from the liver. Kono et al.56 found a significant difference in interval between 
injection and imaging between patients in whom the cystic duct-common hepatic duct 
confluence could be visualized by NIRF imaging and the patients in whom this could not, 
with median intervals of 90 (15–65) minutes and 47 (21–205) minutes, respectively. The 
above is in line with the advice of Boogerd et al.30, for an optimal time interval of 3h between 
administration of ICG and intra-operative fluorescence cholangiography.
Penetration depth 
Circumstances that result in thicker tissue covering the structures to identify are obesity and 
cholecystitis. These require a higher penetration depth of the signal.
Average BMI in the included studies ranged between 20.4 and 32.3 kg/m2 with a 
weighted average of 30.0 kg/m2 for all studies who report mean BMI. Dip et al.35 specifically 
investigated the accuracy of NIRF-guided surgery in morbidly obese subjects undergoing 
laparoscopic cholecystectomy. No differences in hepatic duct, common bile duct and 
accessory duct visualization were detected in the obese and non-obese groups (p value 
0.09, 0.16 and 0.66, respectively). Imagi et al.34 state that obesity is an important factor that 
can prevent identification of biliary structures under fluorescent cholangiography. Other 
studies notice that when not all aimed structures where visualized under
fluorescent cholangiography in every patient, the patients in which the structures were 
not visible were all obese.40, 42, 44, 51 Ankersmit et al.31, however, found no differences in ability 
to visualize the biliary structures in obese patients. Their hypothesis is that other patient 
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and surgical-related factors, including inflamed tissue, may interfere with and influence the 
success rate of fluorescence visualization of the bile ducts in complicated cases.31
Of the included patients in the studies found, 17% had acute cholecystitis. Four of 
the studies make a comment about the influence of cholecystitis on the usefulness of 
the NIRF technique. Zroback et al.33 note that in their experience, during dissection of 
the most inflamed gallbladders was when the technology was most appreciated, but no 
specific remark is made on the hindrance by thickened tissue. The other articles mention 
that the patients in which the biliary structures were not visible with NIRF more often 
had cholecystitis than the patients in which they were visible.13, 39, 42 Although in several 
studies the indication for surgery was also cholecystitis and the number of patients with 
this condition was given, no specific comparison was made with regard to the successful 
imaging of the desired structures between the patients with and without cholecystitis in 
most studies. Liu et al.53 make this comparison and conclude that in these patients, NIRF 
helped to significantly improve the visualization rates of the cystic duct in patients with 
cholecystitis compared to white light, whilst in cases with lithiasis without inflammation, the 
visualization rate of the cystic duct was similar in NIRF and white light.
In our ex vivo experiments, the penetration depth was studied at all concentrations 
separately. We observed a correlation between the thickness of material to be penetrated 
and the resulting signal, with an optimum and a maximum. A maximum penetration depth 
of 3.6 mm was measured. The optimum is at the same concentrations as we observed in our 
experiments on the concentration of ICG namely between 0.00195 and 0.025 mg/ml. See 
also Figure 3.
Distance to the target 
Kono et al.56 described a decrease by 50% of the contrast signal when the distance from the 
bile duct and tip of the laparoscope increased from 5 to 15 cm. However, other manuscripts 
do not clearly describe the distance used between the bile ducts and the laparoscope.
In our ex vivo experiments, a lower fluorescence intensity was found in all concentrations 
when the laparoscope was held at a greater distance. A 5 up to 30 times lower fluorescence 
intensity was observed when increasing the distance from 5 to 14 cm of the ICG solution, 
as is illustrated in Figure 3. When looking at the different concentrations, the maximum 
distance at which the fluorescent signal was still detectable was higher at the ‘optimal 
concentrations’ as shown in Figure 3.
Angle between laparoscope and tissue 
Kono et al.56 point out that the tip of the laparoscope should be placed vertically to 
Calot’s triangle to directly irradiate exciting light on the bile ducts and obtain the optimal 
fluorescence signal. However, as with the distance of the laparoscope, other manuscripts do 
not mention whether the laparoscope was placed vertically or in another angle. Some of the 
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articles use a zero-degree laparoscope, while others use a 30-degree laparoscope, which 
may be of influence on the angle of examination. In our experiments, a higher fluorescence 
intensity was found when holding the laparoscope more vertically towards the tissue.
Differences between systems 
The systems used in the included studies were 10 times a system by Karl Storz; 6 times the 
Firefly system; 3 times an Olympus system; 5 times a Hamamatsu system and 2 Stryker 
systems. Two studies did not mention which system was used. When comparing the studies 
using the different systems studies using Karl Storz can visualize the cystic duct in 93%; 
Firefly in 97% Olympus in 92% Hamanatsu in 92% and Stryker in 94%.
Kono et al.56 compared five imaging systems. Namely, a prototype fluorescence imaging 
system from Hamamatsu Photonics (Hamamatsu, Japan and Shinko Optical, Tokyo, Japan), 
the system from Olympus Medical Systems (Tokyo, Japan), thirdly a high-definition model 
From Hamamatsu Photonics (Hamamatsu, Japan and Shinko Optical, Tokyo, Japan), the high-
definition fluorescence imaging system from Karl Storz (Tuttlingen, Germany) and fifth, the 
high-definition imaging system from Novadaq (Toronto, Canada). A significant difference 
between these systems tested for signal contrast was found.56 It is not clear whether the 
systems tested are exact alike with the systems that are at present commercially available 
and clinically used.
Interpretation of the signal 
Most studies only state whether a certain anatomical structure is visible or not, without 
quantification of the fluorescence intensity. There is no generally applied analytic measure 
to objectify the fluorescence intensity yet. When the fluorescence intensity is measured in 
literature, several methods based on the color-intensity are used. In most of these methods, 
only the fluorescence intensity of the target is measured.
Schols et al.43, 46 uses in both articles measurement of the Target to Background Ratio 
(TBR) to objectify the degree of fluorescence illumination. For this, OsiriX 5.5.1 Imaging 
Software was used. The TBR was defined as the mean fluorescence intensity (FI) of two-
point regions of interest (ROIs) in the target (i.e. CBD, CD, or CA) minus the mean FI of two 
background ROIs in the liver hilum, divided by the mean FI of the two Background ROIs in 
the liver hilum; The used formula was as follows: TBR = (FI of target−FI of background)/FI of 
background.
Ashitate et al.57 apply the same formula, but do not mention which software was used. 
Also, the exposed rectus muscle was used as background57. Objectively this is correct, as any 
consistent background can be chosen, but subjectively, it is more logical to use the liver as 
background, as this is the actual observed background during the operation. 
Kono et al.56 also use a signal to background ratio. In their series, Photoshop CS5 
software (Adobe Systems, San Jose, CA) was used to calculate the fluorescence intensity in 
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the regions of interest with a range of 0–255 from still images. The used formula here was as 
follows: Signal contrast= (FI in fluorescence regions−FI in background)/225.
Zarrinpar et al.54 used ImageJ (US National Institutes of Health, Bethesda, MD; http://
image j.nih.gov/ij/) software to calculate intensity ratios. They divided the fluorescence 
intensity signal of the common bile duct by that of the surrounding fat or liver. Verbeek et 
al.55 use the same formula as Zarrinpar, but do not mention which software was used.
DISCUSSION 
The aim of this article is to give an overview of factors influencing the signal intensity during 
fluorescence imaging, primarily focused on NIRF-guided cholangiography with ICG during 
laparoscopic cholecystectomy. These influences can be divided in patient factors, the 
applied fluorescent dye, the equipment and the method of assessing fluorescence intensity.
Regarding patient factors, obesity and inflammation, i.e. cholecystitis, are of importance. 
These may cause thickening of tissue covering the structures to be visualized, thereby 
decreasing signal intensity. Although fluorescence imaging has a better tissue penetration 
than white light, due to its emission in the near-infrared wavelength zone, penetration is 
limited by such factors.
In several studies, patients with cholecystitis were included. In four studies, a comment 
is given about the influence of cholecystitis on the usefulness of the NIRF technique.
Zroback et al.33 appreciated the NIRF technology most while dissecting the most 
inflamed gallbladders. On the contrary, three other authors mention that in patients in whom 
the biliary structures could not be visualized, more often cholecystitis was present than in 
patients in whom imaging was successful13, 39, 42. Liu et al. report a significant difference in 
visibility of the cystic duct with NIRF compared to white light in patients with cholecystitis.53 
This is an indication that NIRF imaging might be more helpful in cholecystitis patients. No 
difference in complications due to NIRF imaging was reported between patients with and 
without cholecystitis.
Obesity may result in more fatty tissue overlying the extrahepatic biliary tree. The average 
BMI in the included studies ranged between 20.4 and 32.3 kg/m2 with an overall average 
of 30.0 kg/m2. Considering this high average BMI and the good results the manuscripts 
describe; a high BMI seems not to be a burden in the use of NIRF cholangiography. Dip et 
al.35 specifically investigated the accuracy of NIRF guided surgery in morbidly obese subjects 
undergoing laparoscopic cholecystectomy and could not find differences in biliary duct 
visualization between the obese and the non-obese groups.35 Some studies confirm this 
absence of influence of BMI on the visualization scores.54, 56 On the contrary, other studies 
claim that BMI has a negative influence on the visibility of the structures using NIRF.34, 40, 42, 44, 
51 It is even suggested that also a more common inflammatory response is present in these 
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patients.42 The practice of using fluorescence cholangiography is that it is applied while 
gradually dissecting the surgical area. Sooner or later during this dissection, NIRF will lead to 
confirmation of the anatomical structures. More fatty tissue requires more dissection and—
most likely—later visualization of structures. The earlier or later recognition may influence 
the surgeon’s satisfaction with the NIRF technique. Another explanation for differences 
between studies may be that the signal of ICG depends on the concentration used.58 It is 
possible that in patients with a higher bodyweight, the concentration of ICG differs when 
using a fixed and not a weight-adjusted dose. This will be discussed hereunder. 
In the performed ex vivo experiments, a maximum penetration depth of 3.6 mm was 
achieved. This confirms the limits of penetration of the NIRF signal. However, bees wax was 
used to measure the penetration depth. Although spectral properties are similar to human 
tissue, it is possible that the penetration depth in human tissue is different. Anyhow, this in 
vitro method at least offers an objective and simple tool to compare the performance of 
different laparoscopes, light sources, and camera systems.
In conclusion, NIRF seems also to be beneficial in circumstances where penetration 
depth is limited due to thickened overlying tissue. In these cases, the image will be obtained 
later, after relatively more dissection has been performed. The surgeon should be aware of 
this, but with this in mind, can use the technique to enhance recognition of the essential 
structures.
Concerning the fluorescent dye used, several factors may be of influence on the signal 
obtained: the type of dye, the dose used and its concentration, the timing and the route of 
administration.
Regarding the type of dye, there are several factors that determine the effectiveness of 
a fluorescent dye. These are probe targeting (a dye for bile duct imaging should be able to 
reach the bile ducts and to some extent accumulate there), activation, pharma kinetics (how 
fast is the dye at the desired place and how long will it stay there?), biocompatibility and 
photo physics.59 The dye should ideally be in the near-infrared range, since this offers the 
spectral range with best light penetration (so-called near-infrared window). Also, the use 
of a near-infrared filter and light source eliminate autofluorescence.60 Wavelengths below 
600 nm encounter this higher auto-fluorescence due to the presence of many endogenous 
fluorophores and strong scattering. Below 600 nm, there is a strong absorbance of 
haemoproteins such as haemoglobin, myoglobin and cytochromes causing less deep tissue 
penetration.59, 61
Indocyanine green is currently the only clinically used dye for fluorescence cholan-
giography, illustrated by the fact that it was used in all 27 studies of this review. In most of 
these studies, ICG was mostly an abbreviation for indocyanine green, but in four studies 
the iodine-free infracyanine green was used. The absence of iodine in infracyanine seems 
to make it less toxic and available for patients with an iodine allergy. We did not perform in 
vitro experiments with infracyanine green, but the absorption and emission spectra of both 
dyes do not differ62, and thus the signal is expected to be equivalent.
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Another previously tested fluorescent dye is Methylene Blue (MB). This has not been 
used in the studies reported. MB and ICG have been compared in an animal study using 
pigs in which both dyes were directly injected into the gallbladder through a 10 Fr catheter 
that was inserted into the gallbladder fundus.63 Using this method, ICG had a higher target 
to background signal, due to a higher extinction coefficient and higher fluorescence rate. 
An advantage of MB is limited liver uptake resulting in less background signal. The signal 
becomes visible within minutes and remains adequate for 120 min.63 A disadvantage of MB 
is the absorption and emission around 700 nm which is subject to a higher background 
auto-fluorescence63 but also requires different settings of the equipment. Another drawback 
is the need for intra-gallbladder administration of the dye, since methylene blue is cleared 
by the kidneys, not the liver.64 Ashitate et al.57 combined two dyes in an animal study. Herein, 
they compared three different combinations; first methylene blue for visualization of the 
cystic artery and indocyanine green for visualization of the bile duct; secondly ICG for the 
artery and Methylene blue for the bile duct; thirdly ZW-800-1 for the artery and methylene 
blue for the bile duct. The authors’ conclusion is that the third combination had the best 
overall performance, and the second combination was the best combination of clinically 
available dyes.57
Apart from the above mentioned ZW-800, other new preclinical dyes such as VM678, 
IRDye®800CW, IRDye®800BK and IRDye®800NOS have been tested in animals and show very 
promising results.24, 65 These are due to better pharmacokinetic characteristics and target-
to-background ratio of these dyes.24, 66 The IRDyes have the same spectral characteristics as 
ICG, which enables the use of the same equipment. IRDye®800CW is expensive, with a price 
tenfold that of ICG; IRDye®800BK and IRDye®800NOS however cost the same as ICG.65 But 
these dyes are not yet FDA approved.
In conclusion, ICG is currently the most used and preferred dye. Only limited data are 
available on MB and it is not used in clinical practice for cholangiography, probably based on 
the characteristics described above. New preclinical dyes are promising but await approval 
for clinical practice.
The dose used may also be of influence on the performance of the dye. In the studies 
presented, a bolus was given (2.5 mg in 13 studies, 12.5 mg and 3.75 mg in two others); or a 
weight-adjusted dose (0.05 mg/kg in seven studies and 0.04 mg/kg in three other studies). 
Zarrinpar et al.54 undertook a prospective study with systematic variation of dosing and 
timing from injection of ICG to visualization. In 37 patients, doses were given varying between 
0.02 and 0.25 mg/kg. Their conclusion was that with increasing dose, the visualization of the 
extrahepatic biliary tract improved. Visualization was also better with increased time after 
ICG administration (10 min vs. 45 min vs. 3h). Boogerd et al.30 compared a dose of 5 and 10 
mg and advise to use the lower dose of 5 mg.
Our ex vivo experiments suggest that the 2.5 mg bolus that is used in most studies, 
is probably below the optimal clinical dose. One should however take into account that 
these ex vivo experiments are a controlled setting, which is not entirely comparable to the 
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complex in vivo biological system in which we use the NIRF cholangiography. Therefore, a 
recommendation regarding the optimal dose cannot be given based on these experiments. 
Nevertheless, the conclusion can be drawn that applying a weight-adjusted dose seems 
preferable over a fixed dose.
The used concentration of the administered ICG solution was not clearly described in 
every study. The studies that describe the used concentration all use 2.5 mg/ml.19, 33, 34, 40, 46, 
49–52 This is remarkable since the leaflet that comes with ICG advises to dilute the ICG to a 
solution of 5 mg/ml. However, a concentration of 2.5 mg/ml is more feasible in daily practice 
since 1 ml can be retrieved more precise than just 0.5 ml.
Hiratoglou et al.62 investigated the influence of the concentration and solvent medium 
on the light-absorbing prosperities in ICG. When glucose 5% was used as a solvent medium, 
the absorption between 600 and 700 nm was decreased, compared with the absorption 
with Balanced Salt Solution (BSS) or BSS Plus. These differences between BSS/BSS Plus- and 
glucose 5%-diluted ICG decreased when the concentration was lowered. They conclude 
that depending on the used solvent medium, the absorption spectrum of ICG changes with 
different concentrations.62 Based on these findings, it might be advisable to use sterile water 
as a solvent medium, as most groups currently do, and not a glucose solution. 
Kono et al.56 found a lower fluorescence intensity when using a more diluted solution of 
ICG. Our ex vivo experiments show an optimum of ICG concentration. This optimum seems 
to be at a higher concentration than is currently achieved in the clinical situation.
However, this conclusion is an extrapolation of the experimental data to the clinical 
situation for the concentration of ICG in the blood. The extrapolation may not be correct 
and is also not directly translatable to the concentration in the bile ducts. And one must 
be aware that not so much the concentration of the solution applied, but the total dose 
administered determines the systemic concentration of the dye.
The timing of administration ranged mostly between 2 hours and 15 minutes before 
surgery. Verbeek et al.55 investigated whether a longer time between the administration 
of ICG resulted in an improved visibility of the biliary anatomy. The authors found that 
administration 24h prior to surgery results in a significantly better signal to background 
ratio.55 This is mainly caused by a lesser fluorescent signal coming from the liver. A problem 
with this approach is the practical applicability: in day care admissions and in acute 
cholecystitis an injection 24h before surgery often is not feasible. Also, since only 30 min 
versus 24h before surgery were tested, the optimum may lie between these timeslots. 
Kono et al.56 and Boogerd et al.30 also conclude that earlier administration results in better 
visualization. In conclusion, administration closer to the time of surgery can result in a more 
prominent background signal from the liver. Therefore, administration as early as possible 
(but not earlier than 24h) should be considered.
In all studies, except for the study by Graves et al.30 and Liu et al.53, the fluorescent 
dye was administered intravenously. This is easy and convenient for the patient, since 
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intravenous access is needed anyway for induction of anesthesia. However, systemic 
injection results in the disadvantage of occurrence of (background) fluorescence of the 
liver, which considerably decreases the signal to background ratio. Another limitation of 
this administration route is the dependency on the refilling of the gallbladder and cystic 
duct with fluorescent bile by reflux, which is unpredictable.38 A solution might be direct 
injection of ICG into the gallbladder. Lui et al.67 previously examined the feasibility of this 
technique in pigs. They conclude that fluorescence cholangiography through direct intra-
gallbladder injection can rapidly provide an adequate visualization of the gallbladder neck 
and cystic duct. The problems with a high background signal from the liver and the needed 
time for the ICG to be extracted from the blood and secreted into the biliary system are 
solved by this administration route. This is in line with their newer study in humans53 and the 
study by Graves et al.10, who injected the Indocyanine green in eight patients and achieved 
comparable encouraging results as described in the animal study. However, spill of ICG 
at the puncture site of the gallbladder may decrease overall visibility of the structures to 
be visualized. This is illustrated by the remark of Osayi40 that in three of the patients the 
visualization was impaired due to bile leakage from the gallbladder, albeit that this was not 
caused by puncture, but by surgical trauma.
With regard to the imaging system, the distance and the angle between the endoscope 
and the target, and the properties of the system, have influence on the signal.
The distance between the fluorescent dye and the laparoscope seems to be of influence 
on the fluorescence intensity. Kono et al56 describe a decrease by 50% of the signal when 
the distance between the laparoscope and the target increased from 5 to 15 cm. Other 
manuscripts do not describe the distance between the bile ducts and the laparoscope. In 
our experiments, a clear relation was found between the distance of the laparoscope to the 
target and the measured fluorescence intensity (Figure 3). In practice, the distance at which 
the endoscope is held, is primarily dictated by the optimal overview for surgical dissection. 
Ideally, the properties of the dye and the system enable the surgeon to maintain the same 
distance for dissection and for NIRF imaging. However, the surgeon must be aware that for 
optimal fluorescence signal temporarily adjusting of the distance may be necessary.
Kono et al56 point out that the tip of the laparoscope should be held vertically to Calot’s 
triangle to directly irradiate exciting light on the bile ducts to efficiently obtain fluorescence 
signals. However, as with the distance of the laparoscope, other manuscripts do not mention 
whether the laparoscope was held vertically or in another angle. Some of the articles use a 
zero-degree laparoscope, while others use a 30-degree laparoscope, which is also a factor 
that should be kept in mind when aiming for the optimal angle.
In the ex vivo experiments, a better signal was seen when the laparoscope’s central 
viewing axis was aligned perpendicular to the target (i.e. an angle between the tip of the 
laparoscope and the fluid level in het Well’s plate of 90 degrees). Because a 30-degree 
laparoscope was used, this needed to be held at 120 degrees to obtain the highest 
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fluorescence intensity. This confirms the clinical findings of Kono et al.56 As with the distance, 
the position of the endoscope is mainly aimed at facilitating dissection. At moments of 
attention to the NIRF signal, focus should also be on the 90-degree angle to the target.
Five different systems were used in the included studies. As discussed before, the tissue 
depth to which NIRF imaging can detect agents is dependent upon their brightness and 
the sensitivity of the device.68 The main components of a fluorescent imaging device are a 
spectrally adjusted light source for exciting ICG; optical filters for separation of the emitted 
fluorescent light and the background scattering and ambient light; camera(s) for detecting 
the emitted fluorescent signals; display software and display hardware.69 The performance 
of a device is mainly determined by these components.68
The most used light source type in the included studies is a xenon light for laparoscopy, 
and a laser diode in the robotic cases. Laser diodes enable the greatest sensitivity since 
the background due to background excitation light is the lowest. A xenon light source has 
a very broad bandwidth and has therefore a lower sensitivity.68 The detection sensitivity 
in all fluorescent imaging systems is limited by the background signals. There is a spectral 
overlap between the backscattered excitation light and emitted fluorescence signals. In 
this way, non-fluorescent signals can be seen as fluorescence. Another problem is a limited 
optical density that allows passage of a small amount of ambient light, also called filter 
light leakage. This causes a ‘noise floor’, which makes it less probable that a device can 
detect small amounts of the fluorescent dye in tissues.68, 70 A sufficient level of noise floor 
is needed to identify tissues of the surrounding, but when the noise floor is close to the 
fluorescent signal, the sensitivity of the imaging device and depth penetration of the signal 
will be reduced. A way to solve the issue of balancing between visualizing the surroundings 
and signal sensitivity is to superimpose images in real time by using separate cameras for 
reflectance and fluorescence.69, 71
Kono et al.56 performed the only comparative study to date with five laparoscopy 
systems for NIRF during cholecystectomy: Hamamatsu Photonics, Hamamatsu, Japan and 
Shinko Optical, Tokyo, Japan; Olympus Medical Systems, Tokyo, Japan; a high-definition 
unnamed model Japanese system; Karl Storz, Tuttlingen, Germany; Novadaq, Toronto, 
Canada. According to this study, the signal contrast was significantly different among the 
laparoscopic systems used for fluorescence imaging. In the meantime, since this study, 
systems and their properties have changed. The surgeon should be aware that differences 
exist which may influence the choice for a system.
Finally, it is important to evaluate the way the fluorescence intensity is assessed. Most 
studies only state whether a certain anatomical structure is visible or not, without quantitative 
measurement of the fluorescence intensity. There is no uniformly agreed analytic measure 
to objectify the fluorescence intensity. In most methods, only the fluorescence intensity of 
the target is measured, and not the fluorescence of the background.
The target-to-background ratio (TBR) is determined used by some authors (Schols et al.43, 46, 
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Ashitate et al.57, Kono et al56, Zarrinpar45, Verbeek48). Unfortunately, formulas that are used 
to calculate the ratio, the backgrounds chosen, and the software used for measurement of 
the signal are not uniformly. In practice, the absolute signal and the subjective observation 
by the surgeon is what determines the clinical usefulness of the NIRF image. But for 
research purposes and comparison between studies an objective, uniform and validated 
quantification is necessary, which, as illustrated by the differences described, is not available 
yet.
Our in vitro setup offers a simple and very cheap method for objective comparison 
between different system, but it would be recommendable that this topic is further refined 
and preferably standardized (e.g. by IEC). 
The present review has some limitations. The majority of the studies are non-
comparative. Especially to fulfil the purpose of the review, i.e. identify factors that influence 
the fluorescent image, such comparison would have been preferable. To partially address 
this drawback, ex vivo experiments were added to the review. In vivo studies would have 
been preferable, including the effect of human or animal tissue and circumstances on the 
acting of the fluorescent dye.
In conclusion, this study identified and discussed several factors that influence the 
signal of fluorescence cholangiography. Some are patient-specific and cannot be altered, 
such as BMI and cholecystitis. Even with a higher BMI and the presence of inflammation, 
NIRF is often successful. Other factors can be controlled by the surgeon. To maximize the 
fluorescence intensity during laparoscopic cholecystectomies, a weight-adjusted dose 
seems preferable over a fixed dose, especially in overweight patients; administration of 
this dose should take place as long as possible (max 24 h) before surgery; the laparoscope 
should be held at a right angle and close to the target tissue. Surgeons should be aware of 
new dyes that may come to the market and of differences in the properties of systems used, 
in order to benefit most of the potential of NIRF imaging. Further research should focus 
on the possibility of intra-gallbladder injection of ICG, other fluorescent dyes with a higher 
fluorescence intensity and faster clearance from the liver and the validation of a method to 
objectify the degree of fluorescence illumination in order to enable comparison between 
studies.
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CHAPTER 44
Near infrared fluorescence 
laparoscopy of the cystic duct and 
cystic artery: first experience with 
two new preclinical dyes in a pig 
model
Jacqueline van den Bos, Mahdi Al-Taher, Shu Gi Hsien, Nicole D. Bouvy, 
Laurents P.S. Stassen. 
Surgical Endoscopy 2017;31(10):4309-14
NIRF imaging of cystic duct and 
cystic artery using two preclinical 
dyes
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ABSTRACT 
Background
Imaging techniques that enhance visualisation of the anatomy may help prevent bile duct 
injury. Near-Infrared Fluorescence Imaging is such a technique. Previous experiments with 
ICG have shown that illumination of the extra-hepatic bile ducts is feasible. Yet, there is 
room for improvement in the visualisation of the target as compared to the background. 
Experiments with IRDye® 800CW show promising results. However, this dye is too expensive 
for routine clinical use. The aim of this study is to test the first applicability of two newly 
developed preclinical dyes regarding intraoperative imaging of the cystic duct and cystic 
artery, compared with IRDye® 800CW.
Methods 
Laparoscopic cholecystectomy was performed in three pigs, using a laparoscopic 
fluorescence imaging system. Each pig received 6 mg of one of the fluorescent dyes 
(1 mg/mL; IRDye® 800CW, IRDye® 800BK or IRDye® 800NOS) by intravenous injection. 
Intraoperative recognition of the biliary system and cystic artery was registered at set time 
points. All procedures were digitally recorded, and the target to background ratio (TBR) was 
determined to assess the fluorescence signal.
Results 
With all three fluorescent dyes, the cystic artery was directly visualized. For the visualization 
of the cystic duct, 15, 34 and 30 min were needed using IRDye® 800BK, IRDye® 800NOS 
and IRDye® 800CW, respectively. The maximum TBR of the cystic duct was the highest with 
IRDye® 800NOS (4.20) after 36 min, compared to 2.45 for IRDye® 800BK and 2.15 for IRDye® 
800CW, both after 45 min. There were no adverse events.
Conclusion 
IRDye® 800BK and IRDye® 800NOS seem to be good alternatives for IRDye® 800CW for the 
visualization of the cystic duct and cystic artery in pigs.
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INTRODUCTION 
Laparoscopic cholecystectomy is standard care for symptomatic gallbladder stones or 
acute cholecystitis and is one of the most commonly performed surgical procedures in the 
Western hemisphere. The reported incidence of bile duct injuries in laparoscopic surgery is 
0.4–1.4%.1, 2 Such injuries are associated with increased morbidity, reduced survival, impaired 
quality of life and have economic consequences for society.2, 3 Anatomical variations of the 
biliary ducts or vascular system are not uncommon and represent operative challenges 
and looming sources for operative complications.3, 4 Therefore, enhanced intraoperative 
visualization of the biliary anatomy is needed to reduce the incidence of bile duct injuries.
Near-infrared fluorescence (NIRF) imaging is a promising technique for real-time delineation 
of the perioperative anatomy. Among other applications, it is used for visualization of 
the extra-hepatic bile ducts and the cystic artery in laparoscopic cholecystectomy, and 
visualization of the ureter in colorectal, urological and gynecological surgery.5–7 In the 
clinical setting, ICG is the dye used for bile duct imaging, with reasonable visualization results 
that makes clinical use possible. Both the extra-hepatic bile ducts and the cystic artery can 
be identified.8 Subjectively however, imaging of the target is not optimal in all patients. 
Better contrast between target and background is expected to increase the usefulness of 
the technique. Adaptation in the equipment and its characteristics is one way to address 
this issue. Alteration in the dye or its use is another. One such alteration is the suggestion 
to inject the dye a day before surgery.9 However, due to usually performed same-day 
admission, this is undesirable from a logistic standpoint. Applying another fluorescent dye 
is a further possibility.
IRDye® 800CW (LICOR Biotechnology, Lincoln, United States) is an experimental dye, 
which in combination with laparoscopic imaging allows intraoperative visualization of 
crucial anatomical structures. In a previous animal experiment, performed by our group, 
this dye was compared to ICG for imaging of the extra-hepatic bile ducts and the cystic 
artery in the pig. The main results were an earlier visualization of the cystic duct, when 
using IRDye® CW-800 and a higher target-to-background ratio for the cystic artery.10 This is 
in line with two other studies and makes this new dye promising for future clinical use.10–12 
However, a major disadvantage of IRDye® CW-800 is its cost, which is almost tenfold that of 
ICG. Therefore, more affordable alternatives are needed.
Recently, the manufacturer of IRDye® 800CW developed two new preclinical dyes, 
IRDye® 800BK and IRDye® 800NOS, that can be produced at a cost that is comparable to 
commercially available ICG. In general, the three dyes have similar properties. Emission 
and absorption are at about the same wavelength as for ICG. The dyes differ in hydrophilic 
properties, with IRDye® 800NOS being the least hydrophilic. This influences their excretion 
and their uptake in the liver and may make them more potent with regard to their imaging 
capabilities of the cystic duct.
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The aim of the present study was to evaluate the performance of these dyes as compared to 
IRDye® 800CW for NIRF laparoscopy of the extra-hepatic bile ducts and the cystic artery in 
pigs using a commercially available laparoscopic fluorescence imaging system.
MATERIALS AND METHODS
This study was conducted at the central animal facilities of Maastricht University (Maastricht, 
The Netherlands). Animals were used in compliance with the regulations of the Dutch 
legislation for animal research and following a protocol that was approved by the local 
animal ethics committee. A pig model was chosen because of its similarity with human 
hepatobiliary anatomy and because previously successful experiments have been conducted 
with NIRF imaging in pigs.10 Three female Dutch landrace pigs, weighing 40 kg, were used 
for the current study. After surgery, the pigs were sacrificed by the anesthesiologist.
Laparoscopic fluorescence imaging system 
A commercially available laparoscopic fluorescence imaging system (Karl Storz GmbH & CO. 
KG, Tuttlingen, Germany) was used. The NIR light source D-Light P is a xenon-based system 
providing illumination light for fluorescence applications in the near-infrared wavelength 
range. It enables the excitation of all presented dyes: IRDye 800CW ( EX/EM = 775/796 nm), 
IRDye 800BK ( EX/EM = 774/790 nm) and IRDye 800NOS ( EX/EM = 767/786 nm). A foot pedal 
allows the surgeon to easily switch between the two imaging modalities. All procedures 
were digitally recorded. For all three dyes, the same NIRF imaging settings were used.
Characteristics and preparation of near-infrared dyes
IRDye® 800CW is a tetrasulphonated heptamethine indocyanine dye. Intravenous injection 
is rapidly cleared by the liver and excreted into bile. It is also cleared by the kidneys and 
excreted into urine. The peak absorption of this dye is 775 nm and peak excitation emission 
at 796 nm. The molecular weight is 1090.11 Da.13,14
IRDye® 800BK (LICOR Biotechnology, Lincoln, United States) is a newly developed dye, 
primarily developed for intraoperative visualization of the ureters. This hydrophilic dye 
has a maximum absorption of 774 nm and a maximum emission of 790 nm. Because of 
its hydrophilic nature, it is primarily cleared by the kidneys. Nevertheless, being similar in 
structure as IRDye® 800CW, some additional clearance by the liver can be expected.
IRDye® 800NOS (LICOR Biotechnology, Lincoln, United States) is also a newly developed 
dye, less hydrophilic, mainly developed for intraoperative visualization of the biliary system. 
This dye is primarily cleared by the liver and has a maximum absorption of 767 nm and a 
maximum emission of 786 nm.
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All three dyes were prepared following instructions of the manufacturer. They were 
diluted in a sterile phosphate buffered saline (PBS) solution to a concentration of 1 milligram 
per milliliter. Six milligrams of each dye in this dilution was prepared for intravenous injection.
Surgical technique 
Premedication consisted of intramuscular injection of azaperone 3mg/kg, ketamine 10mg/
kg and atropine 0.05mg/kg. Anesthesia was induced with intravenous thiopental 10-15mg/
kg. After intubation, the pigs were maintained under anesthesia with isoflurane and oxygen. 
Two expert endoscopic gastrointestinal surgeons (NB and LS) performed the operations 
and were assisted by residents experienced in the procedure. In each pig, a laparoscopic 
cholecystectomy was performed, according to the Dutch Guidelines and best practice 
for laparoscopic cholecystectomy applying the Critical View of Safety technique.15,16 One 
dye was tested per animal using a 6mg dose (1mg/mL). This was twice the dose proven 
sufficient in an earlier study.10 The dose was chosen to obtain maximal visualization since 
our hypothesis was that a higher dose of the dye would result in better biliary imaging. 
Fluorescence imaging was initiated immediately after dye injection and subsequently 
imaging was performed intermittently in fluorescence mode and white light mode. Intra-
operatively, the researcher systematically documented on a form whether the cystic duct 
or cystic artery could be identified, in either of the imaging modes. For agreement on the 
identification on the aforementioned structures, the attending surgeon was consulted. A 
structure was scored as ‘identified’ if its localization was confirmed with great certainty by 
the experienced surgeon.
Postoperative quantitative fluorescence analysis
The video recordings of the procedures were assessed for the degree of fluorescence 
illumination using OSIRIX v7.0.1 Imaging software (Pixmeo, Geneva, Switzerland). With this 
software, the Target-to-Background Ratio (TBR) could be determined. The TBR was defined 
as the mean fluorescence intensity (FI in arbitrary units, A.U.) of three points of interest in the 
target (cystic artery or cystic duct), minus the mean fluorescence intensity of three points of 
interest in the background (liver hilum), divided by the mean fluorescence intensity of three 
points of interest in the background. In formula: TBR = (FI of target – FI of background)/ (FI 
background).8, 10 Areas with light scattering were avoided in these points of interest.
RESULTS 
In all experiments, the identification of the cystic duct and cystic artery with NIRF imaging 
was successfully conducted. Results obtained during the operation are presented in the 
intraoperative registration form in Table 1.
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In the first pig (IRDye® 800BK), direct clear visualization of the cystic artery was present 
after injecting the fluorescent dye. Already after 15 min, the cystic duct showed NIRF signal. 
The second pig (IRDye® 800NOS) showed immediate visualization of the cystic artery 
after injection of the dye. However, due to a technical problem early in the procedure, this 
visualization was not recorded, and therefore no TBR could be obtained from this fluorescent 
cystic artery. After 34 min, the cystic duct was clearly visible. However, manipulation of the 
gallbladder proved to be of influence on the visualization of the cystic duct. Too much 
stretching of the fragile duct prohibited influx of fluorescent dye. This was corrected at 34 
min. As in the first two pigs, the cystic artery was also clearly visible in the third pig receiving 
IRDye® 800CW dye. After 30 min, the cystic duct could be identified in the fluorescence 
mode. In all three pigs, apart from the cystic duct and cystic artery, other structures became 
visible. The bicornate uterus was subjectively the most fluorescent in the abdomen of all 
three pigs. Also, the ureters, small bowel and lymph nodes were visible in fluorescence 
mode in all three pigs.
Target-to-background ratio
Postoperatively, the video recordings were analyzed by measuring the Target-to-Background 
Ratio (TBR). The TBR’s of cystic artery for IRDye® 800BK and IRDye® 800CW were 6.78 and 
7.54, respectively. The TBR of the cystic artery for IRDye® 800NOS could not be measured 
because of a technical problem regarding the video recording procedures early in the 
operation. The maximum measured TBRs from the three dyes for the cystic duct were 2.45 
(at 45 min), 4.20 (at 35 min) and 2.15 (at 45 min) for IRDye® 800BK, IRDye® 800NOS and IRDye® 
800CW, respectively. Images 1–3 show the cystic ducts during these maximum measured 
TBRs. All images were made in the same fluorescence settings of the Image1 SPIES system. 
However, as can be seen in the images, with the IRDye® 800NOS, the laparoscope was at 
further distance from the cystic duct. The images with the maximum TBR for each dye are 
shown in Fig. 1, 2 and 3.
Safety
In none of the pigs complications or adverse reactions were registered during surgery 
that could be attributed to one of the dyes. In particular, no alteration in heart rate and 
Table 1 Intraoperative registration form 
Experiment
Injected dye 
(6mg)
Visualization of 
cystic artery?
Visualisation of 
cystic duct?
Time to 
identification 
cystic duct
1 IRDye® 800BK Yes Yes 15 minutes
2 IRDye® 800NOS Yes Yes 34 minutes
3 IRDye® 800CW Yes Yes 30 minutes
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blood pressure of respiratory status was observed. Only a slightly and transient decrease 
in intraoperative monitoring of the Saturation of peripheral Oxygen (SpO2) was observed 
during the first minute after injection of the fluorescent dyes.
DISCUSSION
In the present study, the use of two new preclinical dyes for NIRF imaging of the extrahepatic 
bile ducts with a commercially available laparoscopic imaging system was investigated. The 
new dyes resemble the structure and spectral characteristics of the previously favorably 
tested IRDye® 800CW but are much less costly, now being in the range of commercially 
available ICG. Both features are essential for possible future clinical application. The aim of 
Figure 1 Visualization of the cystic duct, 45 min 
(time point of maximal signal) after injecting 6 mg of 
IRDye® 800BK (1 mg/mL).
Figure 2 Visualization of the cystic duct (pointed 
by arrow), and the base of the gallbladder 35 min 
(time point of maximal signal) after injecting 6 mg of 
IRDye® 800NOS (1 mg/mL)
Figure 3 Visualization of the cystic duct (pointed by 
arrow) and common bile duct, 45 min (time point 
of maximal signal) after injecting 6 mg of IRDye® 
800CW (1 mg/mL).
Note: the little white spots are caused by scattering, and do 
not represent the fluorescent signal
Chapter 4 | NIRF imaging of cystic duct and cystic artery using two preclinical dyes
76
the experiments was to perform a first assessment of the NIRF properties of the new dyes 
and compare these to the performance of IRDye® 800CW. Eventually, these dyes could be 
an alternative to ICG, the only dye presently available for human use in NIRF imaging of 
the biliary system. This would be desirable, as with ICG, although NIRF visualization of the 
bile ducts can be achieved, the observed contrast of target-to-background leaves room for 
improvement.
Other advantages are a shorter period between injection of the dye and visualization 
of the target structures and the fact that these new dyes contain no iodine, whereas some 
of the commercially available ICG preparations do.17 These new dyes are therefore also 
applicable in patients that are known with an iodine allergy or hypersensitivity. A final 
benefit could be that these dyes are not only exclusively cleared by the liver, but also by the 
kidneys, a fact that is known from IRDye® 800CW. This may make these dyes appropriate for 
ureter imaging.
All three dyes showed clear visualization of the cystic artery directly after intravenous 
injection. Between 15 and 35 minutes, with all three dyes, clear visualization of the cystic 
duct was achieved. Both IRDye® 800BK and IRDye® 800NOS caused a more prominent 
fluorescent signal than the earlier tested IRDye® 800CW. The TBR of 2.15 found for IRDye® 
800CW in this study is comparable with that in an earlier study, where the TBR was 2.3.10 The 
signal from IRDye® 800NOS was stronger than that from IRDye®800BK. This was expected, 
as IRDye® 800NOS is less hydrophilic and supposed to be excreted through the bile more 
exclusively than IRDye® 800BK. In a previous study, the TBR’s of ICG and IRDye® CW800 were 
comparable.10 The present results suggest that the IRDye® 800NOS might be more potent 
for bile duct imaging. This corresponds to the subjective impression of the surgeons. Of 
course, these data have to be interpreted with caution and need confirmation. A possible 
limitation in the measurement of the TBR in this study is the not uniformly defined distance 
between laparoscope and cystic duct at varying time points. As shown in Images 1–3, this 
distance is greater in the pig with IRDye® 800NOS. A larger distance between the region of 
interest and the laparoscope may lead to a lower fluorescence intensity.18 However, the TBR 
for IRDye® 800NOS was the highest of all found TBRs.
There were no adverse reactions as a result of the administration of the dye. A very early 
and transient decrease in oxygen saturation was measured; this is a common phenomenon 
with the use of intravenous fluorescent dyes.19–21 The transient changing of the color of the 
blood results in the oxygen measurements becoming falsely lower than the real value.
During the experiment, it was observed that the three dyes were all cleared by both 
the liver (and excreted into bile) and the kidneys (and excreted into urine). Therefore, all 
three dyes might be eligible for both imaging of the biliary anatomy and of the ureters, 
although, as previously mentioned, IRDye® 800NOS is more exclusively excreted in bile and 
IRDye® 800BK more in urine. This was confirmed by the higher TBR in the bile duct for IRDye® 
800NOS in this experiment. The exact behavior of these dyes needs further study for both 
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biliary and urinary imaging. Because of the uncertainty on the amount of the dyes that is 
lost in urine, the given dose was set twice as high as in a previous experiment with successful 
bile duct imaging with IRDye® 800CW.10 The TBR of IRDye® 800CW in the present study was 
comparable to the previous observation which might indicate that the double dose is of 
no influence when using IRDye® 800CW. In the present study, IRDye® 800CW took longer 
to become visible than reported in the study by Schols et al. 2014, where the cystic duct 
was distinguishable after 11 min.10 Tanaka et al. 2014 measured fluorescence in the cystic 
duct after around 20 min, which is comparable to the current results.11 The different doses 
used may have had an influence on the time until the appearance of fluorescence. Neither 
can it be ruled out that another dose than the one chosen gives superior imaging. Further 
experiments are needed to determine optimal dosing and timing that are influenced by the 
pharmacokinetic properties of the dyes.
This study has two other limitations. First, because of the limited series of experiments, 
the results have to be interpreted with caution. Since only three pigs were used, each dye 
was tested only in one pig. This resulted in the fact that the failure to start video recordings 
early in the second pig, in which IRDye® 800NOS was tested, could not be corrected in a 
subsequent experiment. Measurement of the visualization of the cystic artery with TBR was 
therefore not possible in this pig. Another limitation is the fact that we observed influence 
of the manipulation with the gallbladder and cystic duct on flow of the fluorescent dye 
in the bile through the cystic duct in the second pig. It cannot be ruled out that earlier 
imaging could have been obtained with adaptation of manipulation. This may have 
influenced the bile flow and the detailed time measurements in the other pigs. A drawback 
of the procedures was the necessity to switch intermittently between NIRF- and white light 
imaging of the biliary system. This is inherent to the equipment used. Although likely that 
simultaneous white- and fluorescent light imaging is more practical, the surgeons did not 
experience this as hindering, and measurements could be performed at a sufficient number 
of time points to perform relevant observations.
This study focusses fully on the evaluation of new dyes to optimize NIRF imaging. 
Another way to improve NIRF imaging is adaptation of the equipment and its properties. 
Such approach is also very important, but outside the scope of the present experiments.
CONCLUSION
The present study shows promising results on two new and affordable dyes for NIRF 
imaging: IRDye® 800BK and IRDye® 800NOS with respect to near-infrared fluorescence 
imaging of the cystic duct and cystic artery. At this moment, these dyes are not yet FDA 
approved, which also still is the case for IRDye® 800CW, and are therefore not applicable for 
human clinical practice yet. The new dyes seem to be good alternatives for IRDye® 800CW 
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in the visualization of the cystic duct and cystic artery in pigs. In order to be an alternative 
for the only dye that is at present available for human use, ICG, further studies and FDA 
approval are needed.
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ABSTRACT 
Aim 
To investigate whether different calculation methods to express fluorescence intensity (FI) 
as target-to background ratio are comparable and which method(s) match with human 
perception. 
Methods 
Comparison of three calculation methods from current literature (OsiriX, ImageJ and 
Photoshop) to objectify FI intensity during laparoscopic cholecystectomy measured at 
the exact same locations within recorded images of two categories: ex-vivo and in-vivo. 
Currently applied formulas to present FI in relation to the background (BG) signal are 
compared with the subjective assessment by the human observers. These three formulas 
are ‘Signal contrast = (FI in fluorescence regions - FI in BG) / 255’; ‘Target-to-background ratio 
= (FI of target - FI of BG) / FI of BG’; ‘Signal-to-background ratio = FI of Cystic duct / FI of liver’ 
and ‘Target-to-background ratio = (FI of Target - Noise) / (FI of BG - Noise)’. 
Results
In our evaluation OsiriX and ImageJ provided similar results, while OsiriX values were 
structurally slightly lower compared to ImageJ. Values obtained via Photoshop were 
less evidently related to those obtained with OsiriX and ImageJ. The formula Target-to-
background ratio = (FI of Target - Noise) / (FI of BG - Noise) was less corresponding with human 
perception compared to the other used formulas. 
Conclusions
Fluorescent intensity results based on measurements using the programs OsiriX and ImageJ 
are similar, allowing for comparison of results between these programs. Results using 
Photoshop differ significantly, making direct comparison impossible. This is an important 
finding when interpreting study results. We propose to report both target and background 
FI in manuscripts, so that proper interpretation between articles can be made. 
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INTRODUCTION 
Intraoperative near infrared fluorescence (NIRF) imaging is gaining both more applications 
and more users. The current main applications for the use of NIRF imaging with indocyanine 
green (ICG) in gastrointestinal surgery are: visualization of the cystic duct during laparoscopic 
cholecystectomy, perfusion assessment of gastrointestinal anastomoses and lymph node 
identification (1-5). The growing popularity of NIRF applications is accompanied by an 
increasing number of (pre)clinical studies published on this topic. In these studies, different 
applications, different fluorescent dyes and different methods for reporting the intensity of 
the signal are used. For objective inter-comparison between studies, a uniform objective 
quantification of the signal is mandatory. For instance, in the application of NIRF angiography, 
the fluorescent signal is reported in several ways, like: ‘adequate/sufficient or inadequate/
insufficient’ (6), ‘good, average or bad’ (7). It is difficult to compare the outcomes of studies 
when only such subjective evaluation is used. Our research group and many others use 
objective assessment of the fluorescence intensity (FI) (8). A review we recently performed 
showed that both different software packages and different formulas are used, still making 
inter-comparison of studies difficult (9). In random order, these software programs are 
OsiriX, ImageJ and Photoshop. Commonly used formulas in current literature are presented 
in Table 1. 
The aim of this technical note is to investigate whether measurements concerning FI 
reported in current literature are comparable and matching with human visual perception. 
A second aim is to evaluate the formulas that are currently used to correct the signal of the 
target with respect to the signal of the background, and to provide an advice on which 
formula to use in future research.
Table 1 Applied formulas as reported in literature and their results 
Reported formulas in literature
Type of image in 
articles
Mean accuracy 
when using grey-
value 
Mean accuracy 
when using blue-
value 
Signal contrast = 
(FI in fluorescence regions - FI in 
BG) / 255
Black and white 10.7 / 18 (range 9-13) 11 / 18 (range 9-14)
Target-to-background ratio = 
(FI of target - FI of BG) / FI of BG
Color (fluorescent 
image in blue) 
10.3 / 18 (range 9-11) 8.8 / 18 (range 6-12)
Signal-to-background ratio = 
FI of Cystic duct / FI of liver
Both black and 
white and color 
(fluorescent image 
in blue or green) 
10.2 /18 (range 9-11) 9.1 / 18 (range 7-12)
Target-to-background ratio = 
(FI of Target - Noise) / (FI of BG - 
Noise)
Black and white 8.5 / 18 (range 7-10) 7.3 / 18 (range 5-10)
FI: Fluorescence intensity; BG: Background
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METHODS 
To explore software packages and formulas used to report FI in laparoscopic cholecystectomy, 
the results of an earlier performed systematic literature search were used (9). 28 articles were 
screened for the use of software packages to measure FI and the applied formulas to quantify 
the intensity of the signal in the cystic duct compared to the background fluorescence. The 
identified software packages were then used in a controlled ex vivo setting to measure the 
FI of ICG in known concentrations with the laparoscope at a fixed distance. Subsequently, 
FI was measured using these programs on screenshots made during NIRF laparoscopic 
cholecystectomies. Finally, with the aforementioned screenshots, the formulas presented in 
literature were evaluated by assessing which formula corresponded best with the subjective 
assessment by the observers. See Figure 1 for an overview of study methods. 
Analysis of NIRF images obtained during ex vivo experiments 
Images from an earlier ex vivo experiment were used (9). In this ex vivo experiment, ICG was 
diluted with 35mg/ml albumin in a 0.9% NaCl solution to known concentrations. For the 
current experiment, images from dilutions of 5mg/ml ICG, 0.5mg/ml and 0.001mg/ml were 
used. For each dilution, 9 times 1ml of the dilution was placed on a wells plate. Images were 
obtained by making screenshots (PNG image) in the videos (mp4) that were made with the 
laparoscopic system (D-Light-P Fluorescence system, Karl Storz, Tuttlingen, Germany). For 
all concentrations, the FI was measured at 5cm and 9, 10, 11, 12, 13 and 14cm distance. The 
FI was measured at three points in the image, by two observers. The points of interest were 
placed on the exact same location; the exact same pixels were included, in the middle of the 
wells-cup, while no light reflections were included in the regions of interest. 
Analysis of NIRF images in laparoscopic cholecystectomy 
We randomly selected four laparoscopic cholecystectomies with NIRF imaging; these 
concern elective procedures performed in the Maastricht University Medical Center 
(Maastricht, the Netherlands). Screenshots were collected from the surgical videos. In these 
screenshots, at least the liver and cystic duct had to be visible in fluorescence light. In all 
screenshots, the FI was measured in three regions of interest (ROIs) in the cystic duct, three 
ROIs in the liver (two on the right of the cystic duct, one left). The regions in the liver were 
used as background reference. Three other regions in the surroundings were measured and 
were assessed as noise. The FI in these ROIs was measured in all programs by two observers 
and both the grey-value and blue-value were measured. Again, care was taken that per 
image, the ROI positions were pixel to pixel aligned on the same locations in all software 
programs. See Figure 2 for an example on the chosen regions of interest in a screenshot. 
Determination of a conversion formula for comparison of data from different programs 
measured FI in the respective programs was compared in order to obtain a conversion 
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formula to enable comparison of obtained FI in the one study with another. Analysis was 
performed in SPSS version 23 (IBM corp. Armonk, NY). First, observations were visualized 
in a scatter plot. A linear regression analysis was performed to assess how results of one 
formula could be converted to another. These analyses were initially performed separately 
for the ex vivo and the in vivo measurements. Then, agreement was quantified using an 
intraclass correlation coefficient and linear regression analysis.
ROI= Region of interest M.D.= Medical doctor.
Figure 1 Overview of Study methods
The ROIs are color-coded as follows: cystic duct in green, liver (Background) in red and noise in orange.
Figure 2 Example of assigned Regions of Interest (ROI) for in-vivo fluorescence intensity measurement 
In-vivo experiments Ex-vivo experiments 
3 Dilutions
7 Distances
-------------------------- +
21 Images in total 
4 laparoscopic 
cholecystectomies 
In total 18 images 
2 observers placed
3 ROIs in the target (Cystic duct) in each image
-------------------------------------------------------------- +
108 ROIs in the target in total 
Visually ranked by 3 
human observers (M.D.) 
18 Images ranked by filling 
in the 4 formula’s 
Formula most accurate 
in ranking compared to 
human perception 
Analysed by two observers
3 ROIs in each image 
---------------------------- + 
126 ROIs in total  
Comparison between ImageJ, Osirix and Photoshop for exact same ROIs 
2 observers placed by using Osirix
3 ROIs in background (liver) in each image 
3 ROIs in the noise (dark surroundings) in 
each image
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Comparison of the objectively measured and calculated fluorescence intensity with 
subjective assessment
The assessed screenshots from the aforementioned NIRF laparoscopic procedures were 
ordered from “very clearly visible fluorescent delineation” of the cystic duct compared to the 
surroundings to “weak fluorescence” of the cystic duct compared to the surroundings based 
on the opinion of three experts. This subjective assessment was compared with the results 
from filling in the formulas identified from literature for both the measured grey values and 
the measured blue-values. The FI and BG intensity used therefore were measured with Osirix. 
A difference in ranking of more than 5 places was considered a mismatch. A ranking score 
within 5 places was scored as an accurate match between subjective order and calculated 
order with the respective formula. The used ROIs were the same for all four formulas as the 
example in Figure 2. The ROIs from both observers were filled in in all formulas. 
RESULTS 
Programs used to objectively measure fluorescence intensity 
In the literature, three software programs were identified for objective quantification of the 
signal, namely OsiriX (Pixmeo, Bernex, Switzerland) (2, 8, 10-12), ImageJ (National Institutes 
of Health, Bethesda, USA) (13-15) and Photoshop CS (Adobe systems, San Jose, USA) (16). 
OsiriX, ImageJ and Photoshop were used in respectively five, three and one of the reviewed 
studies. 
Ex vivo NIRF-images analysis 
Twenty-one images were analyzed for the three ICG concentrations (5mg/ml, 0.5mg/ml 
and 0.001mg/ml) at different distances. Because two observers analyzed three points in 
every image, a total of 126 points were analyzed. As shown in Figure 3, the values obtained 
with ImageJ are very strongly related to the FI measured with OsiriX (Intraclass correlation 
coefficient = 1.0; R2= 0.9999; p <0.001). With the regression analysis, a formula was obtained 
to convert the measured value from ImageJ to a value when OsiriX would have been used: 
Value measured with OsiriX = -0.44 + 0.98(Value measured with ImageJ).
In reverse, the formula value for conversion from OsiriX to ImageJ would be:
Value measured with ImageJ = 0.46 + 1.02(value measured with OsiriX).
When comparing the values obtained with OsiriX with the values obtained with Photoshop, 
also a statistical significant relation between results was found, however with a lower 
interclass correlation coefficient (Interclass correlation coefficient= 0.78; R2 = 0.93; p <0.001). 
As shown in Figure 4, no obvious straight line is formed by the data points obtained with 
Photoshop and OsiriX (in contrast to comparing between OsiriX and ImageJ). Therefore, no 
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straightforward formula to convert between values derived from OsiriX versus Photoshop 
could be obtained using a regression analysis. An approximate conversion formula based on 
a linear regression analysis would be:
OsiriX = 1.26 + 1.88(value measured with Photoshop)
The inverse approximate conversion would be:
Photoshop value = 0.01 + 0.49(value measured with OsiriX)
Note that values obtained with OsiriX are on average roughly two times as high as values 
measured with Photoshop (while using the same FI as input). 
Comparing measured FI values between Photoshop and ImageJ, a similar statistical 
significant relation is found (Interclass correlation = 0.78; R2 = 0.93; p <0.001). This relation is 
shown in Figure 5:
Figure 5 Relation between measured fluorescence 
intensity using Photoshop and ImageJ in ex vivo 
images
Figure 4 Relation between measured fluorescence 
intensity using Photoshop and OsiriX in ex vivo 
images
Figure 3 Relation between measured fluorescence intensity using ImageJ and OsiriX in ex vivo images
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Value obtained with ImageJ = 1.88 + 1.90(value obtained with Photoshop).
With the corresponding inverse approximate conversion:
Value obtained with Photoshop = -0.26 + 0.49 x (Value obtained with ImageJ). 
In vivo NIRF-images analysis (from laparoscopic cholecystectomy) 
Eighteen screenshots in four patients were analyzed. These patients all underwent 
elective laparoscopic cholecystectomy for symptomatic cholecystitis. In these images FI 
was measured on exact the same ROIs with the three software programs, with two sets 
of ROIs chosen independently by two observers. Comparing OsiriX and ImageJ based on 
the measured gray-values in the images, revealed a very strong correlation (Intercorrelation 
coefficient= 1; R2=1; p <0.001) and when data is plotted, a straight line can be drawn between 
the points, as is shown in Figure 6. The conversion formulas from linear regression analysis 
between OsiriX and ImageJ are:
OsiriX = -0.69 + 1.00(value obtained with ImageJ), and
ImageJ = 0.75 + 1.00(value obtained with OsiriX)
When measuring the blue-values, a perfect correlation (interclass correlation = 1; R2 = 1.00; p 
<0.001) was found with the following conversion formulas:
Blue-value OsiriX = 0.42 + 1.00(blue-value obtained with ImageJ), and
Blue value Image J = -0.30 + 1.00(blue-value obtained with OsiriX)
In the in vivo experiments, statistically there seems to be a relation between the values 
measured in Photoshop and OsiriX (interclass correlation = 0.76; R2 = 0.63; p <0.001). However, 
as shown in figure 7, no straightforward conversion formula can be identified to compare 
between studies.
This is the same for Photoshop and ImageJ (Interclass correlation = 0.76; R2 = 0.63; p 
<0.0001), see also figure 8. 
For the blue-values outcomes are comparable. Between OsiriX and Photoshop an 
interclass correlation of 0.96 was found (R2= 0.92, P<0.001), between ImageJ and Photoshop 
the interclass correlation was 0.96 (R2= 0.93, P <0.001). 
Reported formulas for assessment of fluorescence intensity:
As mentioned, the FI in the articles is often presented using a formula. The four formulas 
identified are reported in Table 1. 
Using the described method, the formula Signal contrast = (FI in fluorescence regions - FI 
in BG) / 255 seemed to be the most comprehensive with what the experts reported as their 
visual perceptions. However, as shown in table 1, differences are small. 
As the formulas were applied to grey values in colour images with fluorescence in 
blue, we also tested these formulas using the blue-value. From this refinement, also the 
formula Signal contrast = (FI in fluorescence regions - FI in BG) / 255 emerged as showing the 
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strongest match with the subjective order of FI of the ductus. However, the formula Signal-
to-background ratio = FI of Cystic duct / FI of liver was somewhat more accurate than Target-to-
background ratio = (FI of target - FI of BG) / FI of BG. 
Figure 7 Relation between measured fluorescence intensity using Photoshop and OsiriX in in-vivo images
Figure 8 Relation between measured fluorescence intensity using Photoshop and ImageJ
Figure 6 Relation between measured fluorescence intensity using ImageJ and OsiriX in in-vivo images for both 
grey-value and blue-value 
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DISCUSSION
Despite an increasing number of publications in the field of NIRF imaging, no standard yet 
exists for objective assessment of fluorescence images. This problem has recently been 
highlighted by reports from the American Association of Physicists in Medicine (AAPM) (18). 
Different software packages are used to quantify the fluorescent signal, and also different 
formulas are applied to correct for the background fluorescence. The latter is important as 
for human visual perception not only the absolute signal of the target is important, but also 
the contrast in relation to its surroundings. Such a formula actually is an imitation of the 
human visual perception system that naturally uses such contrast for object identification. In 
the present study we focused on two goals. First, to investigate whether different software 
packages used for measuring FI reported in the current literature yield comparable results. 
Secondly to identify the formulas used in literature to calculate a target-to background ratio 
and try to provide an advice on what formula to use in future research for comparison of 
studies.
In our ex-vivo analysis, a very clear relation between values measured with OsiriX and ImageJ 
was detected. The values obtained with OsiriX were approximately 0.5 units lower than 
those obtained with ImageJ. The relation between the values from Photoshop and from the 
other two programs was less evident as illustrated by a lower correlation coefficient. 
From our in vivo images, a slightly different conversion factor between OsiriX and 
ImageJ was observed. This may be due to the fact that images from an operative field are 
less standardized and influenced by subtle differences in scattering and light intensity. A 
possible explanation for the differences in correlation between the results from the different 
programs is a difference in measuring which is probably more likely to occur when using 
Photoshop. It is our experience that it seems more difficult to exactly select the same pixels 
for analysing the ROI. The various applied analysis programs were treated as a black box 
within this study. However, the software that provides results that are matching well with 
human perception seems to be more promising than others.
Apart from differences in used software, different formulas are used to present the FI. It is 
essential to take the signal from the surroundings due to uptake of the dye into account, 
because this influences the contrast as observed by the surgeon (9). When using a formula, 
the influence of the background is taken into account and thereby might provide a number 
more consistent with human perception. Several formulas are used that use target- and 
background signal, but in different dependency. It is difficult to decide on theoretical 
grounds which approach is best. Some points of attention should be kept in mind. Of 
course, the ROI’s should be chosen carefully, reflecting the signal of the subject best. Next, 
when using a formula, the distance between the laparoscope and the background should 
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be about the same as the distance between the target and the laparoscope. An observation, 
for which the present way of measuring doesn’t correct, is the fact that a small darker zone 
is observed surrounding the cystic duct, which influences the observed contrast, but is not 
taken into account when taking the liver as background.
In current literature, four different formulas were found. We tested these formulas against 
the assessment by the human eye. One formula seemed to be most accurate. This was the 
formula used by Kono et al (16), namely Signal contrast = (FI in fluorescence regions - FI in BG) 
/ 255. However, even though this was the best of the four formulas, there was not a 100% 
match between the subjective order and obtained order with this formula and differences 
with the other formulas were small. The only deviating formula was the formula ‘Target-
to-background ratio = (FI of Target - Noise) / (FI of BG - Noise)’ which provided results less 
compatible with human perception. Most likely this is due to the noise which is taken account 
in this formula. The cystic duct is often directly surrounded by a dark signal due to the shape 
of the cystic duct and shows more light reflections compared to the liver. Therefore, this 
cystic duct is sometimes easier recognizable with the naked eye than what is suggested by 
the outcomes of the formulas. Based on these observations it is not possible to advice one 
formula or the other. From our own experience, it is of great importance, independent from 
the formula used, that the ROI for signal analysis, are very carefully chosen. In the digital 
image, as discussed earlier, subtle differences in signal intensity and scattering occur within 
the same ROI, for example the cystic duct. 
Both OsiriX and ImageJ measure the intensity of the signal on a grey scale. However, the 
fluorescence signal is most often presented in color images, especially in blue or green. 
The equipment used in the present study gives a blue image for fluorescence. This is the 
reason why not only the grey values but also the blue values were measured. However, we 
observed comparable outcomes using both methods. These results may be influenced by 
the fact that the used fluorescence system gives a very dark background, hardly without any 
observable color. The background reference values and therefore the results of the formula 
might have been different when had been used that contains a more mixed light source, 
filtering out less of the white light and therefor showing more of the environment.
A limitation of this study is that it no uniformity existed in the equipment used between 
studies nor in the exact application of the technique. There are more relevant factors of 
influence than only the software used (16, 19). The equipment itself, the used laparoscope 
and the software in the laparoscopic system is of influence. Also, the timing of the application 
of the dye yields different results. As is shown in earlier studies, a longer time between ICG 
administration and assessment causes a more fluorescent cystic duct compared to the liver 
than an injection just 30 minutes before assessment (13, 14). And last, probably the most 
important factor is the selection of the ROI’s and the background, which is a subjective 
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action. We advocate minimizing this influence by choosing three points in both target and 
background and use the mean value of these three. However, the risk for selection bias 
remains. 
CONCLUSION 
When comparing fluorescence values obtained from analysis with different programs, this is 
easiest with those from OsiriX and ImageJ. A conversion with a correction factor as indicated 
in this article is possible, enabling the reader to interpret the presented values correctly. The 
relation between these two programs and Photoshop is less clear, hindering comparison 
of results. Furthermore, to overcome the present use of different formulas by different 
authors to further evaluate the signal, we propose to report both ROI and Background FI 
in the manuscript. This enables calculations to be made between articles independently of 
the preferred formula by the authors. Lastly in interpreting results, other influences on the 
FI and the risk for selection bias in chosen regions of interest for evaluation of the signal 
should be taken into account. 
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PART II
NEAR INFRARED FLUORESCENCE 
IMAGING IN COLORECTAL SURGERY
CHAPTER 61
Near-Infrared fluorescence imaging 
for real-time intraoperative guidance 
in anastomotic colorectal surgery: 
a systematic review of literature
Jacqueline van den Bos, Mahdi Al-Taher, Rutger M. Schols, Sander van Kuijk, 
Nicole D. Bouvy, Laurents P.S. Stassen. 
Journal of laparoendoscopic & advanced surgical techniques 2017 28(2):157-167
NIRF imaging in anastomotic 
colorectal surgery: review
Chapter 6 | NIRF imaging in anastomotic colorectal surgery: review
102
ABSTRACT
Purpose
The aims of this review are to determine the feasibility of near-infrared fluorescence (NIRF) 
angiography in anastomotic colorectal surgery and to determine the effectiveness of the 
technique in improving imaging and quantification of vascularization, thereby aiding in 
decision making as to where to establish the anastomosis.
Methods
A systematic literature search of PubMed and EMBASE was conducted. Searching through 
the reference lists of selected articles identified additional studies. All English language 
articles presenting original patient data regarding intraoperative NIRF angiography were 
included without restriction of type of study, except for case reports, technical notes, and 
video vignettes. The intervention consisted of intraoperative NIRF angiography during 
anastomotic colorectal surgery to assess perfusion of the colon, sigmoid, and/or rectum. 
Primary outcome parameters included ease of use, added surgical time, complications 
related to the technique, and costs. Other relevant outcomes were whether this technique 
changed intraoperative decision making, whether effort was taken by the authors to 
quantify the signal and the incidence of postoperative complications.
Results 
Ten studies were included. Eight of these studies make a statement about the ease of use. In 
none of the studies complications due to the use of the technique occurred. The technique 
changed the resection margin in 10.8% of all NIRF cases. The anastomotic leak rate was 3.5% 
in the NIRF group and 7.4% in the group with conventional imaging. Two of the included 
studies used an objective quantification of the fluorescence signal and perfusion, using ROIs 
(Hamamatsu Photonics) and IC-Calc respectively.
Conclusions
Although the feasibility of the technique seems to be agreed on by all current research, 
large clinical trials are mandatory to further evaluate the added value of the technique.
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INTRODUCTION
Anastomotic leakage is the most feared complication in colorectal surgery. With an incidence 
of 3%–15%1–8 in colorectal surgery, it remains a common problem. Anastomotic leakage 
concerns a severe complication that leads to significant morbidity, prolonged hospital stay, 
considerable extra costs, and increased short-term and long-term mortality.6–9 Known risk 
factors for anastomotic leakage are male sex, American Society of Anesthesiologists-score 
above 3, chronic steroid use, preoperative weight loss, smoking, preoperative chemotherapy, 
disease location (infra-peritoneal anastomosis), and prolonged operation time.6–8,10 Karliczek 
et al.11 discussed in their article that there is a lack of a reliable intraoperative predictive 
test for anastomotic leakage by the operating surgeon. Intraoperatively, the selection of an 
optimal site for anastomosis is now depending on subjective clinical indicators such as color 
of the bowel wall, palpable or visible pulsations of the mesenteric arteries, or bleeding of 
the resection margins.12 Tests to determine the colorectal anastomotic integrity are air leak 
testing or more invasive or complex techniques such as endoscopic visualization, Doppler-
flowmetry, pH readings in the colon, all of which are not very convincing techniques 
according to the review by Nachiappan et al.12 Also, these tests are performed after 
construction of the anastomosis, while a predictor before making the anastomosis could 
prevent anastomotic leakage.
It is thought that a better vascularization of the anastomosis will cause less anastomotic 
leaks.13–16 There is a large variability of the colonic vascular anatomy and many patients 
suffer from arteriosclerotic disease of the mesenteric vasculature.17 Therefore, an easy and 
reliable method to assess the vascularization is desirable. With near-infrared fluorescence 
(NIRF) imaging it is expected that real-time visualization of the vasculature can be improved 
and, ultimately, anastomotic leaks reduced. The use of fluorescence angiography was first 
described in 1976 for choroid angiography18 and is common practice in ophthalmology. 
Applying the technique intraoperatively during colorectal surgery is comparable to this first 
application; by intravenous administration of the dye and its intravascular transportation, 
the vessels in the target region can be seen by illumination of the fluorescent dye.
Indocyanine green (ICG) is the most frequently used NIRF dye in humans. ICG is a 
sterile tricarbocyanine dye composed of N-hydro-3,3,3’,3-tetramethyl-1,1-di(4-sulfobutyl)-
4,5,4’4’5-dibenzoindotricarbocyanine hydroxide sodium and absorbs light between 790 
and 805 nm and re-emits light with an excitation wavelength of 835 nm.19,20 Since a better 
vascularization of the bowel anastomosis is thought to result in less anastomotic leakage, 
identifying the degree of vascularization through fluorescence angiography might help 
reduce the risk of anastomotic leakage.
The first objective of the review was to determine the feasibility of NIRF angiography 
in anastomotic colorectal surgery, with emphasis on ease of use, added surgical time 
and complications related to the technique. A second objective was to determine the 
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effectiveness of the technique in improving imaging of vascularization, thereby aiding in 
the decision making of where to make the anastomosis. Attention was given whether the 
signal was quantified or validated in an objective manner or only subjectively assessed.
MATERIALS AND METHODS
This study was registered in PROSPERO under the number: CRD42015025514 (www.crd.york.
ac.uk/PROSPERO/display_record.asp?ID=CRD42015025514).
Search Strategy 
A systematic literature search was performed in PubMed and EMBASE. The following search 
strategy was followed: (‘‘Indocyanine Green’’ [Mesh] OR Indocyanine Green OR Infracyanine 
Green OR ICG OR ‘‘Fluorescent Dyes’’ [Mesh] OR Fluorescent Dyes OR Near-Infrared Fluorescence 
OR Fluorescent imaging OR Fluorescence imaging OR Near Infrared Imaging) AND (‘‘Laparoscopy’’ 
[Mesh] OR Laparoscopy OR laparoscopic OR Robotic surgery) AND (‘‘Anastomosis, Surgical’’ 
[Mesh] OR Bowel anastomosis OR Anastomotic bowel surgery OR ‘‘Colorectal Surgery’’ [Mesh] 
OR Colorectal Surgery).
First, titles and abstracts were screened. In case of uncertainty, full text reports were 
read to assess eligibility. To complete the search, references within selected articles were 
searched as well. The search was performed by 2 independent reviewers (JvdB and MAT) 
who selected potentially relevant articles by title and abstract.
Inclusion and exclusion criteria
Articles had to be written in English. The aim of the literature search was to identify articles 
that reported on the use of intraoperative NIRF angiography during colorectal anastomotic 
surgery. The NIRF angiography had to be used to assess the perfusion of the exterior surface 
of the bowel. Studies were found eligible for inclusion when the participants were adults, 
aged above 17 years, in whom open, laparoscopic or robotic anastomotic bowel surgery 
was performed for either benign or malignant disease. The intervention had to consist of 
fluorescence angiography during the anastomotic bowel surgery. If a control group was 
present, anastomotic bowel surgery should have been performed without the use of 
fluorescence imaging, also for either benign or malignant disease. Studies only describing 
other applications of fluorescence imaging were excluded. Conference abstracts, animal 
studies, case reports, technical notes, and video vignettes were not included. Studies not 
presenting original patient data were excluded as well.
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Methodological quality appraisal
The Methodological Index for Non-Randomized Studies (MINORS) was used to assess the 
methodological quality of the included articles.21 This validated quality assessment system 
is based on 8 items for noncomparative studies and 12 for studies with a control group.
Data extraction
All the studies were analyzed by 2 independent reviewers (JvdB and MAT). A standard 
form to extract the following data was used addressing the characteristics of the study 
(design, allocation concealment, blinding, method of randomization, withdrawals, or dropouts), 
participants (age, sex, baseline characteristics, indication for surgery), intervention (type of 
fluorescent dye, used dose, timing of administration during surgery, used fluorescence system), 
and the outcomes (influence on duration of surgery, type of outcome measuring, quantification 
of the signal, complications intra- and postoperatively).
Data from all included trials were extracted and presented in the appropriate paragraph. 
Baseline data are summarized as mean or proportion for continuous and categorical 
variables, respectively. Outcome variables are reported as absolute number and percentage 
stratified by intervention, for all studies combined and separately for only those studies 
with a control group. Differences in the proportion of anastomotic leaks between NIRF and 
control using all studies, and using only studies with a control group, were computed using 
a two-sample test for proportions.
RESULTS
The search was performed by 2 independent researchers and resulted in the inclusion of 
10 articles. The search of PubMed (Medline) and EMBASE resulted in 111 citations. Checking 
reference lists of the selected articles identified seven additional studies. After adjusting 
for duplicates, 60 remained. Of these, 46 were discarded after reviewing the abstracts. The 
full text of the remaining 14 articles was examined in more detail. It appeared that 10 of 
these met the inclusion criteria. Four of these contained a comparison-group and were used 
for further quantitative analysis. The flowchart of the performed search and inclusion are 
depicted in Figure 1. 
In total, the outcomes of 1328 patients were described: 894 operated with the use of 
NIRF imaging and 434 patients with conventional imaging.22–31 The study characteristics of 
the included studies can be found in Table 1.
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Figure 1 Flowchart of systematic search
 
Number of records excluded: 4 
Other application of fluorescence 
imaging during colorectal surgery 
(transanal) (n = 2) or for 
identification of inferior 
mesenteric artery only (n = 1) 
Complete overlap in patient 
cohort with other study (n = 1) 
Number of records identified 
through database searching:  
PubMed: 69 
EMBASE: 42 
Total: 111 
 
Number of additional records 
identified through other 
sources:  
References from found articles  
(n =7) 
 
Number of records after duplicates removed (n = 60) 
 
Number of records screened 
(n = 60) 
 
Number of full text articles 
assessed for eligibility (n=14) 
 
Number of records excluded: 46 
No fluorescence imaging (n = 9) 
Other application of fluorescence 
imaging (n = 14) 
Conference abstract (n = 10)  
Review (n = 5) 
Case report (n = 3) 
Technical note (n = 3)  
Language restriction (n = 1) 
Animal study (n = 1) 
   
Number of articles included for 
qualitative synthesis (n = 10) 
 
Number of articles included for 
separate quantitative synthesis  
(n = 4) 
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Methodological quality of studies 
Since all of the included studies were nonrandomized, the risk of bias in the studies was 
evaluated with the MINORS methodological index.21 For studies without a control group, 
the maximum possible score was 16, and 24 for the studies with a control group. The 
overall quality score for the assessed studies ranged between 9 and 14 (mean 10.1) for the 
noncomparative studies and between 12 and 20 (mean 16) for the studies with a control 
group (Table 2). All studies clearly stated the aim and had endpoints appropriate to this aim. 
Five of the studies were prospective feasibility studies, two retrospective feasibility studies, 
and four were retrospective matched pairs studies. The retrospective nature of most of 
the included studies caused an inability to control for unmeasured potential confounders 
between the two groups. Only three studies described loss to follow-up; the period of 
follow-up was unclear in most of the studies. None of the studies performed a prospective 
calculation of the study size. The sample size of all studies was inadequate to detect 1%–2% 
differences in anastomotic leakage rates at 80% power.27 Since from Boni et al.23,25,26 and 
Jafari et al.24,30 more than one article is included in this review, it was checked by the authors 
whether those articles were based on different patient cohorts. The authors confirmed 
there is no cohort overlap.
Baseline characteristics of patients 
The baseline data (number of patients, mean age, gender, and body mass index) are given 
in Tables 3 and 4.
Feasibility of the technique 
Factors contributing to the feasibility of the technique are considered to be the ability to 
obtain a signal illustrating perfusion, ease of use, complications due to the technique, and 
added surgical time. Eight of the 10 included studies make a statement on the feasibility of 
the technique and the ease of use22–29; NIRF imaging of colorectal anastomosis is considered 
‘‘feasible’’ and ‘‘readily achievable.’’ Four of these studies illustrate this by giving the number 
of patients in which images that demonstrate the perfusion were successfully obtained. 
Jafari et al.24 acquired NIRF images in 98.5% of the patients. The imaging was not successful 
in 2 patients due to equipment malfunction. Boni et al.25,26 obtain real-time images 
demonstrating the perfusion in all patients in both studies, as did Wada et al.22 In the study 
by Ris et al.28 the system failed to detect any visible fluorescence in 1 patient.
Complications related to the technique
In none of the articles complications attributable to the use of ICG were observed.
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Added surgical time 
The added surgical time is given in five articles.23,28–31 A mean added time of 4.5 minutes 
to the total duration of the surgical procedure is described. Ris et al.28 noted that a shorter 
additional imaging time is accompanied by experience in the use of this technique. Jafari et 
al.30 described a mean operation time of 4.75 h in NIRF group, compared with 4.4 h in control 
group. Boni et al.23 report a 7-minute shorter mean operative time when using NIRF.
Costs
No comments about the additional costs of using the technique where made in the 
included articles22,23,25,27–30 except for Jafari et al.24 who described a cost of $167,500–223,750 
for the PinpointTM system, which resulted in cost per case of $999–1099. Boni et al.26 state the 
technique seems to be cost effective. However, no cost evaluation to support this is given 
in the article.
Table 3 Table 3 Baseline data of all included studies 
NIRF Control Total
Number of participants 894 434 1328
Mean age 63.4* 64.2 63.7
Male (%) 493 (55) 216 (50) 709 (53) 
Mean BMI (kg/m2) 26.6 # 26.3 26.5
* Wada22 and Ris28 are not included in this number as mean ages are not mentioned. Instead, they give ages as a median of 67 
and 64 respectively
# The studies of Boni25 and Wada22and are not included in this figure. Boni described no BMI in the article; Wada gives BMI as 
median 22.8 (range 15.8-3.43kg/m2) 
Table 4 Baseline data of the four studies with a control group23, 27, 30, 31 
NIRF Control Total
Number of participants 432 434 866
Mean age 63.7 64.1 63.9
Male (%) 218 (50.4%) 223 (51.4%) 441(50.9%)
Mean BMI 26.1 26.3 26.2
ASA I
ASA II
ASA III
ASA IV
10 (5%)*#
78 (41%)*#
98 (52%)*#
3 (2%)*#
17 (9%)*#
83 (43%)*#
93 (48%)*#
2 (1%)*#
27 (7%)*#
161 (42%)*#
191 (50%)*#
5 (1%)*#
Smoking 80 (35%)* 97 (42%)* 177 (38%)*
Preoperative chemotherapy 78 (34%)* 74 (32%)* 152 (33%)*
Indication for surgery:
   Diverticular disease
   Cancer 
   IBD
   Other 
47 (11%)
358 (83%)
4 (1%)
23 (5%)
31 (7%)
367 (85%)
6 (1%)
30 (7%)
78 (9%)
725 (84%)
10 (1%)
53 (6%)
* Kusdzus et al described no ASA classification, smoking and preoperative chemotherapy; these patients are therefore not 
included in the overview of these parameters. 
# Boni et al described no ASA classification in their baseline characteristics; these are not included in the overview of this 
parameter. 
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Quantification or validation of the fluorescence signal and perfusion
Only Wada et al.22 and Kudszus et al.31 performed an objective quantification of the 
fluorescence signal. One of the aims of the study by Wada et al.22 was to evaluate whether 
quantitative assessment of intestinal perfusion by measuring ICG signal intensity could 
predict postoperative outcomes such as anastomotic leakage and bowel movement 
recovery.
For these quantitative measurements analyzing software ROIs (Hamamatsu Photonics) 
was used to assess the pixel intensity. A time curve of this fluorescence intensity was made 
and fluorescence difference between maximum and baseline was measured, as were 
time from first fluorescence to maximum signal, time from first fluorescence to half of the 
maximum signal, and the slope of this graph. For the regions of interest at the transection 
line, the midpoint between the mesenteric and antimesenteric sites was chosen. The 
maximum fluorescence intensity turned out to be lower in the 5 patients with anastomotic 
leakage in this study, compared to the patients in which no anastomotic leakage occurred.
Also, Kudszus et al.31 used an objective quantification of the fluorescence signal and 
perfusion. For this, IC-Calc® software was used. With this software, the perfusion index is 
calculated (i.e., the perfusion between different sites) and curves are plotted.32 The authors 
show the curves but unfortunately no cutoff value of fluorescence intensity for adequate 
perfusion is calculated or given, neither is the fluorescence intensity linked to the risk for 
anastomotic leakage. All other included studies only use a subjective assessment of the 
fluorescence signal. The surgeons’ opinion is used,23,25,27,29,30 or that of the whole surgical 
team (main surgeon, main assistant, fellow in minimally invasive surgery, and the assisting 
resident)26 to assess whether the fluorescent signal was enough to maintain the planned 
resection point. In these studies, no grading was used other than ‘‘adequate/sufficient’’ or 
‘‘inadequate/insufficient.’’ Jafari et al.24 and Ris et al.28 divided the subjective assessment 
in three categories, namely ‘‘optimal, adequate, or inadequate’’ and ‘‘good, average, and 
bad’’ respectively. Neither study describes when a revision of the surgical plan will take 
place based on this classification. Moreover, Ris et al.28 graded the quality of perfusion in all 
patients as ‘‘Good,’’ while Jafari et al.24 doesn’t report the results of this grading.
Added value of the technique 
The outcomes regarding perioperative decision making for all studies are summarized in 
Table 5, for the studies with a control group separately in Table 6.
Influence of NIRF angiography on intraoperative decision making
In total, surgical plan was changed in 97 (10.8%) cases after NIRF, of which in 90 the proximal 
resection margin was initially considered insufficient with NIRF. In this group, anastomotic 
leakage occurred in 8 patients (8.9%), compared to 23 anastomotic leakages (2.8%) in 
the NIRF patients with initially good fluorescent signal. In 7 NIRF patients, initial clinical 
impression of malperfusion was not confirmed by NIRF and resection was not extended.
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In the studies with a control group, the surgical plan was changed in 47 cases (10.9%) 
of the NIRF group and in 1 case of the control group. Of these, in 41 patients the proximal 
resection margin was considered insufficiently vascularized and therefore extended to 
well perfused tissue. In the other 6 patients, a clinical impression of malperfusion of the 
resection margins was not confirmed by NIRF angiography and therefore the resection 
was not extended.23,27,30,31 The change of plan therefore consisted of neglecting the clinical 
impression and instead following the NIRF imaging. In 1 of the 41 patients of the first group, 
two anastomotic leakages occurred. No further information about this anastomotic leakage 
was provided.27 In the second group of 6 patients, no anastomotic leakage occurred.30,31
In the studies without a control group, the surgical plan was revised in 50 patients (10.8%) 
after NIRF imaging. In 49 of these, a revision was performed of the proximal transection site. 
Six of these patients (12%) developed an anastomotic leak, at days 8, 15, 17, and 40.22,29
The other patients in whom the plan was revised, a clinically malperfused anastomosis 
was left unchanged because the NIRF angiography revealed good perfusion. No anastomotic 
leakage occurred in these patients.
Anastomotic leakage and other complications
The definition of anastomotic leakage differed between the studies. Wada et al.22 used the 
following definition: ‘‘Anastomotic leakage was defined as any disruption of the anastomosis 
that was confirmed by digital rectal examination, sigmoidoscopy, and radiographic examination 
(e.g., extravasion of endoluminally administered water-soluble contrast enema, abscess at the 
level of anastomosis and fluid/air bubbles surrounding the anastomosis). Only symptomatic AL 
was included.’’ Kin et al.27 used a broader definition and defined an anastomotic leak as ‘‘at 
least one of the following criteria: 1. An anastomotic defect noted on physical examination; 2. An 
Table 5 Added value of the technique based on all included studies 
NIRF 
(n = 894)
Control
(n = 434)
Total
(n = 1328)
Revision of surgical plan 97 (10.8%) 1 (0.2%) 98 (7.4%)
Anastomotic leak after revision  
of surgical plan 8 (8.3%) 0  8 (8.2%)
Total number of anastomotic leaks 31 (3.5%)* 32 (7.4%)* 63 (4.7%)
* P-value: 0.002
Table 6 Added value of the technique based on the four studies with a control group23, 27, 30, 31 
NIRF 
(n = 432)
Control
(n = 434)
Total
(n = 866)
Revision of surgical plan 47 (10.9%) 1 (0.2%) 48 (5.5%)
Anastomotic leak after revision  
of surgical plan 
2 (4.3%) 0 1 (1.9%) 
Total number of anastomotic leaks 21 (4.9%) 32 (7.4%) 53 (6.1%)
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anastomotic defect confirmed in the operation room; 3. An anastomotic defect seen on 
proctoscopy; 4. Radiologic evidence of a leak consisting of either a defect in the anastomosis 
and an adjacent fluid collection, or stranding or the extravasion of rectal contrast into the 
extraluminal space; or 5. Clinical evidence of a leak such as feculent output from a pelvic drain.’’ 
The other included articles did not give a clear definition of anastomotic leakage.23–26,28–31
Tables 5 and 6 show a summary of the occurrence of anastomotic leaks. A total of 63 
anastomotic leakages occurred in the 10 included studies (NIRF group n = 31; control group 
n = 32). This means that 3.5% (31 out of 894) of all NIRF patients and 7.4% (32 out of 434) of 
all control patients developed an anastomotic leakage (P-value for difference = .002). If only 
considering the studies with a control group, a 4.9% (21 out of 432) leakage rate in the NIRF 
group was found versus 7.4% (32 out of 434) in the control group (P= .123).
Other complications that occurred were inconsistently reported in the included articles. 
Boni et al.,25 Kin et al.,27 and Kudszus et al.31 reported no complications other than anastomotic 
leakage. Ris et al.28 described only the grade of the occurred complications (grades I–IV 
Clavien-Dindo classification): all seven complications were grades 1–3. In the remaining 
six studies detailed information was given about the complications (Table 7). Ileus, urinary 
retention, urinary tract infection, pulmonary complications and wound infection were the 
most common complications, occurring relatively more in the control group.22,24,26,29,30
Table 7 Complications other than anastomotic leakage described by Wada et al22, Boni et al23, Jafari et al24, Boni 
et al26, Hellan et al29 and Jafari et al30 
NIRF (n = 456) Control (n = 60) Total (n = 516)
Ileus (%) 22 (4.8) 6 (10) 28 (5.4)
Urinary retention (%) 10 (2.2) 5 (8.3) 15 (2.9)
Wound infection (%) 7 (1.5) 3 (5) 10 (1.9)
Urinary tract infection (%) 14 (3.1) 7 (11.7) 21 (4.1)
Requiring blood transfusion (%) 10 (2.2) 2 (3.3) 12 (2.3)
Pulmonary complications (%) 16 (3.5) 6 (10) 22 (4.2)
Fever (%) 4 (0.9) 0 4 (0.8)
Sepsis (%) 1 (0.2) 3 (13.6) 4 (0.8)
Incisional Hernia (%) 3 (0.7) 0 3 (0.6)
Rectal bleeding (%) 2 (0.4) 0 2 (0.4)
Pelvic abcess (%) 2 (0.4) 0 2 (0.4)
Bleeding at anastomotic site (%) 1 (0.2) 0 1 (0.2)
Other * (%) 26 (5.7) 5 (8.3) 31 (6.0)
Total (%) 110 (32.0) 37 (61.7) 147 (36.4)
* Thrombosis left renal artery, pancreatic fistula, atrial fibrillation, C difficile colitis acute renal failure, peristomal hernia, 
obstruction at stoma and death by suicide: all occurred once, other complications where described as ‘other’, without further 
specification. 
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DISCUSSION
The aim of this study was to investigate the feasibility of the use of NIRF angiography during 
anastomotic bowel surgery and determining the added value of the technique. Regarding 
the latter, attention was paid to whether the fluorescent signal was quantified or validated 
in any way.
Based on the included studies, it can be concluded that the use of fluorescence 
angiography in anastomotic bowel surgery is feasible. No complications attributable to the 
use of the technique were recorded. This makes the technique easily applicable in daily 
practice. Only few problems were encountered in its application, as system failure occurred 
only in 3 patients. This may be due to the relative inexperience of the team with this novel 
approach. A learning curve in the use of this technique might be present. Therefore, it can 
be expected that such system failure will be less frequent when this technique is used more 
often. It cannot be ruled out that a learning curve effect has been of influence on other 
observed differences between studies.
Minimal additional time is described in most articles. Jafari et al.30 describe an average 
21 minutes extra operation time in NIRF group. In these series, the decision to use NIRF 
angiography was at the discretion of the attending surgeon. Correspondence with the 
author reveals that the ICG imaging was reserved for more complex surgeries, with a longer 
duration for that reason. The NIRF angiography itself was thought to add maximally 10 
minutes to the operation time.
Apart from safety and ease of use, the ability of the technique to change the surgical 
plan with positive outcome on operative results reflects the value of this technique. The 
overall rate of anastomotic leakages in the included studies was 4.7% (63 of 1328 patients); 
this percentage is comparable to what can be found in the literature.33–38 Fluorescence 
angiography changed the surgical plan in 10.8% of all NIRF cases. Anastomotic leakage 
was less prevalent in the NIRF group (3.4%) than in the control group (7.4%). This may be 
considered an indication of the benefit of the technique adding in improving the surgeons’ 
ability to detect areas of poor blood supply. This consideration is supported by a pig 
study by Diana et al.,39 that showed that NIRF angiography allows qualitative assessment 
of the bowel perfusion. Yet, based on the still limited quality of the current research no 
solid evidence is provided to state that NIRF imaging significantly reduces the incidence of 
anastomotic leaks. Likewise, the studies comparing the NIRF technique with a control group 
of conventional imaging, still lack the strength and the evidence. Kin et al.27 published the 
biggest study comparing the NIRF angiography with a control group. Their conclusion is 
that the benefit of NIRF angiography is equivocal. However, in this study only the proximal 
bowel was assessed and the perfusion of the rectal stump was not evaluated. This could 
explain the absence of difference between the two groups, as a malperfusion of the rectal 
stump may have been missed, leaving the potential advantage of the NIRF technique 
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underestimated. This is also identified as a limitation by the authors. The same technique 
was used by Wada et al.22 and Boni et al.26
An anastomotic leak rate of 8.9% was found after revision of the surgical plan, compared 
to 2.8% in the patients with initial good fluorescence signal. This could mean that a good 
fluorescence signal is predicting a good outcome, while a lesser fluorescent signal could 
mean a higher risk of anastomotic leakage, whether or not the transection line is moved.
In this review, attention was given to whether the signal was quantified or validated 
in an objective manner or only subjectively assessed. Unfortunately, in only two studies 
this was attempted. As described, Kudszus et al.31 used an objective measurement using 
IC-Calc. Although this method is validated in rabbits,32 in their present study, no cutoff value 
was given on which revision of the resection margin was based. Wada et al.22 used other 
software, namely ‘‘ROIs’’ (Hamamatsu Photonics K.K.) to measure the fluorescence intensity. 
In this study, four parameters were measured, namely difference in fluorescence between 
maximum signal and baseline, time from first fluorescence to maximum signal, time 
from first fluorescence to half of maximum signal, and the slope; fluorescence difference 
divided by the time until maximum fluorescence. A lower maximum fluorescence signal 
was observed in the patients who developed anastomotic leakage compared to the other 
patients. Also, a less steep slope appeared predictive for anastomotic leakage. The time 
until maximum fluorescence and time to half of maximum fluorescence appeared not to be 
predictive for anastomotic leakage.
In the other studies, the signal was subjectively assessed by the surgeon or his team. The 
assessment was mostly binary: considered sufficiently or not.23,25–27,29,30 Jafari et al.24 and Ris 
et al.28 divided the subjective assessment in three categories, namely ‘‘optimal, adequate, 
or inadequate’’ and ‘‘good, average, and bad’’ respectively. However, no specific relation of 
the three categories on peroperative decision making and outcome was described in their 
articles.
Another possible method to objectively assess the NIRF signal is ad hoc imaging 
software (VR-render) as described by Diana et al.40 This software constructs a cartography 
of the perfused area based on the fluorescence time-to-peak and makes a real-time overlay 
of this cartography on the laparoscopic image. This technique has not yet been used in 
humans, but was validated in an animal study by Diana et al.40
Other methods described in literature are the postoperative measurement of the 
Target to Background Ratio using the fluorescence intensity using OsiriX (Pixmeo, Geneva, 
Switzerland)41; and the Signal to Noise ratio using ImageJ software (National Institutes of 
Health, Washington, DC).42 Unfortunately, these techniques are used for postoperative 
measurement and not applicable yet in the intraoperative setting. Further studies should 
focus on this validation. It may be expected that this will lead to more accurate recognition 
of imperfect perfusion levels that will contribute to the chance of anastomotic leakage and 
therefore to better use of the potential of the NIRF technique.
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In the control group, apart from more anastomotic leakages, also other complications 
occurred more often (61% in the control group as compared to 32% in the intervention 
group). It is unclear from the included articles whether this higher complication rate is due 
to the higher rate of anastomotic leakage.23,30
In the present review, no statement on the cost or savings due of the technique can be 
given, as this is not studied in the majority of the included articles. Yet, this is an interesting 
result to be included in future research. The technique has the potential to reduce anastomotic 
leaks. A rough estimate of its cost is between $10,000 and $50,000 more per patient with 
an anastomotic leak as reported in current literature.8,43,44 Any extra time still spent with its 
application may decrease in more routine use. And further, the fluorescence imaging mode 
is or will soon be commercially available in frequently used endoscopic systems, eliminating 
the need for obtaining a separate and therefore costly extra set of equipment. This leaves 
only about $80 for the required ICG as extra costs. Based on the above given estimate of cost 
per leak, this means that in every 125–625 (10,000/80–50,000/80) patients operated with 
NIRF 1 anastomotic leak should be avoided for this technique to be cost effective.
This review should be viewed with consideration based on the following. First, the 
included studies were all of limited quality. All the included studies were nonrandomized, 
and the studies with a control group were retrospective case matched studies. The case 
matching could prevent bias by selecting comparable groups when taking all risk factors 
for anastomotic leakage in account. However, in the study by Jafari et al.30 the controls were 
selected from cases performed in the same period and it was not described why those 
patients did not undergo fluorescence imaging. This particular reason could be of influence 
on the outcome. Boni et al.,23 Kin et al.,27 and Kudszus et al.31 all selected cases from the 
period before the introduction of the NIRF technique. Although the articles discussed the 
lack of difference in treatment between the two periods of time, minor changes might still 
be present and could therefore have had an influence on the outcome. Furthermore, the 
retrospective nature prohibits correction for unmeasured confounders between the two 
groups. Another limitation is the inclusion of mostly small studies with an unclear follow-up 
period and lack of prospective sample size calculation. Because of the inconsistent reporting 
and the small number of patients no conclusions on the occurrence of complications can be 
made.
In summary, fluorescent imaging for assessment of bowel perfusion in colorectal 
resectional surgery is feasible and easy to use and based on the reports so far, holds great 
potential. All authors are positive about its added value over the usual clinical assessment 
methods. Nevertheless, data are still limited and results on quantification and validation of 
the signal are scarce. Further studies are needed to validate the technique and establish its 
contribution to the prevention of anastomotic leakage.
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ABSTRACT Objective
Near-infrared fluorescence (NIRF) imaging using indocyanine green (ICG) might help 
reduce anastomotic leak-age (AL) after colorectal surgery. This pilot study aims to analyze 
whether a relation exists between measured fluorescence intensity (FI) and postoperative 
inflammatory markers of AL, C-reactive protein (CRP), Intestinal fatty-acid binding protein 
(I-FABP), and calprotectin, to AL, in order to evaluate the potential of FI to objectively predict 
AL.
Methods 
Patients scheduled for anastomotic colorectal cancer surgery were eligible for inclusion 
in this prospective pilot study. During surgery, at three time points (after bowel 
devascularization; before actual transection; after completion of anastomosis) a bolus of 0.2 
mg/kg ICG was administered intravenously for assessment of bowel perfusion. FI was scored 
in scale from 1 to 5 based on the operating surgeon’s judgment (1 = no fluorescence visible, 
5 = maximum fluorescent signal). The complete surgical procedure was digitally recorded. 
These recordings were used to measure FI postoperatively using OsiriX imaging software. 
Serum CRP, I-FABP, and calprotectin values were determined before surgery and on day 1, 3, 
and 5 postoperative; furthermore, the occurrence of AL was recorded.
Results
Thirty patients (n = 19 males; mean age 67 years; mean BMI 27.2) undergoing either 
laparoscopic or robotic anastomotic colorectal surgery were included. Indication for 
surgery was rectal (n = 10), rectosigmoid (n = 2), sigmoid (n = 10), or more proximal colon 
carcinomas (n = 8). Five patients (16.7%) developed AL (n = 2 (6.6%) grade C according to 
the definition of the International Study group of Rectal Cancer). In patients with AL, the 
maximum fluorescence score was given less often (P = 0.02) and a lower FI compared to 
background FI was measured at 1st assessment (P = 0.039). However, no relation between FI 
and postoperative inflammatory parameters could be found.
Conclusion 
Both subjective and measured FI seem to be related to AL. In this study, no relation between 
FI and inflammatory serum markers could yet be found.
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INTRODUCTION
Anastomotic leakage (AL) is the most feared complication in colorectal (cancer) surgery. 
The severity of leakage may vary from a contained peri-anastomotic fluid collection to 
generalized peritonitis. Furthermore, long-term morbidity including stricture formation, 
bowel dysfunction, and an increased chance of locoregional cancer recurrence has been 
described.1–3 Clinically apparent anastomotic insufficiency occurs in 5.6–11.9% of all 
colorectal resections.4–6 As reported in literature, up to 32% of patients with AL die because 
of this postoperative complication.4 These numbers show the urgent need to prevent 
AL. Prevention starts with eliminating provoking factors. Decreased blood perfusion at 
the anastomosis is such a factor that contributes to anastomotic leakage.7–9 Therefore, it 
is hypothesized that a better visualization of the vascularization of the anastomosis will 
aid in preventing anastomotic leaks. Intraoperatively, the selection of an optimal site for 
anastomosis with adequate perfusion is now dependent on subjective clinical indicators 
such as color of the bowel, bleeding of the resection margins, and palpable or visible 
pulsations of the mesenteric arterial vessels (i.e., the clinical judgement of the surgeon). 
Karliczek et al.8 discussed that there is a lack of reliable intraoperative predictive test for 
AL by the operating surgeon. Earlier studies used Doppler ultrasound and laser Doppler 
to assess colorectal anastomotic vascularization.9 Peri-anastomotic tissue oxygenation has 
been evaluated but has not been incorporated in routine practice due to the complexity 
and limited effectivity of the technique.10 There is need for a technique that can accurately 
and consistently assess bowel perfusion at the anastomotic site in real time. Near-infrared 
fluorescence (NIRF) imaging allows surgeons to visualize the micro-perfusion of the bowel 
in real time.11 This technique, with perioperative indocyanine green (ICG) administration, 
has been shown feasible in assessing the vascularization of the bowel to be anastomosed. 
Fluorescence angiography with perioperative ICG administration seems to improve the 
outcome of laparoscopic anastomotic bowel surgery, in terms of safety and efficiency.11, 12 
However, in studies confirming the lower incidence of AL, no objective quantification of 
the signal was performed.1, 2, 7, 13–15 Such quantification is desired to make the technique a 
reliable tool to accurately and consistently assess bowel perfusion at the anastomotic site 
in real time. C-reactive protein (CRP) is an early predictor of postoperative infection and has 
been shown to correlate with AL.16–18 Intestinal fatty-acid binding protein (I-FABP) is a marker 
for enterocyte damage.19, 20 Earlier research showed a significant higher I-FABP at day 3 
postoperatively in patients with AL.21 In the same study, calprotectin levels were elevated on 
day 2 up to day 5 in patients with AL. In this pilot study, we aim to analyze whether a relation 
exists between the objectively quantified signal of ICG fluorescence angiography during 
laparoscopic or robotic colorectal surgery and the levels of the serum markers related to 
anastomotic leakage: CRP, I-FABP, and calprotectin, in order to evaluate the potential of FI 
to objectively predict AL. To our knowledge, this is the first effort to assess the existence of 
such a correlation.
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METHODS
All patients provided written informed consent. This study was approved by the Medical 
Ethical Committee of Maastricht University Medical Center and conducted according to the 
Declaration of Helsinki (October 2013, Fortaleza). Included patients were part of the REVEAL 
study22, which is registered at clinicaltrials.gov (NCT02347735).
Study subjects
Colorectal cancer patients scheduled for either laparoscopic or robotic anastomotic surgery 
were eligible for inclusion. Patients with inflammatory bowel disease were excluded because 
this could influence plasma levels of the inflammatory markers. Additional exclusion 
criteria were known iodine or indocyanine green hypersensitivity, impaired renal function 
(eGFR <45), pregnancy or breast-feeding (all are contraindications for the use of ICG), and 
inability to give informed consent. None of the included patients used non-steroidal anti-
inflammatory drugs (NSAIDs) or corticosteroids. Patient characteristics (sex, age, BMI, 
medical history, tumor location) and surgical characteristics (type of surgery, anastomotic 
technique, ostomy, operation time, conversion rate) were collected.
Surgical techniques
The surgical procedures were performed by experienced laparoscopic colorectal surgeons 
and started as usual in white light. In laparoscopic cases, a system equipped with fluorescence 
imaging (Karl Storz GmbH & CO. KG, Tuttlingen, Germany) with a xenon-based light source 
(D-light P) was used and in robotic surgeries, the da Vinci® System with Firefly fluorescence 
imaging (Surgical Intuitive, Sunnyvale, United States of America) was used. Surgery was 
performed as usual except for three time points, at which a bolus of 0.2 mg/kg ICG (Verdye; 
Diagnostic Green Aschheim, Germany) was administered. These three set time points were:
1. Directly after transection of all the vessels supplying the bowel segment to be 
resected (i.e., after devascularization of the segment)
2. Just before actual transection
3. Directly after the anastomosis is made
After each gift of ICG, the system was switched to NIRF mode and the surgeon was asked 
to rate the fluorescence intensity of the bowel both proximal and distal to the planned 
proximal transection line or stapler line on a scale from 1 to 5. Herein, a score of 1 meant 
no fluorescent signal, while a score of 5 meant ‘maximum fluorescent signal.’ Also, the 
surgeon was asked whether he or she changed the location of transection based on the 
visualized fluorescent signal. When proximal transection was performed extra-corporally, 
the operative room was completely darkened in order to capture the fluorescent signal with 
the respective imaging device.
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Fluorescence intensity measurement 
Postoperatively, the images of the bowel were assessed with OsiriX imaging software 
(Pixmeo, Geneva, Switzer-land) to quantify the FI. This software measures the gray value 
in arbitrary units (AU). At the aforementioned three time points, the FI was measured 
approximately 1 cm proximal and 1 cm distal from the proximal transection point or 
anastomosis and of the background (abdominal wall or fat directly surrounding the relevant 
bowel part) in a screenshot taken approximately 1 min after ICG administration. In the right 
hemicolectomies, the distal transection point was used. In case of extracorporeal proximal 
transection, also three points in the direct surrounding of the bowel were measured as 
background. The target-to-background ratio (TBR) was defined as the mean FI in arbitrary 
units (A.U.) of the bowel wall 1 cm proximal or distal from the planned proximal (or in right 
hemicolectomies distal) transection location or 1 cm from the staple line of the anastomosis 
minus the FI of the background divided by the mean FI in the background (abdominal wall 
or fat directly surrounding the relevant bowel part).
Definition anastomotic leakage 
The patients were followed up to 30 days after surgery, during which the occurrence of 
complications and especially AL was recorded. Clinically relevant AL was defined and 
classified according to the definition from the International Study group of Rectal Cancer.23 
In this definition, AL is a defect of the anastomotic wall integrity at the colorectal or 
coloanal anastomotic site leading to a communication between the intra-and extraluminal 
compartments. A pelvic abscess close to the anastomosis is also considered AL. We applied 
this definition also to the included colocolic and ileocolic anastomoses in our study. A 
distinction is made between the severity of AL based on the intervention required:
 – Grade A: Anastomotic leakage requiring no active therapeutic intervention
 – Grade B: Anastomotic leakage requiring active therapeutic intervention but 
manageable without relaparotomy;
 – Grade C: Anastomotic leakage requiring relaparotomy23
Analysis of inflammatory markers 
Venous blood was drawn at hospital admission (preoperative sample) and on day 1, 3, and 5 
after surgery, unless the patient was discharged home earlier. C-reactive protein (CRP) plasma 
levels were determined by using Immunoturbidimetric assay for the in vitro quantitative 
determination of CRP in human serum and plasma (Roche diagnostics, Germany). Serum 
calprotectin concentration was determined using a commercially available calprotectin 
ELISA (Hycult Biotechnology, Uden, The Netherlands). Intestinal fatty-acid binding protein 
(I-FABP) plasma levels were determined using an in-house ELISA that selectively detects 
human I-FABP.21
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Statistical analysis 
Basic descriptive statistics were applied to calculate means and standard deviation of the 
baseline characteristics. Because of the small sample size, non-parametric tests were used 
to analyze the data retrieved in this study. To compare continuous variables between two 
groups, the Mann–Whitney test was performed. To compare categorical outcomes between 
two groups, a Pearson Chi-square crosstab was used. The relation between the measured 
fluorescence intensity and the values of the inflammatory markers was evaluated using a 
regression analysis. P < 0.05 was considered to denote statistical significance. All statistical 
analyses were performed with SPSS version 23 (IBM, Armonk, NY, USA).
RESULTS
Study population 
Thirty patients were included with a mean age of 67.2 (SD 8.2) years of whom 19 (63%) 
were male. All under-went elective surgery for colorectal cancer, of which 10 (33.3%) 
concerned sigmoid carcinoma, 10 (33.3%) rec-tum carcinoma, 5 (16.7%) colon carcinoma 
in the right hemi-colon, 3 (10%) cecum carcinoma, and 2 (6.7%) rectosigmoid carcinoma. 
Five patients were treated with concomitant chemoradiotherapy before surgery, 4 with 
only chemotherapy (CAPOX–bevacizumab), and 3 received only radiotherapy (5 × 5Gy). A 
conversion to open surgery was needed in 7 patients in whom a laparoscopic procedure 
was started, due to unclear anatomy in obese patients. Further baseline characteristics and 
surgical characteristics are summarized in Table 1.
Near Infrared fluorescence imaging 
A bolus of 0.2 mg/kg ICG was administered intravenously. Thus, the total dose ranged 
between 10.3 and 21.8 mg with a mean of 16.4 mg (SD 3.3). NIRF imaging was aimed to 
be performed at three time points. In 19 patients, fluorescence imaging was achievable at 
all three time points. In 10 patients, the first time point was very close to the second time 
point; therefore, in these patients only just before transection (second time point) and after 
completion of the anastomosis, the bowel was assessed using NIRF imaging, in order to 
prevent potential accumulation of the dye at the second time point. In two patients, the 
anastomosis was too low to visualize the NIRF signal. The time between the first and second 
time point was on average 68.6 min (range 9–201) and between the second and third time 
point on average 40 min (range 11–84).
Intraoperative decision making based on fluorescence imaging 
In six patients, the dissection location was changed, based on the fluorescent signal. One of 
these patients developed AL; the remaining 5 patients did not.
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Anastomotic leakage (AL) 
In 5 patients (16%), AL occurred. In 2 of these cases, only a small abscess around the 
anastomosis was seen on CT scan and could be treated non-surgically with intravenous 
administration of antibiotics and CT-guided drainage. These leakages were considered as 
grade B AL. In 1 patient, AL could be treated with an endo-sponge applied via endoscopy 
and was also considered as Grade B AL. The remaining 2 patients (6% of the total study 
population) needed relaparotomy for AL treatment (grade C). All patients with AL underwent 
a low anterior resection of a rectum or rectosigmoid carcinoma. Two of the AL patients had 
undergone pre-operative chemoradiotherapy: one preoperative radiotherapy and one 
preoperative chemotherapy. The remaining patient was not preoperatively treated with 
neoadjuvant radiotherapy or chemotherapy. There were no statistical differences in age at 
the time of surgery, preoperative chemotherapy, BMI, administered dose of ICG per bolus 
(mg), conversion to open surgery, type of anastomosis, TNM classification after surgery, 
and difficulty of surgery between the patients who developed AL and the patients who did 
not. There were significantly more smokers in the AL group (P = 0.046).  The postoperative 
hospital stay was on average 16 days (median 12 days) in the patients with AL, which was 
Table 1 Baseline characteristics and surgical characteristics 
n (%) Mean (SD)
Male 19 (63.3)
Age, years 67.2 (8.2)
Weight, kg 82 (16.4) 
BMI, kg/m2 27.2 (4.9)
Smoking 12 (40)
Both preoperative chemo- and radiotherapy 5 (16.6)
Preoperative chemotherapy 4 (13)
Preoperative radiotherapy 3 (10)
Location of suspected tumor 
     Cecum
     Right hemi colon
     Sigmoid 
     Recto-sigmoid 
     Rectum 
3 (10)
5 (16.7)
10 (33.3)
2 (6.7) 
10 (33.3)
Type of surgery 
     Laparoscopic right hemicolectomy
     Laparoscopic sigmoid resection
     Laparoscopic low anterior resection
     Robot-assisted low anterior resection
8 (26.7)
11 (36.7)
4 (13.3)
7 (23.3)
Deviating stoma 11 (36.7)
Type of anastomosis 
     Side-to-end
     End-to-end
     Side-to-side
16 (53.3)
9 (30) 
5 (16.7)
Conversion to open surgery 7 (23.3)
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significantly longer compared to the patients without this complication, who stayed on 
average 5 days (P =   0.004). A deviating ileostomy had been constructed more often in 
the AL group. See Table 2 for an overview of these characteristics. Other postoperative 
complications were postoperative ileus in one patient, which resolved without further 
consequence. The two patients who needed relaparotomy due to anastomotic leakage 
both developed pneumonia after the second surgery which was treated with antibiotics.
Subjective fluorescence intensity (FI) 
The FI was scored by the surgeon on a scale from 1 to 5. In all cases, in all three assessments, 
this score ranged between 3 and 5 for the bowel proximal to the proximal transection 
site, or distal transection site in right hemi-colectomies. In the second assessment, the 
subjective score given for the FI was 4 in four of the anastomotic leakage cases. In one of 
the anastomotic leakage cases, a score of 5 was given, this was one of the cases in which 
only an abscess close to the anastomosis was present. In the patients who did not develop 
AL the maximum score of 5 was given in 16 cases (73%), which was significantly more often 
Table 2 Characteristics of patients with anastomotic leakage compared to those without
No AL (total 25) AL (total 5) P-value 
Male n 15 /25 4 /5 0.397
Age, years (median (IQR)) 65.5 (11.5) 65.0 (17) 0.787
BMI, kg/m2 (median (IQR)) 28.3 (5.27) 24.4 (14.1) 0.627
Smoking n 8 /25 4 /5 0.046*
Preoperative chemoradiation 3/25 2/5 0.183
Preoperative chemotherapy 3 /25 1/5 0.538
Preoperative radiotherapy 2/25 1/5 0.433
Indication for surgery 
Cecum carcinoma 
Right hemi colon carcinoma 
Sigmoid carcinoma
Rectosigmoid carcinoma 
Rectum carcinoma
3 
5 
10 
1 
6 
0 
0 
0 
1 
4 
0.058
Type of surgery 
Laparoscopic right colectomy
Laparoscopic sigmoid resection 
Laparoscopic low anterior resection 
Robotic low anterior resection 
8 
10 
2
5 
0
1 
2 
2 
0.107
Change of dissection place 5 /25 1 /5 1.000
Ileostomy 7/25 4/5 0.028*
Type of anastomosis 
Side-to-end 
Side-to-side
End-to-end
13
9 
3 
3
0 
2 
Conversion to open surgery 6 /25 1 /5 0.847
Surgical time, minutes (median (IQR)) 203.5 (95) 287.0 (358) 0.344
Postoperative hospital stay, days (median (IQR)) 4 (2.25) 12 (22) 0.004*
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compared to the AL group (P = 0.02). In both the first and third assessment, no significant 
differences in subjective fluorescence intensity between the patients with and without 
anastomotic leakage were seen. See Table 3 for the given scores.
Measured fluorescence intensity
Next to subjective scoring by the surgeon, the FI of the bowel proximal and distal from the 
proximal transection or distal in right hemicolectomies and the background was measured 
by image quantification. As shown in Tables 4, 5, 6, and 7, the FI in patients without AL 
was higher at almost all measurements compared to the FI in patients who develop AL. 
This difference is however only statistically significant when we take the background into 
account and assess the bowel distal from the proximal anastomosis in the 1st assessment (P 
= 0.039) (see Table 7).
Inflammatory serum markers 
As shown in Table 8, CRP was significantly higher on postoperative day 5 in anastomotic 
leakage patients. As is shown in Table 8, all other measured markers do not show a statistical 
difference between the occurrence of anastomotic leakage and serum levels on day 1, 3, or 5. 
Fluorescence intensity in relation to inflammatory serum markers 
The relation between the respective serum markers CRP, Calprotectin and I-FABP, and 
the fluorescent signal was assessed using a regression analysis. For none of the serum 
markers on any time point, a significant relation could be found with the fluorescence both 
proximal and distal or measured as TBR, with one exception. At the third time point, after 
the anastomosis is made, a higher TBR of the distal part of the anastomosis was related to a 
lower serum calprotectin level on postoperative day 5 (P = 0.046).
Table 3 Subjective fluorescence intensity (FI) scores and anastomotic leakage (AL)
FI score 3 FI score 4 FI score 5
Total no of 
patients 
assessed
1st assessment No AL 1 5 10 16
AL 0 1 3 4
2nd assessment No AL 3 4 18 25
AL 0 4 1 5
3rd assessment No AL 2 11 11 24
AL 1 1 2 4
The fluorescence intensity on first and second assessment is scored on the distal side of the distal anastomosis in laparoscopic 
right hemicolectomies, whilst on the proximal site of the proximal anastomosis in all remaining procedures.
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DISCUSSION 
NIRF angiography with ICG is used more and more in colorectal surgery as this technique 
holds the potential to lower the risk for anastomotic leakage.11 However, it is unknown 
when the bowel is fluorescent enough to actually predict optimal anastomotic healing. In 
this respect, a cut-off value is desirable. To come to such consensus, we first need to know 
Table 4 Fluorescence intensity (FI) bowel proximal from the proximal transection line and anastomotic leakage 
(AL) (distal from distal transection line in right hemicolectomies, thus side from the transection line that stays 
in the patient). 
Median FI no AL Median FI AL P-value 
1st assessment 38.8 (61.2) 34.2 (28.7) 0.494
2nd assessment 49.2 (45.0) 44.1 (94.6) 0.385 
3rd assessment 86.5 (54.8) 99.5 (68.1) 0.336
Median fluorescence intensity (interquartile range) 
Table 5 Fluorescence intensity (FI) bowel distal from the proximal transection-line and anastomotic leakage 
(AL) (proximal from the distal transection line in right hemicolectomies, thus side from the transection line that 
will be resected) 
Median FI no AL Median FI AL P-value 
1st assessment 31.7 (23.7) 36.7 (27.1) 0.064
2nd assessment 40.8 (32.4) 64.5 (72.8) 0.448
3rd assessment 59.9 (37.6) 55.9 (30.5) 0.952
Median fluorescence intensity (interquartile range)
Table 6 Target to background ratio (TBR) bowel proximal from the proximal transection line and anastomotic 
leakage (AL) (distal from distal transection line in right hemicolectomies, thus side from the transection line 
that stays in the patient)
Median TBR no AL Median TBR AL P-value 
1st assessment 2.8 (4.7) 1.1 (1.4) 0.820
2nd assessment 2.2 (13) 0.5 (2.1) 0.229 
3rd assessment 1.4 (2.6) 1.4 (1.0) 0.669
Median fluorescence intensity (Interquartile range)
Table 7 Target to background ratio (TBR) bowel distal from the proximal transection line and anastomotic 
leakage (AL) (proximal from distal transection line in right hemicolectomies, thus the side from the transection 
line that will be resected) 
Median TBR no AL Median TBR AL P-value 
1st assessment 3.4 (6.9) 1.2 (1.3) 0.039 
2nd assessment 2.6 (13.5) 1.8 (4.0) 0.482
3rd assessment 1.4 (2.9) 0.9 (0.1) 0.364
Median fluorescence intensity (interquartile range)
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whether a “more fluorescent bowel” actually is indicative for a lower risk for anastomotic 
leakage and accompanying lower postoperative inflammatory parameters. Therefore, we 
performed this clinical pilot study, in which we aimed to correlate the signal strength of 
fluorescence angiography with the occurrence of AL and with the level of the serum markers 
that are thought to be predictive of AL: CRP, calprotectin, and I-FABP. The fluorescence 
intensity was measured after administration of 0.02 mg/kg ICG intravenously at three time 
points. CRP, calprotectin and I-FABP were determined preoperatively and on day 1, 3, and 5 
after surgery. Follow-up for anastomotic leakage was until 30 days postoperatively. 
In the current study, 5 (16.7%) patients developed AL. Three of these leakages were 
considered a grade B leakage, while the remaining two were grade C anastomotic leakages 
which needed re-laparoscopy. The number of patients with AL is somewhat higher 
compared to the literature (5.6–11.9%) 4–6, and especially when compared to other studies 
in which NIRF angiography is used during colorectal surgery.11 This could be explained by 
the fact that both grade B and grade C anastomotic leakage were taken into account in this 
study, while other studies may have only considered grade C leakage only. In addition, 40% 
of patients smoked, which is a risk factor for developing AL.4, 24 Remarkably, preoperative 
radiotherapy, which is also a known risk for leakage was not identified as such in our study. 
The limited number of patients may have contributed to this discrepancy. 
In all cases, the subjective score for FI proximal from the (planned) proximal transection 
line or distal from distal transection line (in right hemicolectomies), ranged between 3 and 
5 on a scale from 1 to 5. For the bowel proximal from the transection line, the maximum 
score of 5 was given significantly more often in the patients that healed without a leak. This 
is in line with the study by Ris et al.2 in which the fluorescence score ranges from ‘good,’ 
‘average,’ to ‘bad.’ In all patients, the fluorescence was scored ‘good’ by the surgeon and 
Table 8 Serum markers anastomotic leakage versus no anastomotic leakage. 
No anastomotic 
leakage
Anastomotic 
leakage
p-value
Mean CRP 
     Pre-operative (mg/ml) ±SD 
     Postoperative day 1 (mg/ml) ±SD
     Postoperative day 3 (mg/ml) ±SD
     Postoperative day 5 (mg/ml) ±SD
2.9 ±2.3
87.4 ±35.8
101.1 ±48.0
48.5 ±24.66
2.1 ±0.9
87.4 ±35.3
183.6 ±123.5
152.8 ±90.7
0.69
0.90
0.09
0.01*
Mean Calprotectin 
     Preoperative (ng/ml (SD) 
     Postoperative day 1 (ng/ml) ±SD
     Postoperative day 3 (ng/ml) ±SD
     Postoperative day 5 (ng/ml) ±SD
822.9 ±765.4
7587.3 ±17589.9
2467.0 ±1430.3
3326.7 ±2783.0
3451.6 ±3987.1
7743.5 ±12026.8
1683.3 ±1549.4
2756.1 ±1974.3
0.41
1.0
0.15
0.68
I-FABP 
     Preoperative (pg/ml) ±SD
     Postoperative day 1 (pg/ml) ±SD
     Postoperative day 3 (pg/ml) ±SD
     Postoperative day 5 (pg/ml) ±SD
805 ±376.6
644.7 ±370.4
574.8 ±431.4
496.9 ±291.4
520.1 ±516.1
383.2 ±160.4
373.9 ±335.3
143.0 ±49.6
0.16
0.14
0.31
0.05
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none of the patients developed AL. Other studies scored the fluorescence intensity as 
‘good enough’ or ‘not good enough’ based on subjective score of the surgeon. In these 
studies, if the fluorescence intensity was considered not good enough, the dissection place 
was changed.13, 25–29 The anastomotic leakage rate in patients with changed dissection level 
was equal13, 25–27, 29 or higher 28 compared to the patients in which no change was needed 
after NIRF imaging. A possible explanation for a higher leak rate after change of transection 
location may be the fact that a clearly insufficiently perfused bowel end may be indicator 
of a longer segment of moderate perfusion. This emphasizes the need for cut-off values 
for level of perfusion.11 In the current study, revision of surgical plan based on the FI of the 
bowel occurred in six patients. One of these developed AL. These numbers are too low to 
draw conclusions. 
In the present study, the objectively measured FI was higher in the patients who did not 
develop AL. This difference was only significant when taking the background into account 
and expressing data as TBR. By using TBR, a correction is made for the distance between 
the endoscope and the bowel. A shorter distance between the laparoscope and the target 
causes a higher FI.30 By taking the background into account, this effect is minimized, since the 
background will also show increased fluorescence intensity when holding the laparoscope 
closer to the tissue. Such correction of the signal seems necessary, as in practice, it is not 
always possible to exactly measure and standardize the distance to the bowel. 
According to literature, the CRP trajectory is highly predictive for AL.6 In the current 
series, CRP on postoperative day 5 was significantly higher in patient who developed AL. 
This observation is in line with findings reported in literature. An earlier study by Reisinger 
et al.21 showed a rise in postoperative CRP in patients with an anastomotic leak, which was 
only significant on day 4. Bigin et al.31 showed a significant higher CRP on postoperative day 
3, but unfortunately CRP was not measured on postoperative day 5. Reynolds et al.17 found a 
significantly higher CRP level in patients with grade C AL on day 5 up to day 7. Unfortunately, 
in the current study, no relation of CRP and subjective or measured fluorescence intensity 
or TBR could be found. 
Calprotectin is a non-specific marker for acute inflammation32. An earlier study by 
Reisinger et al.21 showed higher calprotectin levels on postoperative day 2, 3, 4, and 5 in 
patients who developed AL. Similar results were found by Cikot et al.33 In the current study 
however, no statistical difference in serum calprotectin levels could be found between 
patients with and without anastomotic leakage on postoperative day 1, 3, or 5. Interestingly, 
serum calprotectin levels on postoperative day 5 were negatively correlated with TBR of 
the distal part of the anastomosis. This relation needs to be confirmed in a larger study to 
determine its clinical relevance. 
I-FABP is an intestinal cell damage marker.21 An earlier study by Reisinger et al.21 showed 
significantly higher I-FABP levels preoperatively in patients who developed anastomotic 
leakage. The I-FABP levels remained higher in these patients after surgery, but only 
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statistically significant on postoperative day 3. In the current study however, I-FABP levels 
were lower at all time points in the patients who developed anastomotic leakage, although 
this difference was not significant. Moreover, we could not detect a significant relation 
between FI and serum I-FABP values in this study. 
A possible explanation for this discrepancy might be the low specificity of I-FABP. This 
marker for enterocyte dam-age is not only elevated in case of inflammation, but also in 
patients with colorectal cancer compared to patients with-out colorectal cancer.34 When 
only taking the patients with a grade C anastomotic leakage into account, a (non-statistically 
significant) higher I-FABP value is found in the leakage patients. More research is needed to 
determine its place in the management of the colorectal operative patient. 
A higher fluorescence intensity was found in all cases in the bowel at the side that will 
remain in the patients after surgery. This means that the de-vascularized bowel results in a 
lower signal, indicating that the fluorescent signal does reflect bowel perfusion. 
This study has some limitations. First, it was designed as a pilot study to explore 
whether there is a potential relation between FI and inflammatory serum markers that 
correspond with AL. A relatively small and heterogenous group of patients was included. 
With the markers and the patient group chosen here, it was not yet possible to identify a 
cut-off value of fluorescent signal that indicates an optimal anastomotic healing potential. 
A more homogenous patient group (e.g., only right hemicolectomies or rectal resections) 
might have given different results. Another factor of influence could be that only the 
measurements at single time points were performed, and not an evaluation of the signal 
intensity over time after administration of the respective boluses of ICG. The small number 
of included patients can be an explanation for finding few statistical significant differences 
for most outcome parameters. 
In this study, several time points of ICG administration were chosen. Although arterially 
the dye washes out very quickly—which is evident when observed with the naked eye—it 
cannot be ruled out that some retention of the dye occurred. Although this phenomenon 
will take place in both the bowel wall and the background, this may have influenced the 
objective measurements.  The time between the first and second dose administration was 
on average 68.6 min (range 9–201) and between the second and third bolus of ICG 40 min 
(range 11–84). A cut-off value for the optimal interval is not known in literature. 
In conclusion, both subjective and measured FI seem to be related to the occurrence 
of AL. In this pilot study, no relation between FI and inflammatory serum markers could yet 
be found nor a cut-off value of FI predicting AL. A larger study based on the current study, 
with a single time point of measurement in a homogenous population seems preferable 
to enhance the chance that an objective cut-off value of the fluorescent signal to predict 
AL will be identified. Ideally, future research identifies such cut-off value, but also leads 
to presenting the objective result of fluorescence measurement real time to the surgeon, 
thereby supplying the surgeon with essential per-operative information for the optimal 
transection point to prevent anastomotic leakage.
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ABSTRACT 
Background 
Ureteral injury during laparoscopic surgery is rare, but when it occurs, it can be a serious 
problem. Near-infrared fluorescence (NIRF) with methylene blue (MB) administration is a 
promising technique for easier and potentially earlier intraoperative visualization of the 
ureter. Aim of this prospective study was to assess the feasibility of NIRF imaging of the 
ureter during laparoscopic colorectal surgery, using MB.
Methods
Patients undergoing laparoscopic colorectal surgery were included and received intravenous 
injection of MB preoperatively. The ureter was visualized using a laparoscope, which offered 
both conventional and fluorescence imaging. Intraoperative recognition of the ureter 
was registered. The precision of ureter distinction with MB imaging was compared to the 
conventional laparoscopic view.
Results
Ten patients were included. All procedures were initially performed using a laparoscopic 
approach. Dose per injection ranged between 0.125 mg/kg and 1.0 mg/kg bodyweight. 
There were no adverse effects attributable to MB administration. The ureter was successfully 
detected in five patients, with highest contrast between ureter and surrounding tissue at an 
administered dose of 0.75–1.0 mg/kg. The fluorescent signal was only picked up after the 
ureter was already visible in the conventional white light mode.
Conclusion
Ureteral fluorescence imaging using MB proved to be safe and feasible. However, the 
present technique does not provide practical advantage over conventional laparoscopic 
imaging for identification of the ureter during laparoscopic colorectal surgery. Future 
research is necessary to explore more extensive dose finding, alternative fluorescent dyes, 
or improvement of the imaging system to make this application clinically beneficial.
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INTRODUCTION 
There is great public attention on the safety of surgery, especially in laparoscopic surgery.1 
In addition, efficiency is of constant concern in modern healthcare. Laparoscopic colorectal 
surgery is an advanced procedure requiring a high level of endoscopic skills. Finding the 
right tissue structures and anatomical planes takes time and incorporates risks. Iatrogenic 
ureteral, vascular, or nerve injury are complications that may occur.
Ureteral injury during surgery is rare, but when it occurs, constitutes a serious problem. 
The major causes are trauma, iatrogenic injury during open surgery, and injury during cath-
eter or endoscopic intervention. Ureteral injuries are often insidious since they are found 
only after other, more profound injuries are addressed, which may lead to worse outcomes. 
Risk factors for iatrogenic injury during colorectal surgery are previous pelvic operations, in-
fection, and inflammatory bowel disease, but most ureteral injuries occur in patients lacking 
these risk factors.2 Earlier studies have reported an incidence of 0.1% to 7.6% in colorectal 
and gynecologic surgery, with more than 80% of cases going unrecognized intraopera-
tively.3–6 Assimos et al.6 compared the incidence of iatrogenic ureteral injuries between the 
pre-laparoscopic and laparoscopic era and found that the incidence of iatrogenic ureteral 
injuries was significantly greater in the latter. Thus, the early detection and prevention of 
ureteral injury are important. If in any other way than with normal vision and common an-
atomical knowledge, essential anatomical planes and structures could be identified, this 
would beneficially influence the safety and efficiency of laparoscopic colorectal surgery.
To help avoid injury, intravenous pyelography, retrograde pyelography, or urologic 
computed tomography can be performed preoperatively; however, none of these imaging 
techniques provides real-time guidance during the actual procedure.7 Another applied 
method is ureteral stent placement. However, in laparoscopic surgery, the results are not 
convincing and apart from added operation time, can cause complications itself.2,8,9
Intraoperative fluorescence ureteral identification with preoperative optical dye 
administration is a promising new technique for easier and earlier intraoperative 
visualization of the ureter and could thereby improve the outcome –safety and efficiency–
of laparoscopic colorectal surgery.10,11
Matsui et al.10 showed that the clinically available dye methylene blue (MB) has 
near-infrared (NIR) fluorescence properties (even in very low doses) that permit real-
time intraoperative visualization of the ureters in a pig model in open and laparoscopic 
procedures. Verbeek et al.12 were able to visualize the ureters during open human surgery, 
using MB in combination with a near-infrared fluorescence (NIRF) imaging system.
We hypothesize that the application of the NIRF technique using MB during laparoscopic 
colorectal surgery can improve the visualization of the ureter, thereby speeding up the time 
of dissection and identification of the ureter, which increases patient safety by lowering the 
risk of ureteral injury. Therefore, in this study, we assessed the feasibility of this technique 
for the detection of ureters in patients undergoing elective laparoscopic colorectal surgery.
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MATERIALS AND METHODS
Patients 
This prospective observational study has been approved by the Medical Ethics Committee of 
the Maastricht University Medical Center and was performed in accordance with the ethical 
standards of the Helsinki Declaration of 1975. The study was conducted in the Maastricht 
University Medical Center (MUMC) and registered in the Netherlands National Trial Register: 
registration number NTR3605 (www.trialregister.nl/trialreg/adminrctview.asp?TC=3605). 
Randomly chosen patients meeting the inclusion criteria (Table 1) were enrolled between 
January 2014 and July 2015. All patients scheduled to undergo laparoscopic colorectal 
surgery, in which identification of the left ureter was part of the standard procedure, were 
eligible for participation in the study. All included patients provided written informed 
consent and the collected data were anonymized.
Intraoperative imaging system 
A commercially available laparoscopic fluorescence imaging system (Karl Storz GmbH 
& CO. KG, Tuttlingen, Germany) was used. This system has been described in more detail 
previously.13 For this study, the system had been adapted with a special filter to detect the 
fluorescent signal of MB, which is at around 670 nm. The equipment included a plasma light 
guide and a 30-degree 10-mm laparoscope applicable for NIRF imaging. Procedures were 
digitally recorded.
MB preparation and injection 
Methylthionine chloride (Methylene blue [MB]) 10 mg/mL was prepared by the hospital 
pharmacy of the Catharina Hospital (Eindhoven, the Netherlands). After intravenous 
administration, MB is rapidly taken up by the tissues. The majority of the dose is excreted in 
the urine, usually in the form of leucomethylthioninium chloride. Peak MB absorbance and 
emission occur at 668 and 688 nm, respectively.10 An intravenous MB solution for injection 
was administered preoperatively. Fluorescence imaging was performed at various moments 
during the phase of surgical dissection in which ureteral identification was relevant.
Surgical technique
The operations were performed by gastrointestinal surgeons with extensive experience 
in laparoscopic colorectal surgery. MB was administered using a preoperative intravenous 
injection in a vein of the upper extremity. Doses ranged from 0.25 mg/kg up to 1.0 mg/
kg body weight. In the course of the study, these were increased based on previous 
publications.10,14 The dye administration occurred during the induction of anesthesia and 
ranged between 40 and 0 minutes before the introduction of the first trocar.
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After surgery, the NIRF technique was assessed using an intraoperative registration 
form and visual recordings. Visual (both conventional and fluorescence) recordings were 
obtained during the same laparoscopic procedure. Urine from four included patients was 
collected from the bladder catheter at the end of the surgical procedure for NIRF imaging.
Ex vivo assessment of the NIRF technique
As a quality check of the procedure, in an ex vivo experiment, urine samples of two healthy 
volunteers were collected and accumulating concentrations of MB diluted in urine were 
made. Thereafter, fluorescence imaging was performed in a dark room with the camera at 
a 2cm proximity of the sample. For each sample, a target to background ratio (TBR) was 
calculated as explained below. For this calculation, a vial filled with sterile phosphate-
buffered saline was used as the background.
Target-to-background ratio
In image-guided surgery research, the target-to-background ratio is commonly used for 
analyzing recordings. For assessment of the degree of fluorescent illumination, OsiriX 5.0.1 
Imaging Software was used. The fluorescent images were analyzed by determining the TBR. 
The fluorescence intensity of the target was measured as a mean of three point regions 
of interest in the ureter minus the mean fluorescence intensity of three regions in the 
immediate surrounding tissue as background, divided by the mean fluorescence intensity 
of the background. Hence, the following formula was used: TBR = (Fluorescence intensity of 
Target - Fluorescence intensity of Background)/Fluorescence intensity of Background.
RESULTS
A total of ten patients were included in this study. Patient characteristics and clinical data are 
summarized in Table 2. Median age was 73.4 years (range 52–87) and median BMI was 27.44 
kg/m2 (range 23.24–37.04). All patients were scheduled to undergo elective laparoscopic 
Table 1 Inclusion and exclusion criteria for participation in the study
Inclusion criteria Exclusion criteria 
Patients scheduled for laparoscopic colorectal 
surgery (i.e., rectal surgery, sigmoid resection)
Not able to give written informed consent
No hypersensitivity for methylene blue Known methylene blue hypersensitivity
Males and females (not pregnant) Pregnant, breast-feeding women
Age >18 years Age <18 years
Able to understand the nature of the study and 
what will be required 
Medication use: SSRI’s
Willing to participate Not willing to participate
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surgery for colorectal cancer. Administration of the dye ranged from 0 to 40 minutes before 
the introduction of the first trocar.
A dose of 0.125 up to 1.0mg/kg resulting in a total dose of 8–90 mg per patient was 
administered preoperatively. The dose was gradually increased during the time span of the 
study, due to disappointing results of the low doses. In only two of the six patients in which 
a concentration of 0.125–0.25 mg/kg MB was administered, there was (weak) visualization of 
the ureter in the fluorescence mode. In the other four, up to 100 minutes after administration, 
no fluorescent imaging of the ureter could be obtained, even after the detection of the 
ureter in white light mode. One of these procedures was converted to open procedure (due 
to intra-abdominal adhesions) before it was possible to analyze the ureter in fluorescence 
mode.
In one of two patients with a dosing of 0.5 mg/kg, the ureter was detected in fluorescence 
mode. This occurred with a weak signal and after the ureter had already been identified in 
white light mode. In the other patient, conversion to an open procedure was performed 
(because of intra-abdominal adhesions) before actual imaging of the ureter in fluorescence 
mode could take place.
In the remaining two patients, a concentration of 0.75 and 1 mg/kg showed a clear 
delineation of the ureter during the pulsatile movement of the urine through the ureter 
(see example screenshot in Fig. 1). The laparoscope had to be held close (within a few 
centimeters) to the ureter to obtain this visualization.
In four consecutive patients (patients number 5–8 in Table 2), urine was collected from 
the bladder catheter at the end of the procedure. Ex vivo fluorescence imaging with the 
same camera system as explained in the methods section showed a clear fluorescence 
signal of all four urine samples with a TBR varying between 6.88 and 9.2 (Table 3).
In the ex vivo experiment, a strong fluorescence signal in a wide range of considerable 
dilutions was obtained (Table 4).
Very high concentrations of MB revealed no signal (TBR <0) and in very high dilutions, 
only a weak, although still present, signal.
Figure 1 Screenshot of ureter visualization with fluorescence imaging at dosing of Methylene Blue of 1.0 mg/
kg (top screenshot) and 0.75 mg/kg (bottom screenshot). In this screenshot, red is the illumination of the ureter 
and black is surrounding tissue 
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Table 2 Patient characteristics and ureteral identification results 
No. Sex
Age 
(years)
Weight 
(kg) 
BMI 
(kg/m2)
Dose 
(mg/kg) 
Total dose 
(mg) NIRF imaging of the ureter 
1 F 69 61 23.24 0.50 30.5 Ureter detected with scope very 
close to tissue.
Ureter is also visible in white light 
mode
2 M 67 78 26.06 0.50 40 Conversion due to intra-abdominal 
adhesions
before NIRF imaging
3 M 68 98 31.64 0.25 25 Left ureter detectable with scope 
very close to
tissue, but weak signal. Ureter is also 
visible in
white light mode
4 F 87 66 23.04 0.125 8 Left ureter detectable with scope 
close to tissue,
but very weak signal. Ureter is also 
visible in
white light mode.
5 F 60 72 27.44 0.25 18 No visualization of ureter in NIRF 
mode during the procedure. Ureter is 
visible in white light mode.
6 M 63 103 32.15 0.25 26 Conversion due to intra-abdominal 
adhesions
before NIRF imaging.
7 M 63 89 31.53 0.25 22 No visualization of ureter in 
fluorescence mode.
Ureter is visible in white light mode.
8 M 67 120 37.04 0.25 30 No visualization of ureter during the 
procedure.
Ureter is visible in white light mode.
9 M 69 70 25.10 0.75 52.5 After 45 min: good visualization of 
both right and
left ureter. In left ureter, better 
visualization of
peristaltic movements. Ureter is also 
visible in
white light mode.
After 60 min: good visualization of 
left ureter.
After 90 min: good visualization of 
left ureter.
10 M 52 90 25.74 1.00 90 After 30 min: good visualization of 
ureter. Ureter is also visible in white 
light mode.
After 50 min: pulsatile movement of 
urine through ureter.
NIRF: near-infrared fluorescence
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Table 3 Target-to-Background Ratio measurement for urine samples from patients 5–8 collected for the urine 
catheter at the end of the surgical procedure
Patient Target-to-background ratio
5 6.88
6 8.81
7 7.15
8 9.20
(Target-to-background ratio: target = urine in vial; background is saline in vial)
Table 4 Target-to-Background Ratio for different dilutions of methylene blue in urine of two healthy volunteers
Sample No.
Dilution
MB:Urine
TBR urine
sample 1
TBR urine
sample 2
1 1:1 -0.64 -0.64
2 1:2 -0.196 1.04
3 1:4 0.18 3.32
4 1:8 0.76 4.12
5 1:16 5.58 5.82
6 1:32 8.23 8.21
7 1:160 9.40 8.88
8 1:800 10.33 8.52
9 1:4000 10.33 9.27
10 1:20000 9.90 9.30
11 1:100000 8.70 8.53
12 1:500000 5.08 6.88
MB: methylene blue; TBR: target-to-background ratio (target = urine in vial; background is saline in vial) 
DISCUSSION
Various recent studies have paid attention to the use of NIRF imaging in minimally invasive 
surgery.15 This report describes a clinical feasibility study investigating the utility of NIRF 
imaging using MB for ureteral recognition during human laparoscopic colorectal surgery. 
Previously, promising results were reported with MB in an animal model10 and in two 
human studies during open and laparoscopic surgical procedures.12,16 The primary objective 
of this study was to investigate the feasibility of intraoperative NIRF imaging using MB 
administration for detection of the left ureter during laparoscopic colorectal surgery.
In this study, it was found that this type of imaging provides additional visual distinction 
of the left ureter from its surrounding tissues, compared to the conventional laparoscopic 
view. However, this signal was not strong enough to support the surgeon with enhanced 
ureteral visualization over the conventional white light mode. When the ureter was identified 
in fluorescent mode, it could already be seen in white light mode. Another disadvantage is 
the close proximity (few centimeters) that was required between the endoscope and the 
ureter to obtain a signal. In the aforementioned previous studies, the authors described 
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a distance of 18 and 30 cm between the camera and the surgical field in open surgery. No 
distance was given for the laparoscopic experiments.10
In this study, higher doses of MB resulted in better visualization of the ureter. The dose 
chosen in the beginning of our study was based on the study of Matsui et al.10 The better 
recognition with higher doses is in accordance with the observations of Verbeek et al.14
The ex vivo experiments with MB dilutions in urine of healthy volunteers showed a 
strong fluorescence signal in a wide range of dilutions (Table 3), revealing that even very 
small concentrations of methylene blue in urine can give a clearly visible fluorescence 
signal. This confirms the possibility to obtain a good signal using the present equipment. 
Also, in the collected urine from four patients at the end of the surgical procedure, we 
were able to clearly obtain a fluorescent signal in these urine samples, even though in vivo 
ureteral detection in these patients was not possible with NIRF imaging. It is hypothesized 
that the absence of a clear fluorescence signal in the included cases may be influenced by 
anatomical barriers, such as the ureteral wall thickness and the fatty tissues surrounding the 
ureter, hindering fluorescence signal detection. Currently, fluorescence imaging at the NIR 
range of wavelengths has the potential of a better tissue penetration than visible light, up 
to 10 mm, but the in vivo situation often exceeds this tissue thickness.17
The results found in this study are not compatible with the results found in the study 
by Matsui et al.10 in which the feasibility of methylene blue application in open surgery in 
20 pigs was investigated. In all animals, the ureter was identified successfully. A possible 
explanation for these results is the thinner ureteral wall and sub-retroperitoneal layer in 
pigs and less intra-abdominal fat compared to humans. Verbeek et al. found similar results 
in humans.10,12 However, in their study, they only investigated the feasibility of the use of 
methylene blue in open surgery. A clear identification of the ureters was observed at doses 
between 0.25 and 1.0 mg/kg. Perhaps, in the setup of this study, the optimal combination 
of dye (e.g., dosage and timing of administration) and laparoscopic system has not yet been 
reached to obtain similar results.
There were no adverse (immediate or delayed) reactions with regard to the clinical 
outcome following MB administration in this study. However, shortly after the administration 
of the dye intravenously, a transient decrease of the oxygen saturation was observed, which 
was measured by a finger pulse oximeter. This phenomenon is known and is caused by 
the principle of pulse oximetry, which is based on the red and infrared light absorption 
characteristics of oxygenated and deoxygenated hemoglobin, which is influenced by the 
transient passage of MB18. Preoperatively, the patient should be notified that intravenous 
MB administration could potentially cause a severe anaphylactic reaction; however, this risk 
is very low to negligible.
Main limitation of this study is that the study population is too small to draw firm 
conclusions regarding variables such as optimal timing and dosage of dye administration. 
Furthermore, the patients were included over a relatively long time-span. This was due to 
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changing of the involved researchers. This is not likely to have had a negative effect on the 
performance of the study.
In the cases where the ureter was recognized using the fluorescence mode of the 
laparoscope, recognition was only possible after the ureter had already been identified 
using the conventional white light mode, suggesting that fluorescence imaging of the 
ureter using MB does not provide any added clinical value to this procedure. Therefore, this 
particular imaging modality in this setup is not yet deemed to be suitable in aiding the 
identification of the ureter during laparoscopic colorectal surgery.
In conclusion, we report the human clinical experience with near-infrared fluorescence 
imaging and methylene blue during laparoscopic colorectal surgery for intraoperative 
ureteral detection. Although promising, as indeed visualization of the ureter could be 
obtained, this imaging modality did not provide added value in the delineation of the 
ureter because simultaneous with the fluorescent signal, the ureter could be visualized even 
in conventional white light mode. Future research should focus on exploring alternative 
fluorescent dyes (for example preclinical dyes19) and optimization of the equipment to 
make this promising technique clinically relevant.
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ABSTRACT 
Background 
Ureteric injury is reported to occur in 1–7.6% of colorectal surgeries. To reduce the incidence 
of ureteral injury, it is essential to identify the ureters. The use of near-infrared fluorescence 
(NIRF) imaging with intravenously administered dyes might be of added value for ureteral 
visualization during laparoscopy. The aim of this study is to assess the performance of 
three preclinical dyes; IRDye® 800BK, IRDye® 800NOS and IRDye® 800CW, for near-infrared 
fluorescence laparoscopy of the ureter in pigs.
Methods 
In three female Dutch landrace pigs, the new dyes were evaluated. In each pig, 1 dye was 
tested using a 6-mg intravenous dose in a concentration of 1 mg/ml. Imaging was performed 
in fluorescence mode and white light mode with a laparoscopic imaging system. In order 
to further evaluate the dyes, an ex vivo imaging experiment was performed, in which 8 
decreasing concentrations per dye, diluted in PBS, were evaluated in a transparent test tube 
with NIRF mode at a distance of 1, 5 and 10 cm from the laparoscope.
Results 
All three dyes were effective in allowing the identification of the ureter with NIRF imaging. 
The ureter became fluorescent after 35, 45 and 10 min, respectively, for IRDye® 800BK, 
IRDye® 800NOS and IRDye® 800CW with a maximum target-to-background ratio (TBR) of 
2.14, 0.66 and 1.44, respectively. In the ex vivo imaging experiment, all three dyes produced 
a strong fluorescence signal at all concentrations and all distances evaluated.
Conclusions 
Intravenous administration of the preclinical dyes IRDye® 800CW, IRDye® 800 BK and IRDye® 
800NOS facilitated successful identification of the anatomical course of the ureter in living 
pig models. The highest measured TBR occurred with the use of IRDye® 800BK. Ex vivo, 
a correlation was observed between the fluorescence intensities of the signal with the 
concentration of the dye and with the distance to the object.
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INTRODUCTION 
With a reported incidence rate of 1% up to 7.6%, the occurrence of ureteric injury is one 
of the feared complications in colorectal surgery.1–4 Ureteric injury can result in pain, intra-
abdominal sepsis, systemic infection, abscesses, urinoma, ureteral stricture, ureteric fistula, 
renal failure and loss of the ipsilateral renal unit.4–6
Failure to identify the relevant anatomy seems to be the main factor leading to ureter 
damage.7 To avoid ureteric injury, it is therefore essential to identify both ureters during 
surgery. However, this may be difficult and time-consuming. Ureter stent placement is a 
technique which can be used in open surgery to help identify the ureters.4 In laparoscopic 
surgery, however, in which tactile feedback is limited, this application is hardly useful. A 
technique improving the visualization of ureters in laparoscopic surgery is therefore 
needed. The use of near-infrared fluorescence (NIRF) imaging might be able to meet this 
need. This technique is already used in hepatobiliary surgery to visualize the bile ducts8 or 
the perfusion of the liver9, and in colorectal surgery to assess the perfusion of the bowel 
anastomosis.10–15 A few studies have also been published on the use of NIRF imaging to 
identify the ureters.
The most commonly used fluorescent dye in laparoscopic surgery is indocyanine green 
(ICG). However, administering this dye intravenously does not facilitate the visualization of 
the ureters, as it is exclusively cleared by the liver, and therefore not excreted via the urine.16 
Alternatively, ICG might have potential for visualizing the ureters if administered through a 
ureter stent.17, 18 Disadvantages of this technique include its invasiveness, the requirement 
of cystoscopy and possible complications such as urinary tract infections, hydronephrosis 
and hematuria.4 This indicates that the use of ICG is a less than optimal option for the 
visualization of ureters during laparoscopy.
The above illustrates that there is a need for a potent fluorescent dye that can be 
administered intravenously, is cleared by the kidneys and has no side effects. A previous 
study showed that the preclinical IRDye® 800CW (LI-COR Inc., Lincoln, NE, USA) provided 
clear ureter visualization in a porcine model19 and, as such, has the potential to be such a 
dye. As this dye is quite expensive for this application, the manufacturer of IRDye® 800CW 
developed two new, less expensive dyes: IRDye® 800BK and IRDye® 800NOS. These dyes 
proved to be very promising in cystic duct and cystic artery visualization after intravenous 
administration.20 They are both partially cleared by the liver and by the kidneys, which makes 
them eligible to be used in NIRF imaging of the ureters after intravenous administration.
The aim of this study is to assess the performance of IRDye® 800BK, IRDye® 800NOS and 
IRDye® 800CW in visualizing the ureter in pigs during near-infrared fluorescence laparoscopy.
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MATERIALS AND METHODS 
This study was conducted at the central animal facilities of Maastricht University (Maastricht, 
The Netherlands). Animals were used in compliance with the regulations of the Dutch 
legislation concerning animal research, and the study was done according to a protocol that 
was approved by the local animal ethics committee. A pig model was chosen because of 
the similarities between pig anatomy and human anatomy and because of earlier successful 
application of NIRF imaging in pigs.19 The experiments were done in three female Dutch 
landrace pigs (each weighing 40 kg).
Laparoscopic fluorescence imaging system
A laparoscopic fluorescence imaging system (Karl Storz GmbH &CO. KG, Tuttlingen, Germany) 
with a xenon- based light source was used. This system enables excitation and detection of 
all three dyes used in this experiment: IRDye 800CW ( EX/EM = 775/796 nm), IRDye® 800BK 
( EX/EM = 774/790 nm) and IRDye® 800NOS ( EX/ EM = 767/786 nm). All procedures were 
digitally recorded with the built-in recording equipment. The same NIRF imaging settings 
were used for all three dyes tested.
Characteristics and preparation of the dyes 
IRDye® 800CW is a tetrasulphonated heptamethine indocyanine dye. After intravenous 
injection, it is cleared by the kidneys and excreted into urine. It is also partially cleared by the 
liver and excreted into bile. It can therefore be used for both bile duct and ureter visualization. 
Its maximum absorption occurs at 775 nm and its maximum excitation emission at 796 nm. 
The molecular weight of IRDye® 800CW is 1090.11 Da.21
IRDye® 800BK and IRDye® 800NOS are two newly developed dyes. IRDye® 800BK is a 
hydrophilic dye with a maximum absorption of 774 nm and a maximum emission of 790 
nm. Because of its hydrophilic nature, it is primarily cleared by the kidneys. This makes the 
dye especially useful for intraoperative ureter imaging. Nevertheless, some clearance by the 
liver takes place.
IRDye® 800NOS is less hydrophilic and, as such, primarily cleared by the liver. This 
theoretically makes it especially useful for visualization of the biliary system. However, 
this dye is also partially excreted by the kidneys and could there- fore also facilitate the 
visualization of ureters. The maximum absorption occurs at 767 nm and its maximum 
emission at 786 nm.
The dyes were prepared and used following instructions of the manufacturer.
Surgical technique and assessment guidelines 
The surgical procedures were performed under general anesthesia, as has been previously 
described in an earlier study.20 Surgical residents performed a laparoscopic partial excision 
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of the bicornate uterus, mimicking a laparoscopic appendectomy. These procedures were 
strictly supervised by two expert endoscopic gastrointestinal surgeons (NB and LS). Each 
pig received one of the three dyes intravenously at a total dose of 6 mg (1 mg/ml).
Imaging was performed intermittently in fluorescence mode and white light mode. 
Intraoperatively, the first authors (MA and JvdB) systematically documented whether 
the ureters could be identified in fluorescence mode, by filling in a registration form. The 
attending surgeon was consulted to reach agreement on the identification of the ureters. 
A structure was defined as ‘identified’ if its localization was confirmed with certainty by the 
experienced surgeon.
Ex vivo NIRF imaging 
In the ex vivo experiment, 8 decreasing dye concentrations, diluted in PBS, were evaluated 
in NIRF mode, in a completely darkened room with the laparoscope held at a distance of 
1, 5 and 10 cm, respectively. A transparent 10 ml test tube was filled with 10 ml of each 
dye concentrations. The initial dilution consisted of 10 mg of the dye being diluted in 10 
ml of PBS. From this basic concentration, decreasing dye concentrations were made. The 
evaluated concentrations of dye/PBS were 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 and 1:128.
Postoperative analysis of the fluorescence
For an objective assessment of the fluorescence illumination, OSIRIX Lite v9 imaging software 
(Pixmeo, Geneva, Switzerland) was used. Fluorescence was analyzed by deter- mining the 
fluorescence intensity (FI) and the target-to-back- ground ratio (TBR). By doing so, it could 
be objectified whether the target organ (the ureter) was more fluorescent compared to the 
surrounding tissues. The TBR is defined as the mean fluorescence intensity (FI in arbitrary 
units, A.U.) of three points of interest in the target (ureter), minus the mean fluorescence 
intensity of three points of interest in the background divided by the mean fluorescence 
intensity of three points of interest in the background. In formula: TBR = (FI of target − FI 
of background)/(FI background).19, 20, 22 Areas with light scattering were avoided in these 
points of interest. The background FI in the ex vivo experiments was negligible due to the 
completely darkened room, and therefore, no TBR was calculated.
For the FI of the target, three centrally located regions of interest were chosen in the 
ureter. The mean fluorescence intensity of these three regions was the FI of target. When 
using this technique to establish the TBR, choosing a reproducible background is important. 
Therefore, as background 3 regions of interest 1 cm bilateral (2 right and 1 left) from the 
ureter were chosen in the in-vivo study. The mean scores of these three fluorescence 
intensities were used as the FI of background.
For the ex vivo study, the mean of three regions of interest at the center of the test tube 
filled with dye dilution was chosen as a target.
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RESULTS 
In all three experiments, it was possible to successfully identify the ureters with NIRF imaging. 
Results obtained during the operations are presented in the intraoperative registration 
form in Table 1. A representative screenshot in fluorescence mode was made of each of the 
three pigs.
The first witnessed identification of the ureters occurred within minutes after dye 
administration with all three dyes. The ureteral wall became fluorescent in NIRF mode 
together with the uterus, bowel and lymph nodes. No peristaltic movement of urine within 
the ureters could yet be seen. Therefore, we could not identify the course of the ureter with 
absolute certainty at this stage. 
Thirty-five minutes after the administration of the IRDye® 800BK dye, peristaltic 
movement of the urine was clearly visible in NIRF mode due to the fluorescent dye excreted 
in the urine. The ureters remained fluorescent until the final assessment 3.5 h after dye 
administration. The highest measured TBR was 2.14 (Figure 1a).
The first appearance of fluorescence of the ureters in the second pig (IRDye® 800NOS) 
occurred 45 min after dye administration with clear peristaltic movement of urine within the 
ureters. The highest measured TBR was 0.66 (Figure 1b).
In the third pig, the first fluorescent imaging of the ureters occurred 10 min after the 
IRDye® 800CW dye was administered. Both ureters were clearly distinguishable from their 
surroundings. A second evaluation, 25 min after dye administration, showed a persistent 
clear delineation of the ureters in NIRF mode. The highest measured TBR was 1.44 (Figure 
1c).
No complications or adverse reactions were observed in any of the experiments.
Ex vivo NIRF imaging 
With all three dyes, a strong fluorescence signal was achieved in all concentrations and at all 
distances evaluated. The results are depicted in Figure 2a–c.
At 1 cm distance, all dyes in all concentrations showed comparable FI without clear 
fluctuations. At 5 cm distance, the FI of all dyes was lower in the highest concentrations. In 
these concentrations, IRDye® 800CW showed the highest FI. This effect disappeared in the 
lower concentrations. At 10 cm distance, also an inverse relation between concentration 
and FI was observed for all three dyes. IRDye® 800CW and IRDye® 800BK showed a higher FI 
in all concentrations when compared to IRDye® 800NOS. All three dyes showed a decrease 
in FI when the laparoscope was held at a 10 cm distance, as compared to when it was held 
at 1 and 5 cm distance, respectively. The highest FIs were achieved at 1 cm distance for the 
higher concentrations and at a 5 cm distance for the lower concentrations.
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Figure 1 Visualization of the ureter with the experimental dyes: a with IRDye® 800BK with highest TBR (2.14), b 
with IRDye® 800NOS with highest TBR (0.66), c with IRDye 800CW with highest TBR (1.44)
Table 1 Intraoperative registration form 
Injected dye
Visualization 
left ureter 
Visualization 
right ureter 
Time to first certain 
visualization of 
ureter 
Highest 
measured TBR 
IRDye® 800BK Yes Yes 35 min 2.14
IRDye® 800NOS Yes Yes 45 min 0.66
IRDye® 800CW yes Yes 10 min 1.44
TBR: Target-to-background ratio
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Figure 2 Fluorescence intensities (FI) for the three dyes for different dye concentrations with the laparoscope 
held at 1 cm (A), 5 cm (B) and 10 cm (C) distance from the object. 
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DISCUSSION
The most frequently used near-infrared fluorescent dye, indocyanine green, is exclusively 
cleared by the liver20 and can therefore not be used for ureteral imaging after intravenous 
administration. Such imaging requires a dye that is excreted in urine or invasive techniques 
with a ureter catheter insertion through which the fluorescent dye can be introduced into 
its lumen.18, 23
Verbeek et al. used methylene blue as a fluorescent dye for ureter visualization in open 
pelvic surgery in 12 patients. In all 12 patients, the ureters could be clearly visualized.24 
Yueng et al. showed visualization of the ureters in 10 out of 11 included patients. The 
technique was considered useful in 4 of these 10 cases. A recent study by Barnes et al. 
showed promising results allowing visualization of the ureter in a clinical study in which 
fluorescence imaging with methylene blue was of added value compared to white light 
in 14 of 69 ureters assessed.25 However, in another study that used methylene blue as a 
fluorescent dye in laparoscopic colorectal surgery, this technique was not found to be 
superior to conventional white light laparoscopy in any of the included cases.26 Although 
no side effects are reported in these studies, a disadvantage of using methylene blue is that 
it comes with some potential side effects, such as a small risk of anaphylactic reaction27 and 
the potential occurrence of vasoconstriction.
A promising near-infrared fluorescent dye that is cleared by the kidneys is IRDye® 
800CW.23 However, this dye is expensive for this application. Newer pre- clinical dyes which 
are cheaper to produce are IRDye® 800NOS and IRDye® 800BK. The manufacturer estimates 
their cost to be in the range of commercially available ICG (personal communication). In 
the present study, the usefulness of three preclinical dyes for NIRF imaging of the ureters 
was explored. IRDye® 800BK is especially developed for excretion via the urine, being 
hydrophilic in nature. It is therefore expected that this dye will equal or outperform the 
imaging capabilities that have previously been described for IRDye® 800CW.20
All three dyes enabled clear and satisfactory visualization of the anatomical course 
of both ureters, as can be seen in Fig. 1a–c. The highest maximum in-vivo FI and TBR was 
measured with the IRDye® 800BK, and the lowest maximum FI and TBR was found with the 
IRDye® 800NOS. This is in line with expectations, as the hydrophilic IRDye® 800BK is mainly 
cleared by the kidneys, while IRDye® 800NOS is less hydrophilic and only partially cleared 
by the kidneys. Nevertheless, all three dyes give clear visibility of the ureters. The TBRs for 
IRDye® 800CW were comparable with previous experiments.19
In the ex vivo study, a clear fluorescence signal was achieved with all concentrations 
and at all the tested distances. The highest FIs were achieved when the laparoscope was 
held at 1 and 5 cm distance, whereas the lowest FI was achieved at a distance of 10 cm. This 
supports earlier studies which showed that the FI is negatively influenced by an increase in 
the distance of the laparoscope from the target.28
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Further studies evaluating more concentrations and distances may be helpful in 
identifying the ideal distance/concentration combination.
There were no adverse reactions as a result of the administration of the dyes. A transient 
decrease in SpO2 oxygen saturation is known with the use of intravenous fluorescent dyes, 
temporarily resulting in falsely lower oxygen levels.29, 30 An advantage of these new dyes 
over iodine containing ICG is that these dyes can also be used in patients with a known 
hypersensitivity to iodine or iodine allergy. Due to the low number of pigs assessed, no 
conclusion may yet be drawn regarding the safety of the dyes.
Despite the promising results, the findings of this study have to be interpreted with 
caution. Since each dye was only tested in-vivo at one specific dosage and each dye was 
only tested in one pig, further experiments are needed to determine optimal dosing and 
timing of the dyes which are dependent on the pharmacokinetic properties of the dyes. 
Furthermore, testing in human subjects should be awaited in order to assess the clinical 
value of the dyes.
CONCLUSION
Intravenous administration of the preclinical dyes IRDye® 800CW, IRDye® 800BK and IRDye® 
800NOS allowed for successful NIRF identification of the course of the ureters in a live 
pig model. The use of IRDye® 800BK resulted in the highest contrast between ureter and 
background.
Ex vivo, a correlation of the signal was observed with the concentration of the dye and 
with the distance to the object.
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ABSTRACT 
Background 
Iatrogenic ureteric injury remains a risk in laparoscopic pelvic procedures. Near-infrared 
fluorescence (NIRF) imaging is a promising new technique for enhanced intraoperative 
visualization of anatomical structures that could improve the safety of laparoscopic surgery. 
A new fluorescent dye, IRDye® 800BK has been developed for intraoperative visualization of 
the ureters using NIRF. The present study was a first evaluation of the performance of IRDye® 
800BK for ureteric imaging during NIRF laparoscopy. 
Methods
This study consisted of three parts: real-time in vivo NIRF imaging using IRDye® 800-BK in 
pigs during laparoscopic surgery, ex vivo NIRF imaging of freshly explanted pig ureters and 
ex vivo NIRF imaging of explanted human ureters.
Results 
In all animals, both left and right ureters were visualized throughout the laparoscopic 
procedure for 120 min, with the best results at a dose of 0.15 mg dye per kg bodyweight. 
NIRF imaging was successful in all human and porcine ureters studied, with a range of dye 
concentrations.
Conclusions
NIRF imaging of the ureters using IRDye® 800-BK was used successfully both in vivo in a 
porcine model, and ex vivo in porcine and human ureters.
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INTRODUCTION 
Despite advances in laparoscopic surgery, iatrogenic ureteric injuries during laparoscopy 
may still occur.1 Several studies2–5 have reported an incidence of between 0.1 and 7.6 per 
cent in colorectal and gynecological surgery, with more than 80 per cent of injuries going 
unrecognized during surgery. Ureteric injury leads to significant postoperative morbidity 
even if identified and repaired during the same procedure.6 Near-infrared fluorescence (NIRF) 
imaging is a promising new technique for easier and earlier intraoperative visualization of 
target organs with the potential to improve the safety of laparoscopic surgery.7,8 Indocyanine 
green (ICG) and methylene blue are currently the only clinically available dyes that may be 
helpful in intraoperative visualization of the ureter.9–11 However, a feasibility study12 recently 
showed that, even though imaging using methylene blue was safe and feasible, it did not 
provide a practical advantage over conventional laparoscopic imaging for identification of 
the ureter during laparoscopic colorectal surgery.
IRDye® 800CW (LI-COR Biosciences, Lincoln, Nebraska, USA) is an experimental dye 
that allows intraoperative visualization of crucial anatomical structures using NIRF imaging. 
Animal studies have successfully demonstrated the potential of this dye for identification of 
the ureters.13 – 15 However, a major disadvantage of IRDye® 800CW is its cost, which is almost 
tenfold that of ICG. 
Recently a new preclinical dye, IRDye® 800-BK (LI-COR Biosciences), has been developed 
specifically for intraoperative NIRF visualization of the ureters. Because of its hydrophilic 
nature, it is primarily cleared by the kidneys and may therefore have great potential for real-
time NIRF imaging of the ureter. According to the manufacturer, the price of IRDye® 800-BK 
is expected to be similar to that of ICG. The aim of the present study was to evaluate this dye 
for ureteric imaging during NIRF laparoscopy.
METHODS
This study was conducted at the central animal facilities of Maastricht University (Maastricht, 
The Netherlands). Animals were used in compliance with the regulations of Dutch legislation 
for animal research and following a protocol approved by the local animal ethics committee. 
Three female Dutch Landrace pigs were used as well as explanted porcine and human 
ureters. The ARRIVE guidelines16 were followed for reporting these experiments.
A laparoscopic fluorescence imaging system (Karl Storz, Tuttlingen, Germany) was used. 
The D-Light P system includes a plasma light guide and a 30degree 10-mm laparoscope 
applicable for white light and NIRF imaging. It enables excitation of the dye under evaluation. 
A foot pedal allows the surgeon to switch easily between the two imaging modalities. All 
procedures were recorded digitally.
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IRDye® 800BK has a maximum absorption at 774 nm and a maximum emission at 790 
nm. The dye was prepared before use according to the manufacturer’s instructions and 
diluted in sterile phosphate-buffered saline (PBS) to a concentration of 1 mg/ml.
The experiments consisted of three parts. The performance of the dye was tested in 
vivo in a pig model, as a dose-finding study. Then, the influence of the thickness of the 
ureter wall and the dose administered on the signal achieved was tested during ex vivo 
experiments using both porcine and human ureters.
In vivo fluorescence imaging 
The dye was tested during laparoscopic surgery in three female Landrace pigs, each 
weighing between 39 and 39.6kg. Premedication consisted of intramuscular injection of 
azaperone 3mg/kg, ketamine 10mg/kg and atropine 0.05mg/kg. Anesthesia was induced 
with intravenous thiopental 10-15mg/kg. After intubation, the pigs were maintained under 
anesthesia with isoflurane and oxygen. Vital parameters were monitored continuously.
The pigs were placed supine in a steep Trendelenburg position and three trocars were 
introduced: a 12-mm trocar in the midline superior to the umbilicus and two 5-mm trocars 
on either side. Pneumoperitoneum was established with carbon dioxide. Surgery and NIRF 
imaging were performed by two surgeons specifically experienced in laparoscopic surgery 
and NIRF imaging. The ureters were not dissected or exposed in any animal.
The first pig received an intravenous dose of 6 mg (6 ml) IRDye® 800BK as a bolus, which 
was in the range of doses used in previous experiments with IRDye® 800CW. The second 
and third pigs received half (3mg) and double (12mg) this dose respectively. The dye was 
administered directly after introduction of the laparoscopic trocars. Observation of the left 
and right ureters, in white light and fluorescence mode, was planned for every 10 min for 
1h, starting after 20min, and every 20min during the second hour. However, the ureter was 
visualized clearly after 20 min in the first pig, so it was decided to initiate visualization right 
from the start of the operation in the next two animals. After surgery, the pigs were killed in 
accordance with the guidelines of the Dutch legislation for animal research.
Ex vivo fluorescence imaging of porcine ureters 
Freshly explanted pig ureters were collected from the abattoir on the day of the experiments. 
Ureters were flushed with PBS followed by flushing with the diluted IRDye® 800-BK, during 
which first the distal and then the proximal part of the ureter was clamped, ensuring 
watertight closure on both sides. The whole process was recorded with the laparoscope in 
fluorescence mode at a distance of 10 cm from the ureter. The same background was used in 
all ureters studied. The following dilutions were examined: 1:4, 1:16, 1:64 and 1:256.
Ex vivo fluorescence imaging of human ureters
Tissue was obtained from the Maastricht Pathology Tissue Collection. Collection, storage, 
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and use of tissue and patient data were in agreement with the code for proper secondary 
use of human tissue in the Netherlands (http://www.federa.org). A pathologist explanted 
the ureters during post-mortem examination of patients not previously known to have 
urological diseases or ureteric abnormalities. All ureters were explanted within 2weeks 
before experimentation and stored at -20 degrees Celsius. They were defrosted at room 
temperature 3h before the experiments. The NIRF imaging procedure was similar to that for 
ex vivo porcine ureters. Dilutions examined were: 1:1, 1:4, 1:16, 1:64, 1:256, 1:1024 and 1:4096.
Measurement of ureter wall thickness
In ex vivo experiments, a representative cross-section of the distal third of the ureter was 
analyzed microscopically, on the basis that this part of the ureter is usually of interest during 
laparoscopic colorectal and gynecological surgery.17 Ureter wall thickness was defined as 
the distance from the surface of the luminal urothelium to the outer layer of smooth muscle. 
Wall thickness values presented are the mean of nine measurements per cross-section.
Analysis
Video recordings of the laparoscopic procedures were assessed for the degree of 
fluorescence illumination using OSIRIX version 5.0.1 imaging software (Pixmeo, Geneva, 
Switzerland). Signal and target-to-background ratio (TBR) were determined from 
representative screenshots. The TBR was defined as the mean fluorescence intensity (FI) of 
three points of interest in the target (ureter) minus the mean FI of three points of interest 
in the background directly adjacent to the ureter, divided by the mean FI of three points of 
interest in the background.18
The ex vivo experiments were performed in a completely darkened room with the 
laparoscope 10cm from the explanted ureter. The fluorescence from an area 1 cm lateral to 
the ureter was chosen as the background fluorescence for each ureter.
RESULTS
In vivo fluorescence imaging 
Pig 1, with a bodyweight of 39.4 kg, received an intravenous bolus of 6 mg dye, resulting in 
a dose of 0.15mg dye per kg bodyweight. The first clear and distinct visualization of both 
the left and right ureters in fluorescence mode occurred 20 minutes after administration 
of the dye. Pig 2, with a bodyweight of 39.0 kg, received an intravenous bolus of 3mg dye 
(0.08 mg dye per kg bodyweight). The first clear and distinct visualization of both ureters in 
fluorescence mode occurred 20 minutes after dye administration. Pig 3, with a bodyweight 
of 39.6 kg, received an intravenous bolus of 12 mg dye (0.30 mg per kg bodyweight). The first 
visualization of both ureters in fluorescence mode occurred 1 minute after administration 
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of dye. At this stage, it was the wall of both ureters that became clearly visible. The first 
peristaltic movements of urine through the ureter were observed 10 minutes after 
administration of dye.
In all three pigs, both the left and right ureter were visualized with peristaltic movement 
until the end of the experiment after 120 minutes, confirming transportation of the dye-
containing urine through the ureter. A very clear and certain course of the ureter could be 
observed subjectively in pigs 1 and 3. In contrast, the FI of the ureter in pig 2 was significantly 
lower than in the other two pigs, making it difficult to distinguish the ureter from the 
surrounding tissues. The measured FI is shown in Figure 1. Pig 1 had the highest absolute 
FI measured, followed by pig 3 and pig 2. Figure 2 shows TBRs at various points during the 
laparoscopy for the left ureter in the three pigs. The TBR was highest for the highest doses 
administered.
In all pigs, the subjective maximum intensity of the fluorescence signal was seen at 
moments of peristaltic contractions of the ureter, showing transport of intraluminal urine 
from proximal to distal. Screenshots of the left ureter 30 and 120 min after injection of 6 mg 
IRDye® 800-BK in pig 1 are shown in Figure 3, with the ureter distinct from the surrounding 
tissue.
Ex vivo fluorescence imaging of porcine ureters
The wall thickness of the four pig ureters ranged from 93.3 to 129.0 (mean 113.6) μm. A clear 
delineation of all four ureters was possible using fluorescence imaging, even at the lowest 
concentration of dye tested. FI and TBR ranged from 38 to 56 and 6.60 to 10.20 respectively 
(Table 1). An initial lowering of the concentration seemed to improve the signal, despite 
increasing wall thickness (TBR ureter 2 versus 1). Further dilution gave varying results: an 
initial decrease in the signal, as observed in ureter 3, but an increase in ureter 4. Variations in 
concentration and wall thickness are shown in Table 1. A further observation was that fatty 
tissue on the ureter strongly influenced the fluorescence signal (Figure 4). A signal could be 
obtained only in areas where the ureter was not covered by fat as seen by the naked eye. 
This effect was consistent across all ureters and at all concentrations tested.
After rinsing the ureter extensively with pure PBS, a low fluorescence signal remained in the 
ureter, both in the lumen and in the outer layer of the ureter (Figure 5), suggesting uptake of 
the dye in the wall of the ureter.
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Figure 1 Absolute fluorescence intensity (FI) at various time points for the left ureter in a pig 1 (IRDye® 800-BK 
dose 6 mg), b pig 2 (dose 3mg) and c pig 3 (dose 12 mg), showing the mean FI for the target (ureter) and its 
background
Table 1 Influence of wall thickness and dye concentration on fluorescence intensity and target-to-background 
ratio of pig ureters
Ureter 
No
Concentration of 
IRDye® 800BK in 
PBS 
Ureter wall 
thickness (μm)
Fluorescence 
intensity
Target to 
background ratio 
1 1:4 119.2 38 6.6
2 1:16 129.0 56 10.2
3 1:64 112.7 40 7.0
4 1:256 93.3 46 8.2
PBS: phosphate-buffered saline 
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Figure 2 Target-to-background ratio (TBR) at various time points during laparoscopy for the left ureter in a pig 
1 (IRDye® 800-BK dose 6mg), b pig 2 (dose 3 mg) and c pig 3 (dose 12 mg)
Figure 3 Screenshots of left ureter after 30 min (right) and 120 min (left) after injection of 6mg IRDye® 800-BK 
in pig 1. Arrow indicates the ureter.
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Right: inner surface of the ureter. Left outer layer of the same ureter. The blue arrow indicates the luminal surface of the ureter, 
the red arrow the outer layer of the ureter, and the yellow arrow the overlying fatty tissue.
Figure 5 Screenshots of explanted pig ureter 1
The blue arrow indicates the ureter, and the yellow arrow the overlying fatty tissue
Figure 4 Screenshot of explanted pig ureter 2
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Ex vivo fluorescence imaging of human ureters
Wall thickness of seven post-mortem human ureters ranged from 133.8 to 189.0 (mean 162) 
μm. Clear delineation of all seven ureters was possible using fluorescence imaging, at all dye 
concentrations, with FI and TBR ranging from 11 to 49 and 1.20 to 8.80 respectively (Table 2). 
Again, areas of ureter covered by a layer of fatty tissue did not show fluorescence.
DISCUSSION
IRDye® 800-BK has been developed specifically for intra- operative NIRF visualization of the 
ureters. The goals of the present experiments were to see whether the new dye would be 
suitable for visualization of the ureter and to perform a first preliminary evaluation of factors 
likely to influence the signal produced.
The study confirmed visualization of the ureters in real time both in vivo and ex vivo. 
In vivo, administration of a bolus of 6 and 12 mg (0.15 and 0.30mg/kg respectively) allowed 
excellent and clear visualization of the ureters in NIRF mode. The dose of 3mg (0.08mg/kg) 
also provided enhanced imaging of the ureter, although the FI was weak.
The maximum intensity of the fluorescence signal was seen during contractions of the 
ureter, showing the transport of intraluminal urine from proximal to distal. The relationship 
with peristalsis is a slight drawback, as the signal is not present permanently, although this 
will be the case for every signal produced by a dye transported in urine. This seems greatly 
surpassed by the excellent signal during these episodes of contractions.
A signal was observed for up to 120 min after the administration of dye, when the 
surgical procedures were terminated. A study with longer continuous NIRF visualization of 
the ureter may be beneficial.
Each ureter showed varying FI and TBR throughout the in vivo study. A possible 
explanation may have been failure to standardize the laparoscope-target distance. It is 
Table 2 Influence of wall thickness and concentration of dye on fluorescence intensity and target-to 
background ratio of human ureters 
Ureter 
No
Concentration of 
IRDye® 800BK in 
PBS 
Ureter wall 
thickness (μm)
Fluorescence 
intensity
Target to 
background ratio 
1 1:1 150.8 42 7.4
2 1:4 171.6 49 8.8
3 1:16 158.9 37 6.4
4 1:64 167.8 45 8.0
5 1:256 189.9 25 4.0
6 1:1024 133.8 22 3.4
7 1:4096 162.1 11 1.2
PBS: phosphate-buffered saline 
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possible that the laparoscope was at different distances from the ureter, resulting in different 
amounts of fluorescence being detected and influencing the TBR. Kono and colleagues19 
reported that the signal contrast on fluorescence images of bile duct samples differed 
significantly between the laparoscopic imaging systems, and tended to decrease as the 
laparoscope-target distance increased and porcine tissues covering the samples became 
thicker.
In the in vivo study, all concentrations of dye tested resulted in enhanced visualization 
of the ureter compared with conventional white light, as indicated by a positive TBR value. 
Doses of 6 and 12 mg gave the best intraoperative results. Doses that resulted in a subjectively 
better signal and a higher measured absolute intensity did not always result in a higher TBR. 
This may be explained by the influence of the dose both on target and background signals. 
A low FI of the target may be accompanied by a very low FI of the background, whereas a 
higher FI of the target may be accompanied by a high background signal.
At all doses studied it was observed that urine flow in the ureter was not continuous 
but related to contractions, with the fluorescent signal related to urine flow, resulting in 
fluctuations in the fluorescence signal detected. As a result, the observed and measured 
signals and TBRs may vary over time during in vivo studies. In contrast, in the ex vivo 
experiments a uniform background could be chosen, which enabled comparison of the TBR 
between experiments.
To further study the dose-visibility relationship, explanted pig ureters and dye dilutions 
ranging from 1:4 to 1:256 were used. A clear delineation of the ureters was obtained at 
all doses, with a TBR ranging from 6.6 to 10.20. As it has been suggested previously that 
ureter wall thickness may have a negative influence on NIRF intensity12, and that findings 
in animal studies may not be representative of humans, human ureters with their thicker 
walls were also subjected to ex vivo NIRF imaging. Dye concentrations from 1:1 up to 1:4096 
showed successful NIRF imaging in all human ureters, with TBRs ranging from 1.20 to 8.80. 
The increased wall thickness therefore did not prevent the fluorescence signal, although a 
decrease in FI was observed at the lowest concentrations. In both the porcine and human 
ex vivo experiments, not all results for TBR had a logical explanation, but it seems that the 
concentration of dye had a greater influence than thickness of the ureter wall.
No complications or adverse reactions attributable to the dye were observed during 
any operations. Only a slight and transient decrease in intraoperative peripheral oxygen 
saturation was noted during the first minute after injection of the fluorescent dyes.
A limitation of the ex vivo experiments is that two influences were studied at the same 
time: dye concentration and wall thickness. Ideally, different concentrations of dye should 
be tested in the same ureters, and the same con- centration in different ureters. The first of 
these types of experiment is not feasible, because the fluorescent signal was retained in the 
ureter wall. Such an experiment can therefore be performed only using artificial material. 
The second experiment has not yet been undertaken.
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Despite the promising results, the present findings must be interpreted with caution. 
Owing to the limited availability of pigs and ureters, it was not possible to study enough 
ureters for solid statistical conclusions to be drawn. Another limitation is that concentrations 
of dye in the urine were not measured. This requires availability of the structural formula of 
the dye and a method for such measurement. These were not available to the authors in this 
early phase of development and application of the dye.
It was disappointing in the ex vivo study that even the smallest layer of fat covering the 
ureter prevented a decent signal from being obtained. It is known that penetration of the 
NIRF signal is limited to approximately 10 mm.20 NIRF imaging with a stronger dye or with 
optimized equipment was hoped to enhance such penetration. The present experiment 
illustrates that the signal may be improved with use of a better dye, but that this does not 
affect depth penetration per se. In the in vivo study, nevertheless, the porcine ureters could 
be identified clearly without any manipulation or dissection of the overlying tissues. This 
suggests that IRDye® 800BK has the potential to detect the ureter in spite of the overlying 
peritoneum. Future studies should evaluate the maximum depth of penetration of the NIRF 
signal and the clinical value of this dye in human subjects.
This novel dye enables visualization of the ureters. NIRF imaging with this dye seems a 
valuable addition to conventional white light laparoscopy. Further studies are needed to see 
if it can become a worthwhile addition to improve clinical practice.
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ABSTRACT 
Background
This study assessed the feasibility of near-infrared fluorescence imaging with indocyanine 
green (ICG) to identify the parathyroid glands (PGs) intraoperatively and to assess their 
perfusion after thyroid resection.
Methods
Patients undergoing elective thyroidectomy were enrolled in this prospective study. An 
intravenous bolus of 7.5 mg ICG was administered twice: the first bolus to identify the PGs 
before resection of the thyroid and the second to assess vascularization of the PGs after 
resection.
Results
A total of 30 operations in 26 patients were included. In 17 surgeries (56.7%), fluorescence 
imaging was of added value, especially to confirm the presence of a suspected PG. No 
intraoperative or postoperative complications occurred because of the use of ICG.
Conclusion
Near-infrared fluorescence imaging with the use of ICG for intraoperative identification of 
the PGs and the assessment of its vascularization is feasible and safe and can provide more 
certainty about the location of the PGs.
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INTRODUCTION 
Iatrogenic injury of the parathyroid glands (PGs) is the most common complication after 
total thyroidectomy.1 Damage of the PGs can cause hypoparathyroidism, which results 
in hypocalcemia. The reported incidence of hypocalcemia after total thyroidectomy 
varies widely: between 1.6% and 50%.2–4 Hypocalcemia can result in increased morbidity, 
including cardiac arrhythmias and tetany leading to pro-longed hospitalization and even 
death.5 To avoid parathyroid injury, it is essential to identify the PGs and preserve their blood 
supply. However, this can be challenging due to their small size and the fact that they can 
be difficult to distinguish from their surrounding tissues. Intraoperative guidance to help 
identify and assess the PGs during thyroid surgery may prevent surgical damage and thus 
provide a better post-operative outcome and quality of life. A few intraoperative imaging 
techniques have been described. Dudley6 was the first to use intravenous administration 
of methylene blue (MB) to stain parathyroid tissue in vivo in 1971. After publication of 
this study, MB has been implemented by other surgeons.7 The chance of complications 
due to intravenous administration of MB, including neurotoxicity and acute MB-induced 
phototoxicity, pain at infusion site and nausea is a major drawback of thistechnique.7–10 
To avoid these complications due to a high dose of MB, a lower dose in combination with 
near-infrared fluorescence (NIRF) imaging was investigated.11However,in analogy with the 
use of MB for staining without NIRF-imaging, this technique mainly visualizes abnormal 
PGs. To avoid iatrogenic damage, visualization of normal PGs is essential. A technique in 
which both abnormal and normal PGs can be identified is fluorescence imaging with 
5-aminolevulinicacid.12 However, this technique also has its side effects and requires 
extensive photosensitization preparation and thereby, patients have to be shielded from 
direct light exposure for 48 hours to prevent phototoxic reactions.13 A promising technique 
to visualize healthy and diseased parathyroid tissue has emerged in the use of intraoperative 
NIRF imaging using intravenously administered indocyanine green (ICG). This safe and 
rapidly evolving intraoperative imaging modality is described for use in a wide range of 
surgical procedures, such as identification of the biliary anatomy, assessment of anastomotic 
perfusion, and sentinel lymph node mapping.14–16 Suh et al. showed fluorescent PGs when 
using NIRF imaging with ICG in three dogs.17 Other studies showed the possibility of ICG 
fluorescent angiography to assess the remaining blood supply to the PGs in humans.18–20 
Thus, NIRF imaging with ICG seems to be a promising technique to identify PGs during 
thyroid surgery and assess remaining perfusion of the PGs after thyroid removal. The aim 
of this study was to assess the feasibility of NIRF imaging with ICG to identify PGs during 
thyroid surgery and to get an impression of the vascularization of the preserved PGs.
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METHODS 
This study was conducted at the Department of Surgery of the Maastricht University Medical 
Center (MUMC, Maastricht, Netherlands) between March 2017 and October 2017.The Medical 
Ethical Committee approved of this study, the study was conducted in full accordance with 
the ethical principles in the Declaration of Helsinki 201421 and the protocol was registered 
on Clinicaltrials.gov with registration number NCT03012438. Consecutive men and women 
patients, aged 18 years and older, scheduled for elective total, hemithyroidectomy or 
completion thyroidectomy, with a normal liver and renal function and with written 
informed consent were eligible for inclusion. Subjects were excluded in case of known ICG, 
iodine, penicillin or sulfa-hypersensitivity; pregnancy or breastfeeding; intravenous heparin 
injection in the last 24 hours (all contraindications for the use of intravenous ICG). A flowchart 
of the study procedures is shown in Figure 1. 
Laparoscopic fluorescence imaging system and ICG administration
A commercially available laparoscopic fluorescence imaging system (Karl Storz GmbH & 
CO., Tuttlingen, Germany), including a plasma light guide, a 30-degree 10 mm laparoscope 
applicable for near infrared (NIR) light was used. Observations were done using white light, 
from the regular operation room-lights and without camera, and in NIRF mode, using the 
dedicated system. Video recordings were made using the laparoscopic system. ICG is a 
fluorescent contrast dye, which binds to plasma proteins and becomes fluorescent once 
excited by NIR light between about 820 and 840 nm. The dye was diluted with sterile water 
to a concentration of 2.5 mg/mL. Although having the laparoscopic imaging system in 
NIRF modus pointed at the thyroid, a bolus of 7.5 mg (3 mL) ICG (VERDYE, Diagnostic Green 
GmbH, Aschheim-Dornacht, Germany) was administered intravenously at two different 
time points. The aim of the first bolus was to identify the PGs before removal of the (hemi-)
thyroid. The second bolus was used to assess vascularization of the PGs directly after 
thyroid resection. Both boluses of ICG were given just before using the NIRF-modus of the 
fluorescence system. In all total thyroidectomies, the surgeons searched for four PGs. In all 
hemithyroidectomies and completing thyroidectomies the surgeons searched for two PGs.
Data collection 
The following intraoperative parameters were registered: whether PGs were identified, 
subjective fluorescence intensity of the PGs according to the surgeon, opinion of the 
surgeon about the usefulness of the technique, occurrence of intraoperative complications, 
the amount of time used for fluorescence imaging, and total surgical time.
The fluorescence intensity was scored by the performing surgeon on a 1-3 grading scale: 
1 means that the PG is black after injection of ICG, no fluorescence visible, 2 means that the 
PG is fluorescent, but no more than the surrounding tissue, and 3 if the PG is more fluorescent 
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than the surrounding tissue. Postoperatively, the thyroid specimen was checked by the 
pathologist for the presence of parathyroid tissue in the thyroid specimen. Perioperative 
complications were registered and fluorescence intensity on the video images was analyzed. 
The fluorescence intensity was analyzed using OsiriX Lite V8.5.2 Imaging software (Pixmeo, 
Geneva, Switzerland) to determine the target-to-background ratio (TBR). The TBR was 
defined as the mean fluorescence intensity (FI) of three points region of interest (ROIs) in the 
target (i.e., PGs) minus the mean FI of three ROIs in the back-ground (BG) (i.e., surrounding 
tissue) divided by the mean FI of the BG ROIs. In formula TBR = (fluorescence intensity of 
target−fluorescence intensity of background)/fluorescence intensity of background.22 When 
this score is zero, there is no difference between the fluorescence intensity of the PG and 
the surrounding tissue. A TBR above zero indicates a more fluorescent PG compared to 
surroundings, and a TBR below zero indicates that the surroundings are more fluorescent 
compared to the PG.
Figure 1 Flowchart of the study procedures 
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Statistical analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences 
v23 (IBM, Amonk, NY). A descriptive analysis was conducted for the patients’ baseline 
characteristics and the following outcome measurements: total operation time, extra 
operation time, the presence of PGs in the resected thyroid, number of PGs identified in 
white light and NIRF, occurrence of perioperative complications, and the usefulness of the 
technique. The independent sample-test was used to assess whether there was a relation 
between the fluorescence intensity and factors, such as malignant or benign disease and 
normal or low calcium.
RESULTS
A total of 30 surgeries (hemi-, total or completion thyroidectomy) in 26 patients were 
included. The majority of participants were female (73%) and the most common indication 
for thyroid surgery was suspected thyroid cancer (56.7%). Median body mass index (BMI) 
was 25.21 kg/m2. Further patient characteristics are shown in Table 1.
Feasibility 
No perioperative or postoperative complications due to the use of ICG occurred. 
Complications that occurred were an arterial bleeding after surgery for which reoperation 
was needed and a postoperative wound infection that required antibiotic treatment in 
another patient. The mean surgical time was 92 minutes (±32 minutes) for all surgeries. 
Herein, on average 5 minutes and 35 seconds (±94 seconds) were used for NIRF imaging. For 
a total thyroidectomy, mean surgical time was 126 minutes (±54 minutes); herein, 6 minutes 
and 27 seconds (±95 seconds) were spent using NIRF. A hemithyroidectomy took on average 
83 minutes (±17minutes) of which 5 minutes and 29 seconds (±55 seconds) were used for 
NIRF imaging. A completing thyroidectomy took on average 92 minutes (±22 minutes), 4 
minutes and 51 seconds (±55 seconds) were spent using NIRF imaging.
Subjective usefulness of the technique 
In 17 patients (57%), fluorescence imaging was rated as useful by the performing surgeon. In 
these patients, NIRF imaging provided certainty on both the localization and the preserved 
vascularization of the PGs. In two of the 17 patients, without the use of ICG, the surgical team 
would not have succeeded to identify a PG. In the remaining 15 patients, NIRF imaging was 
mainly helpful to confirm the suspicion of parathyroid tissue. An example of the obtained 
images is given in Figure 2 and an overview of reasons for usefulness or a lack of usefulness 
is given in Table 2. Three reasons were given for a lack of additional value in the remaining 
13 patients. In five patients, the PGs were already clearly visualized in white light, no extra 
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certainty was needed for these patients. A second reason given for a lack of added value 
was that the PGs remained black after ICG administration in three patients. However, in 
these patients, the surgeon notes that itis possible that the PG was already dissected (n=1 in 
which a PG was found in the histology assessment), or the thyroid was already manipulated 
extensively before using NIRF, possibly causing damage of the blood supply toward the PG 
(n= 2 hemithyroidectomies in which no calcium levels were determined due to the expected 
remaining two PGs in the other half thyroid). Therefore, although not for localization, the 
found black PG in these patients could have been of added value to indicate the surgeon 
that auto transplantation of this PG should be considered. The third reason surgeons gave 
for a lack of added value was in two patients of lymphatic metastatic disease and two 
patients of non-metastatic malignant cases: “the well-vascularized cancerous tissue seemed 
to show misleading fluorescence intensity.” Because this tissue was so well vascularized, a lot 
Table 1 Demographic and clinical details of included patients
Patients (n=30) *
Age (years) 56.3 ± 16
Weight (kg) 78.9 ± 17.6
BMI (kg/m2) 28.3 ± 6.9
Gender 
    Male 8 (26.7)
    Female 22 (73.3)
ASA-classification 
     1 3 (10)
     2 25 (83.3)
     3 2 (6.7)
Type of surgery 
     Total thyroidectomy 6 (20)
     Completion thyroidectomy 6 (20)
     Hemi-thyroidectomy 18 (60)
Indication for surgery 
     Multinodular goiter 5 (16.7)
     Graves’ disease 1 (3.3)
     Suspected thyroid cancer 17 (56.7)
     Proven thyroid cancer 7 (23.3)
Histology thyroid specimen 
     Multinodular goiter 10 (33.3) 
     Thyroid cancer 11 (36.7) 
     Normal thyroid 3 (10)
     Follicular adenoma 5 (16.7)
     Thyroiditis 1 (3.3)
*The 4 patients with two included surgeries are counted twice.
Data are presented as mean ± SD or number (%). 
SD: Standard deviation
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of background fluorescence was present in these patients, making it difficult to distinguish 
between the cancerous tissue and the PGs based on NIRF imaging. Further perioperative 
data are listed in Table 3.
Objective imaging and PG identification 
In all total thyroidectomies and hemithyroidectomies, at least one PG was seen in either 
white or NIRF light before thyroid resection. In total, 41 PGs were visualized in white light in 
25 patients, whereas with NIRF imaging in total 31 PGs could be identified in 23 patients. In 
three patients, no PG was identified during thyroid resection. All three patients underwent 
a completion thyroidectomy. In two hemithyroidectomy patients in whom initially no PG 
could be identified in white light, one PG was seen after the use of NIRF. In one patient, 
only one PG was seen in white light, whereas two were seen in NIRF light. These three 
patients underwent a hemithyroidectomy and no PGs were found in the resected material. 
In nine patients, more PGs were visualized in white light. This group consisted of three total 
thyroidectomies and six hemithyroidectomies. In three of these patients, NIRF was used 
after extensive manipulation of the thyroid. In 18 patients, the same number of PGs was 
seen in white light as in NIRF light. In three patients, the number of PGs seen in white light is 
higher than expected, indicating a possible wrong identification of a PG. In NIRF imaging, a 
lower number of PGs were seen in two of these patients.
Histology 
In seven patients, parathyroid tissue was found in the histopathology specimen. As can be 
seen in Table 4, in all these patients, only one PG was found in the specimen. Three out of 
these seven patients underwent a total thyroidectomy. In one of these patients, three PGs 
were seen both in white and NIRF light; in another patient, three PGs were seen in white 
light and one in NIRF; and in the third patient, two PGs were seen in white light and no PGs 
were seen with NIRF imaging. Another patient underwent a completion thyroidectomy in 
whom two PGs were seen in both white and NIRF light. The remaining three patients under-
went a hemithyroidectomy. In all of them, two PGs were identified in white light; in one 
of those patients, no PG was seen with NIRF; and in the other two, only one PG was seen 
with NIRF imaging. Because in these patients parathyroid tissue was found in the resected 
thyroid, it is possible that what the surgeon called parathyroid tissue in white light actually 
was other tissue. No significant correlation was found between the existence of parathyroid 
tissue in the histology specimen and the subjective fluorescence intensity during surgery.
Fluorescence intensity
Mean subjective fluorescence before and after thyroid re-section was 2.53 (±0.6) and 2.37 
(±0.7), respectively. Mean TBR before and after thyroid resection was 4.2(±7.6) and 2.5 (±4.7), 
respectively. The subjective score on a scale 1-3 was compared with the measured TBR. In 
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two PGs, a subjective score of 1 (meaning PG is darker com-pared to surrounding) was given 
before thyroidectomy. In these patients, a mean TBR of 0.8 (±1.4) was found for those PGs, 
compared to a mean TBR of 0.7 (±0.3) in the PGs with a score of 2 (meaning PG as fluorescent 
as sur-rounding) and a mean TBR of 6.0 (±8.9) in the PGs in which a score of three was given 
(PG more fluorescent com-pared to surrounding). After thyroid resection in two patients, a 
score 1 was given, with a mean TBR of 0.2 (±0.2), a score of 2 resulted in a mean TBR of 2.4 
(±6.1) and a subjective score of 3 in a TBR of 2.8 (±4.1). In none of the PGs which was scored 
as 3, a TBR below zero was measured. A higher TBR of the PGs before thyroid re-section was 
seen in patients with benign pathology com-pared to patients with a malignancy (P= 0.044; 
CI =−9.6 to−0.14). This fluorescence intensity was on average 6.01(±2.2) for benign histology 
and 1.1 (±0.8) in patients with malignant disease of the thyroid. The TBR after thyroid 
removal was with 3.0 (±5.1) and 1.8 (±4.0), respectively, not significantly different in patients 
with benign histology compared to malignant disease. No other factors contributing to a 
significant higher or lower TBR or subjective fluorescence intensity were found.
Function
In all patients who underwent total thyroidectomy, calcium supplementation was started 
postoperatively to prevent hypocalcemia, according to standard care practice. Normal 
calcium levels were found in all patients 6 hours after surgery. In three patients who 
underwent total thyroidectomy, calcium ion levels dropped temporarily below the normal 
calcium-ion value of our laboratory (normal range = 1.1-1.3mmol/L) the day after surgery. 
Calcium ion levels of these patients were 1.02, 1.03, and 1.09 mmol/L, respectively. Measured 
TBR in these patients after thyroid resection was lower than average with a mean TBR of 0.6 
(±0.7), compared to a mean TBR of 5.1 (±2.4) in patients with a normal calcium ion level the 
day after surgery (P= 0.12). Calcium levels in these patients were restored after 2 weeks to 
2.16, 2.30, and 2.32 mmol/L, respectively.
Left: the suspected PG indicated by tweezers in white light. 
Right: the suspected PG illuminated bright blue in fluorescence light. The NIRF signal outside the parathyroid gland is caused 
by the blood vessels towards and from the parathyroid gland.
Figure 2 Example of obtained images
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Table 3 Usefulness of the technique 
NIRF imaging considered useful: Total 17 cases
Reasons:
PG was only identified using NIRF
Confirmation of suspected location PG
No. of cases
2
15
NIRF imaging considered not useful: Total 13 cases
Reasons:
PGs already clearly visualized in white light, no extra certainty 
needed
PGs remained black after ICG administration 
Surroundings too fluorescent to distinguish PGs
No. of cases
6
3
4
Table 4 Number of identified parathyroid glands in both white and NIRF light
Surgery 
ID
Type of 
thyroidectomy 
Number of PGs 
to be expected 
Number of PGs 
visible in white 
light
Number of 
PGs visible in 
NIRF 
Number of PGs 
in resected 
thyroid 
1 Total 4 4* 1 1
2 Hemi 2 2 1 0
3 Total 4 3 3 1
4 Hemi 2 2 0 1
5 Total 4 2 1 0
6 Hemi 2 2 2 0
7 Hemi 2 2* 1 1
8 Hemi 2 0 1 0
9 Hemi 2 2 2 0
10 Hemi 2 0 1 0
11 Completion 2 0 0 0
12 Total 4 1 1 0
13 Total 4 1 1 0
14 Completion 2 2* 2* 1
15 Completion 2 1 1 0
16 Completion 2 0 0 0
17 Hemi 2 2 2 0
18 Hemi 2 1 1 0
19 Hemi 2 1 2 0
20 Hemi 2 2 1 0
21 Hemi 2 2 2 0
22 Completion 4 1 1 0
23 Hemi 2 1 1 1
24 Hemi 2 1 1 0
25 Hemi 2 1 1 0
26 Completion 2 0 0 0
27 Hemi 2 1 0 0
28 Hemi 2 1 1 0
29 Hemi 2 1 0 0
30 Total 4 2 0 1
Total 72 41 31 7
*The tissue called parathyroid tissue in these cases could possibly be wrongly identified as PG tissue, since parathyroid tissue 
is found in the resected thyroid specimen.  
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DISCUSSION 
The main aim of this prospective, clinical study was to assess the feasibility of NIRF imaging 
with ICG to intraoperatively identify the PGs and to assess the perfusion after thyroid 
resection. The use of NIRF imaging seems safe with no occurrence of complications due to 
the use of ICG in this study. The marginal extension of operation time in this study, related 
to the use of fluorescence imaging, will probably further decrease with growing experience. 
Eventually, it is expected that the total operation time will be shorter because of earlier 
identification of the PGs. The NIRF technique has been evaluated frequently in previous 
studies for several purposes, but the experience with this technique in thyroid surgery is 
limited. In 2014, Suh et al.17 were the first to evaluate ICG for NIRF imaging of the PGs in an 
animal model. In three dogs, several doses of intravenous ICG ranging from 12.5 to 100μg/
kg were administered to illuminate the PGs. In all dogs, NIRF imaging was able to detect the 
PGs. The optimal dose of ICG based on these experiments was estimated to be 18.75μg/kg. 
Sound et al.23 used NIRF imaging with ICG in three patients who underwent re-operative 
neck surgery for primary hyperthyroidism. In these series, initially, a dose of 5 mg ICG was 
given, and a second dose of 5 mg in one patient, and 3.25 mg in the other two patients. In 
all three patients, the PGs could be visualized after 2 minutes and stayed fluorescent up to 
20 minutes. According to Yuet al.,24 a dose of 10 mg ICG might give better PG visualization 
intensity and time. 
In the current study, PGs could be visualized in all 6 total thyroidectomies and all 18 
hemi thyroidectomies. In three of the six completion thyroidectomies, the PGs could not 
be detected in either NIRF or white light. This is unfortunate, as especially in these more 
difficult cases facilitation of PG identification is helpful. Possible, explanations are the 
absence of PGs in the remaining thyroids or the perfusion of these PGs might have been 
cut off before performing fluorescence imaging. The absence of parathyroid tissue in the 
resected specimen shows that PGs in these patients were not located deeper in the thyroid. 
Possible explanations for the inability to visualize PGs seen in white light with NIRF light 
are manipulation of the thyroid, causing damaged blood supply toward the PG. A second 
possible explanation is bright background signal due to highly vascularized malignant tissue. 
This is supported by the lower TBRs seen in patients with malignant histology conclusions. 
A third possibility is that those PGs seen in white light were not actually PGs, as parathyroid 
tissue was present in two patients in which more PGs were seen in white light compared to 
NIRF light. The anatomical location of the inferior PGs can make it hard to visualize the PGs. 
The PGs can be found around the crossing of the recurrent nerve and the inferior thyroid 
artery. As we use the NIRF angiography to identify the PGs, the nearby artery could confuse 
the location of the PG.
As the NIRF imaging is meant as a tool to assist the surgeon, we consider the scoring of 
the technique by the surgeon the most relevant. The operating surgeons were, therefore, 
Chapter 11 | Feasibility of NIRF in parathyroid identification
194
asked to give a subjective score for the visibility of the PG compared to the surrounding 
tissue. This score ranged between 1 and 3. On average, a higher subjective score had a higher 
TBR although it had a broad SD. This means that the subjective observed score does not 
always correspond to the measured TBR. One possible explanation is the possible difference 
between the moving images during surgery based on which the subjective fluorescence 
intensity is determined and the screenshot in which the TBR is measured. Furthermore, the 
subjective score might be blurred by expectations, whereas the TBR is a more objective 
measurement, but influenced by the chosen regions of interest and background. Also, 
the operating surgeons were asked whether they considered the used NIRF imaging of 
added value. In majority, NIRF imaging was considered of added value. In two patients, it is 
expected that no PGs would have been visualized without the use of ICG. In other patients, 
the added value consisted of reassuring the surgeon who is in doubt over the location of the 
PGs. Reasons for a lack of added value were mainly the surgeon who is already very certain 
about the location or other well-vascularized tissue such as cancerous tissue that was also 
very fluorescent, causing the PGs not to be more fluorescent than the surroundings.
Apart from using ICG to identify the PGs, we also investigated the possibility to assess 
postoperative perfusion of the PGs. Earlier studies described the use of NIRF angiography of 
the PGs to estimate postoperative function.18 In our study, the post-resection TBR was lower 
than before resection, suggesting confirmation of decreased vascularization. Lang et al.18 
used NIRF for intraoperative angiography with ICG to evaluate postoperative functioning 
of the PGs. They included70 patients and found that a high fluorescent light intensity was 
even more predictive for postoperative hypocalcemia than hypocalcemia immediately 
after operation. Vidal Fortuny et al.25 found that in all patients who had at least one well-
vascularized PG demonstrated by ICG-angiography, the PTH levels 1 day postoperatively 
were normal. In our study, we did not measure postoperative PTH levels. This is only standard 
care in parathyroid surgery in our institute. However, we do have information on calcium 
levels. Postoperatively calcium supplementation was started 1 day after surgery in all 
patients who underwent total thyroidectomy as standard care. Blood is drawn the day after 
a total thyroidectomy, before calcium supplementation was started. A normal calcium-ion 
level 1 day postoperatively would suggest normal parathyroid function, whereas calcium-
ion levels below normal can indicate reduced parathyroid function. In three patients, calcium 
levels were below normal value (1.1 mmol/L). In these patients, also TBR-values seemed 
lower compared to patients with normal calcium levels the day after surgery, although 
not statistically significant. This is in line with the study performed by Zaidi et al.20 where a 
possible relation between fluorescence intensity and remaining function was found. In the 
current study, none of the patients developed permanent hypoparathyroidism.
In the current and the other available studies,17,20,23,25 ICG is administrated just before 
aiming to visualize the PGs, as it is meant as angiography. After intravenous administration 
of the ICG, it takes about 30 seconds to reach the PG and thereby illuminate the gland of 
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interest. We observed that not only the PG but also the thyroid gland and, to a lesser extent, 
the surrounding tissue are illuminated because of their vascularization, which causes ICG-
staining of the background and diminishes the contrast, both subjectively and objectively 
by the TBR. Previous studies have shown that ICG has the property of accumulation in 
pathological, hyperplastic PGs, which attributes to higher fluorescence intensity of the 
PG contrary to the surrounding tissues.26 It is not yet known whether this is also the case 
in normal PGs. Further studies are warranted with earlier administration of the ICG to 
evaluate its influence on contrast and accumulation in the normal PG. The present study 
has some limitations. As the study was designed to be a feasibility study, a small number 
of patients were included, of which a minority of patients underwent a total or completion 
thyroidectomy. Therefore, only 12 patients were actually at risk of permanent hypo-
parathyroidism. The calcium-ion level was measured postoperatively in the patients after 
a total thyroidectomy. However, a limitation of this study is that we could not histologically 
check the tissue we saw as parathyroid tissue in NIRF because of ethical reasons. We did, 
however, ask the pathologist to cut extra thin samples of the removed thyroid gland to 
check if parathyroid tissue was found in the extracted tissue.
In summary, this study showed that NIRF imaging with ICG for identification of the PGs 
during thyroid surgery is feasible. For the cases in which the ICG was helpful, it especially 
confirmed the suspicion of the presence of a PG as seen in white light and helped to assess 
its vascularization after thyroid resection. In a minority of cases, NIRF identifies more PGs 
than white light imaging. However, it seems that in white light more wrongly identified 
PGs occurred. The findings of this pilot study confirm a possible role for ICG fluorescence 
imaging in the identification of the PGs, mainly in benign disease. Directions of further 
research should be aimed at improving the technique. Also, more in-depth study of the 
correlation between the signal and the postoperative function of the PGs will further 
substantiate the relevance of the technique. In conclusion, NIRF imaging with the use of 
ICG for intra-operative identification of the PGs and the assessment of its vascularization is 
feasible and safe and can provide more certainty about the location of the PGs.
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Summary 
Misidentification of vital anatomical structures such as bile ducts, arteries and ureters may 
lead to iatrogenic injury. Therefore, detection of these structures is of utmost importance. An 
optical tool to enhance identification of structures might be helpful in preventing iatrogenic 
damage. One such optical tool is Near Infra-Red Fluorescence (NIRF) imaging. Preliminary 
studies, concerning experimental and limited human series, report encouraging results. 
However, at the start of the studies of this thesis, the technique was yet not standardly 
incorporated in daily practice. The overall aim of this thesis was to investigate and critically 
assess some of the possible applications of near infrared fluorescence imaging during 
surgery in order to prevent iatrogenic damage due to misrecognition of the anatomy. 
The first part of the thesis concerns the use of NIRF cholangiography in laparoscopic 
cholecystectomy. In the second part, we investigated the possibilities of NIRF anatomical 
imaging in colorectal surgery. In the third part a pilot study is presented exploring the use 
of NIRF imaging to identify the parathyroid glands and to assess its remaining perfusion at 
the end of surgery. 
PART I NEAR INFRARED FLUORESCENCE CHOLANGIOGRAPHY 
Laparoscopic cholecystectomy is the most commonly performed laparoscopic procedure. 
The most feared complication in this type of surgery is bile duct injury. Although fortunately 
not occurring commonly (0.3-0.7% of cholecystectomies), bile duct injury results in major 
morbidity and in some cases even mortality.1-9 Misidentification of the extrahepatic bile 
duct anatomy is the main cause for the occurrence of this complication.10 The Critical View 
of Safety (CVS) technique is developed to minimize the chance for misidentification of the 
anatomy.11 Pilot studies have shown that by the use of near infrared fluorescence (NIRF) 
cholangiography the visualization of the biliary anatomy can be enhanced, and the CVS 
can be achieved earlier. We assume that the CVS is thus easier to achieve using NIRF. In 
Chapter 2, the study protocol for an international multicenter randomized controlled trial 
is presented. This trial should prove whether the use of NIRF cholangiography does help the 
surgeon by obtaining earlier CVS or not. 
When using NIRF cholangiography, great differences in obtained fluorescent signals in 
the images are found. These differences may originate form (differences in) background 
fluorescence from the liver and in the penetration depth of the dyes used, but more factors 
are of influence.12 In Chapter 3, currently used techniques during NIRF cholangiography 
are compared. Factors of influence on the fluorescence intensity are explored in ex vivo 
experiments combined with knowledge presented in current literature. The factors found 
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to be of influence are given dose, timing of ICG administration, route of administration, 
distance between the laparoscope and the area of interest, patient factors such as BMI 
and presence of cholecystitis, used system and used software to analyze the data. In this 
chapter, advise is given on how to use NIRF cholangiography. The concentration of ICG in 
the bile ducts should be between 0.00195 and 0.025 mg/ml, ICG should be given as early as 
logistically possible (up to 24h before surgery), the laparoscope should be held close to the 
tissue and the best available system should be used.
In Chapter 4, two new pre-clinical dyes are compared to a third, earlier tested preclinical 
dye. This third dye, IRDye® 800CW was very promising in previous experiments and possible 
even better than ICG.13 However, this dye is expensive, and more expensive compared to 
the newly developed dyes IRDye® 800BK and IRDye® 800NOS. When comparing these three 
dyes in a pig model, the cystic artery was immediately visible using all three dyes. The cystic 
duct appeared later, but with the new dyes at least as good as with the use of IRDye®800CW. 
Thereby, IRDye® 800BK and IRDye® 800NOS seem to be good alternatives for IRDye® 800CW. 
Our conclusions are based on the subjective evaluation, but also based on the measured 
target to background ratio. 
In Chapter 5, we compared the used methods in literature for objectification of the 
fluorescent signal. We found that the most commonly used software programs (Osirix and 
ImageJ) are compatible and comparison of results obtained with these programs seems 
legitimate. A third used software program (Photoshop) gives less comparable results and 
these are therefore not easily comparable with the results obtained with the other programs. 
When using the software programs both grey and blue-value (or green-value depending on 
the used system) can be measured to determine fluorescence intensity. However, in our 
images no clear difference between using the grey- and blue- value could be seen. Another 
aspect is that different formulas are used in literature to assess fluorescence intensity 
compared to the background. No clear advice can be given on the best formula to be used. 
Therefore, reporting of both target and background fluorescence intensity in manuscripts 
is recommended and not only the Target-to-background ratio. This will enable researchers 
and readers to make a more proper comparison of results between studies.
PART II NEAR INFRARED FLUORESCENCE IMAGING IN COLORECTAL 
SURGERY
During colorectal surgery there are two complications surgeons fear most. These two 
complications are anastomotic leakage in the patients in whom an anastomosis is made 
and ureter damage in pelvic surgery. Unfortunately, reported incidence of anastomotic 
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leakage is high, namely 3-15% in colorectal surgery.14-21 Anastomotic leakage is a very serious 
complication since it has a great impact on the patient by increasing morbidity, often 
requiring a second surgery, but also mortality rates are high.16, 20-22 Several risk factors for 
anastomotic leakage have been identified, of which an important factor is perfusion of the 
bowel segments adjacent to the anastomosis.23-25 A good perfusion is required for adequate 
anastomotic healing. Since the perfusion can be visualized using near infrared fluorescence 
imaging, it is thought that the use of near infrared fluorescence imaging can prevent part 
of the anastomotic leakages. In Chapter 6, we investigated this hypothesis in a systematic 
review and found that the use of NIRF angiography in anastomotic colorectal surgery seems 
easily applicable. After NIRF angiography, the resection margin was changed in 10.8% of 
cases and a significant lower anastomotic leak rate was found in published literature 
when using NIRF angiography. Especially an initially bright fluorescent signal seems to be 
predictive for good anastomotic healing. 
In our systematic review in chapter 6, we found that in most studies, the place of resection 
margin after NIRF angiography was based on the subjective view of the surgeon: whether 
the bowel was ‘fluorescent enough’. However, a clear cut-off value of fluorescence intensity 
indicating sufficient perfusion is not available yet by would be desirable to base such 
decisions on rather than on a subjective view. 
In Chapter 7 therefore, we explored whether the fluorescent signal correlates to serum 
markers of anastomotic leakage and postoperative inflammation such as CRP, I-FABP and 
calprotectin. In the heterogenous pilot-group of 30 colorectal cancer-patients we included, 
no relation between the fluorescence intensity and the inflammatory markers studied 
could be found. However, a higher measured fluorescence intensity of the proximal bowel 
compared to the background both before and after surgery was found in the patients who 
did not develop anastomotic leakage. Also, a subjective scoring of the surgeon during 
surgery just before transection of the proximal bowel was higher in the patients who did 
not develop anastomotic leakage. 
A second major complication after colorectal surgery is iatrogenic ureter damage. In this 
surgery, the ureter can be very close to the surgical field and may be hard to identify. 
Identification of the ureter is the most important step in avoiding ureter damage. By using a 
near infrared dye that is cleared by the kidneys, the ureters may be visualized during surgery 
and thereby lessen the chance of iatrogenic ureter damage. In Chapter 8, we investigated 
the feasibility of NIRF imaging with methylene blue to visualize the ureter in patients 
undergoing elective laparoscopic colorectal surgery. This dye is registered for clinical use 
and cheap: NIRF using this dye would be a very practical and promising technique. The only 
drawback was that a dedicated filter had to be developed, as the commercially available 
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equipment didn’t have filters for the appropriate wavelength. Ten patients were included, 
and different doses were tested. We could detect the ureter in five patients, who received 
the highest doses, namely between 0.75 and 1mg/kg. However, in all five cases the ureter 
was also visible in white light before detection in NIRF light. The results were disappointing. 
Therefore, the use of NIRF imaging with methylene blue in these cases was not considered 
of added value in clinical practice. 
A potent dye with excitation and emission in the range of ICG would be preferable as the 
commercially available equipment can be used for obtaining the fluorescent signal. In 
Chapters 9 and 10, we explored the use of two new such dyes. These are still pre-clinical 
dyes, emitting fluorescent light at around 800nm instead of the 688nm at which methylene 
blue emits fluorescent light. The wavelength of 800nm is more in the near infrared range 
and thus has a higher penetration depth. Based on this theory we expected to see the 
ureters more clearly using these new dyes, IRDye® 800BK and IRDye® 800NOS. We compared 
these with another, earlier tested preclinical dye, IRdye® 800CW in a pig model. In these 
experiments three pigs were used, one of the three dyes each. These three dyes are cleared 
by the kidneys and showed a bright fluorescent signal, very clearly delineating the ureters 
in the pigs, especially during pulsatile movement of urine through the ureter. IRDye® 800BK 
seemed to give the best results of these two new dyes and is further explored in Chapter 10. 
Three different doses of the IRDye800BK were administered in three different pigs to search 
for the optimal dose. The used doses were 3mg, 6mg and 12 mg. The results obtained with 
these three doses were comparable. Also, the dye was used in explanted human and pig 
ureters to see if the penetration depth of the emitted light from the dye was high enough to 
penetrate through the human ureter. We found that this was possible, but that the presence 
of fat on the ureter is a limiting factor. 
PART III NEAR INFRARED FLUORESCENCE IMAGING IN THYROID SURGERY
In thyroid surgery, iatrogenic injury of the parathyroid glands should be prevented. Here 
again, the key to prevention is identification of the anatomical structure, the parathyroid 
gland. However, in this type of surgery, only identifying is not enough to prevent injury. 
In some cases, the parathyroid glands are identified and kept in the patient, but due to 
manipulation of the thyroid, the blood supply towards the parathyroid is impaired, resulting 
in an insufficient remaining function of the parathyroid glands. In Chapter 11 we evaluated 
the possibility of both identifying the parathyroid glands and assessing post-thyroidectomy 
perfusion of the parathyroid gland. In 30 (hemi) thyroidectomies, NIRF imaging was used. 
This technique was found safe and easily applicable. In 17 surgeries NIRF imaging was of 
added value, mainly due to providing more certainty to the operating surgeon about the 
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location and remaining function of the parathyroid glands. In all patients, normal calcium 
levels were found 6 hours after surgery, however a temporary drop in calcium level the day 
after surgery occurred in three patients in whom the average TBR was lower compared to 
the measured TBR in the remaining patients. The calcium levels in these patients restored 
after two weeks. 
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General discussion and future perspectives 
PART I NEAR INFRARED FLUORESCENCE CHOLANGIOGRAPHY 
The RCT as described in Chapter 2 is meant to identify the advantages of NIRF in laparoscopic 
cholecystectomy. The main aim of applying this imaging technique is to make the operation 
safer in terms of reduction of bile duct injury (BDI). However, due to its low incidence BDI 
can unfortunately not serve as a primary endpoint for the study described in Chapter 2. 
The decision to choose a surrogate primary endpoint such as time till CVS in our RCT can be 
considered as a limitation of this study.
Depending of the future outcomes of this trial, the use of NIRF cholangiography should 
be incorporated in clinical practice or not, as is suggested already in current literature 
that appeared after publishing this study protocol.12,26-28 Reduced operating time but also 
enhanced surgeon’s satisfaction will promote the use of NIRF for this indication. This opens 
the possibility of future large prospective registration studies that will reveal whether 
indeed with this technique surgery has also become safer.
In Chapter 3 some clear advice is given on how to perform NIRF imaging and how to obtain 
the best images with current techniques. However, this advice is not perfect. For example, 
holding the laparoscope close to the cystic duct gives a brighter fluorescent signal of the 
cystic duct. But also, the fluorescent signal from the liver in the background will increase by 
holding the laparoscope closer. The background fluorescence-noise can be reduced when 
administrating the dye earlier, preferably the day before surgery.29 Unfortunately, this is not 
always logistically feasible. A solution to this problem of background fluorescence might 
come from using another way of administration, as is shortly discussed in the article. By 
injecting the fluorescent dye directly into the gallbladder, the gallbladder and cystic duct 
become fluorescent without the liver having to clear the fluorescent dye from the blood and 
thereby becoming fluorescent. This is investigated by Liu et al30 and seems to be a promising 
method which merits further evaluation. In this way, one does not have to decide beforehand 
whether or not to use NIRF cholangiography during a laparoscopic cholecystectomy, but 
this technique can be started in selected, difficult, cases when needed. On the other hand, 
from our personal experience observing the surgeon’s satisfaction resulting from the 
clearer anatomical picture and ease of use of the technique, we expect most surgeons will 
prefer applying the technique in all cases instead of selected ones. This of course, will be 
influenced by the results of trials, such as the FALCON trial described in chapter 2.
Apart from the used route of administration, also other fluorescent dyes need to be 
explored further. In current practice, ICG is used for nearly all applications of identifying 
normal anatomy. There is a lot of experience with this dye and this dye is generally assessed 
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as a very safe dye, although in rare instances, Indocyanine green can cause an allergic 
reaction due to the iodine present in the dye.31,32
Chapter 4 explores dyes that may provide a better signal in NIRF cholangiography 
compared to current practice. One of the downsides of this study is that we had to use 
an animal model to investigate these dyes and were not able to perform human testing 
yet, as the dyes are not registered for use in humans yet. Fortunately, our results are part 
of the process of obtaining FDA approval. As soon as the dyes IRDye® 800 BK and IRDye® 
800NOS become available for clinical practice their role in fluorescence cholangiography 
in humans should be determined. IRDye® 800CW, the predecessor of the new dyes, is 
also promising for bile duct imaging, but a major downside is its high cost. An interesting 
property of IRDye® 800CW however is that it can be coupled to another substance. It can for 
example be coupled to bevacizumab in order to enable targeted imaging, e.g. to visualize 
colorectal neoplasms.33 Another application is the conjugation of cetuximab-IRDye® 800CW 
to identify metastatic disease in lymph nodes in patients with head and neck cancer.34 These 
very promising and interesting applications are beyond the scope of this thesis but will be 
subject of future research.
The experiment described in Chapter 5 focusses on the comparability of the fluorescence 
signal as reported between studies performed by different study groups. Used techniques 
in assessment of fluorescence intensity are explored. In this experiment also, the use of grey-
values and blue-values are compared. These results did not differ as much as the authors 
expected. Caution must however be taken that apart from the used software and chosen 
formula the selection of regions of Interest is also of influence on the measured fluorescence 
intensity.
In summary, the future concerning NIRF-cholangiography is dependent on the outcomes 
of randomized controlled trials such as presented in Chapter 2 but should also include a 
search for ways to improve currently used techniques further, for example by using better 
fluorescent dyes, optimizing equipment and keeping in mind the factors of influence on the 
signal during application of the technique.
PART II NEAR INFRARED FLUORESCENCE IMAGING IN COLORECTAL 
SURGERY 
Regarding NIRF for colorectal perfusion measurement, large clinical trials are needed. 
Since the publication of the systematic review presented in Chapter 6, a large cohort 
study is published.35 This multicenter study included a heterogenous group of 504 patients 
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undergoing colorectal surgery involving resection and anastomosis. In all included patients, 
NIRF was used to assess perfusion just before and after construction of the anastomosis. An 
anastomotic leak rate of 2.6% was found in this cohort. Compared to reported incidence 
in literature, this is very low. It is very well possible that in persisting anastomotic leakage 
cases other risk factors than impaired perfusion play a role, since anastomotic leakage is a 
multifactorial problem. 
A randomized controlled trial concerning the technique is not published yet but a 
research group in Leeds took the initiative to start such a randomized trial.36 The results of 
this trial are planned to be presented in 2021 and will give us further arguments whether or 
not to use this technique in all anastomotic colorectal surgery. Awaiting the results of such 
trials, one could defend the standard use of NIRF during colorectal anastomotic surgery, 
given the promising results of clinical studies so far. Another way to go, apart from an RTC, 
is a prospective registry in which all such patients are collected. This will give insight in the 
results of the technique in daily practice.
The information of previous studies that a higher fluorescence intensity at the bowel ends 
adjacent to the (future) anastomosis at certain time points was related to less anastomotic 
leakage, brought us to the study as performed in Chapter 7. The limitation of all studies 
so far is that no objective clear cut-off point for adequate perfusion has been studied or 
identified. We hoped to find a correlation between the objective value of the fluorescent 
signal and other parameters indicative of inflammation and predictive of anastomotic 
leakage. Unfortunately, no such correlation was found. This is in part due to the small pilot. 
Another factor may be that the other parameters studied are not as predictive as previous 
studies suggested. A next step is to investigate in a larger cohort of NIRF patients what 
an optimal cut-off value would be to reassure the surgeon that the bowel is fluorescent 
‘enough’. And even further: to come to an absolute cut-off value that can be actually used 
during surgery. During our experiments, such a measurement for use during surgery was not 
available, as our measurements were done after surgery. However, the technique for intra-
operative evaluation of the fluorescence intensity is being developed and tested. Diana et al 
explored the possibility of real-time fluorescence measurement in a pig model.37,38 Not only 
the eventual signal itself, but also the time it takes for the tissue to produce this signal seems 
indicative of adequate perfusion. To date, no results on in-human use of this technique are 
reported yet. 
For now, it seems that we can and have to depend on the subjective assessment of 
fluorescence intensity by the surgeon, just before transection of the proximal bowel. As soon 
as more data on in-human intra-operative objective fluorescence intensity measurement is 
available, a cut-off value should be determined for more reliable use of the technique.
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From Chapter 8 on, we evaluated the possibility of visualizing the ureter during laparoscopic 
colorectal surgery. The experiments we performed on dyes for ureteral NIRF imaging are 
promising and relevant as this technique might help to prevent ureteral injury and diminish 
this feared complication. The first logical step was to test the performance of methylene 
blue, as this dye is already registered for human use, albeit in other indications. A downside 
of the use of methylene blue is its excitation and emission wavelength. Although called a 
near infrared dye, the wavelengths concerning this dye are 668 and 688nm for excitation and 
emission respectively, which is on the lower limit of being in the near infrared range.39 This 
requires equipment that is specifically adjusted with adequate filters. For other applications, 
a dye with a wavelength of 800nm which is more clearly in the near infrared range is chosen 
because of a lack of disturbance of the normal white light image, and a higher penetration 
depth.39 Such dye is indocyanine green, which is cleared solely by the liver, thus this dye will 
not end up in the ureters after intravenous administration. ICG can be brought in the ureters 
by the use of ureteral catheter and ureters can be visualized using this method.40,41 However, 
ureter catheter placement is an invasive procedure, requires additional expertise and adds 
to operation time.42 While using a dye cleared by the kidneys is easy to apply without added 
surgical time. Thus, a dye emitting light at around 800nm which is cleared by the kidneys is 
desired. Three of these dyes are tested in Chapters 9 and 10. This concerned experimental 
dyes tested in a pig model. The experimental dyes tested are promising, because of their 
characteristics concerning their wavelengths, their performance with regard to the very 
clearly observed signal and their price. The images obtained were subjectively by far 
superior to the images obtained with methylene blue.
Future research should be performed in humans as soon as approval of authorities is 
obtained to use these dyes in humans.
Apart from the mentioned dyes, other possible new dyes are also explored. Mahalingam 
et al published in 2018 an article in which they describe the use of ‘Ureter-glow’ to visualize 
the ureters.43 This new dye is highly water soluble and has an excitation wavelength of 
800nm and emission wavelength of 830 nm. The dye was tested in mice and pigs and seems 
promising.43 Whether the signal will be of the same quality in the human situation, with the 
presence of peri-ureteral fat, will have to be awaited as is the case with the dyes tested in 
our own experiments. 
In summary, currently we do not have an ideal tool to visualize the ureters in human 
colorectal surgery using near infrared fluorescence imaging. Nevertheless, promising 
experimental dyes have been tested with good results. Future research is needed to test 
the new fluorescent dyes for ureter imaging as soon as authorities allow human application.
Summary and general discussion | Chapter 12
211
Ch
ap
te
r 1
2
PART III NEAR INFRARED FLUORESCENCE IMAGING IN THYROID SURGERY
Concerning the application of NIRF in thyroid surgery we concluded in Chapter 11 that in 
17 of 30 surgeries the technique was of added value, increasing the certainty of the location 
of the parathyroid glands and their function. 
One can debate whether such reassuring the surgeon is enough for daily clinical use. 
To our opinion, this technique should be further improved before entering daily practice. 
Currently, the background signal of the thyroid is quite high. Another downside of the 
technique was that in our patients, this background fluorescence was especially high in 
patients with lymph node metastases. Especially in these cases parathyroid glands may 
be hard to distinguish from surrounding tissue by the naked eye and thus a technique to 
enhance visualization might be most helpful. Recently, other positive research results were 
published. A randomized controlled trial was performed by Fortuny et al.44 This research 
group used a lower dose (2.5mg) compared to our experiment (7.5mg) and a different 
fluorescence imaging system (Pinpoint® instead of the Karl Storz system). Adult patients 
were included undergoing total thyroidectomy or completion thyroidectomy in whom 
an ICG score of 2 was observed in at least one identified parathyroid gland, meaning the 
parathyroid gland was bright fluorescent. These patients were randomized in two groups. 
The control group recieved standard follow-up with calcium and PTH measurements on 
day 1 and 10-15 postoperatively and oral supplementation with 1 mg calcium and 800 units 
25-hydroxyvitamin D twice daily upon the postoperative appointment after 10 to 15 days. 
In the intervention group patients were assessed for symptoms of hypocalcemia, but no 
blood test was done the day after surgery, nor supplementation of calcium and vitamin D 
was given. On day 10-15, calcium and PTH levels were measured to confirm that levels were 
normal. The results show that in all included patients postoperative calcium levels were 
normal. The conclusion of this RCT is that the use of NIRF angiography in thyroid surgery 
obviates the need for postoperative measurement of calcium and PTH and supplementation 
with calcium in patients with at least one well perfused parathyroid gland.44
Other methods for parathyroid visualization are being assessed. One of these methods 
is using methylene blue instead of ICG as a fluorescent dye.45 However, high doses of 
Methylene blue are needed, causing a risk for serious hemodynamic complications caused 
by methylene blue and its effectiveness is not proven. Because of this risk and limited 
benefit, the use of this technique is discouraged.46 Using a lower dose would lower the risk 
of side effects but another disadvantage of the use of methylene blue as a fluorescent dye 
is that equipment with other filters than used with ICG are needed because of the different 
excitation and emission wavelength of the dyes.47 A comparative study between methylene 
blue and ICG as a fluorescent dye in this application should be performed to determine 
what dye to prefer. 
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Autofluorescence is another promising method for intra-operative parathyroid identi-
fication.48-50 Using this technique, no exogenous fluorescent dye administration is needed. 
However, for perfusion assessment of the remaining parathyroid gland an intravenously 
administered fluorescent dye is still needed and might then as well be used for identification 
of the parathyroid glands, instead of using multiple systems and techniques. A comparative 
study by Kahramangil et al51 concluded that earlier detection with autofluorescence imaging 
was possible, but autofluorescence and ICG NIRF imaging have similar high detection rates. 
In conclusion, in this thesis we critically assessed the possible applications of near infrared 
imaging during laparoscopic cholecystectomy, colorectal anastomotic surgery and thyroid 
surgery. We described positive results of this technique, points of attention and future 
directions of development and research. Randomized trials but also prospective cohorts 
will give valuable information. The availability of potent dyes for human use will further 
enhance its application. It seems likely that for the next years this technique will not only 
remain but will be increasingly incorporated in daily practice. 
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Wanneer anatomische structuren zoals galwegen, arteriën en ureteren tijdens operaties 
niet goed herkend worden kan dit leiden tot iatrogene schade. Het is daarom van groot 
belang om deze anatomie optimaal te detecteren. Een hulpmiddel dat het identificeren 
van deze structuren makkelijker maakt zou er daarom voor kunnen zorgen dat de kans op 
iatrogene schade verminderd wordt. Het gebruik van nabij-infrarode fluorescentie (NIRF) 
beeldvorming zou zo’n hulpmiddel kunnen zijn. Eerdere studies in de (dier)experimentele 
setting laten veelbelovende resultaten zien. Deze techniek werd voorafgaand aan het 
schrijven van deze thesis echter nog niet in de dagelijkse praktijk gebruikt. Het doel van 
deze thesis is het onderzoeken en kritisch beoordelen van de mogelijke toepassingen van 
NIRF-beeldvorming in het voorkomen van iatrogene schade als gevolg van misidentificatie 
van de anatomie. 
Het eerst deel van de thesis omvat het gebruik van NIRF-cholangiografie bij 
laparoscopische cholecystectomie. In het tweede deel worden de mogelijkheden van NIRF-
beeldvorming ter voorkoming van iatrogene schade in colorectale chirurgie onderzocht. Het 
derde deel betreft het gebruik van NIRF-beeldvorming ter identificatie van de bijschildklier 
en voor de resterende perfusie van de bijschildklier na een schildklieroperatie. 
DEEL 1 NABIJ-INFRARODE FLUORESCENTIE CHOLANGIOGRAFIE
Laparoscopische cholecystectomie is de meest uitgevoerde laparoscopische procedure. 
Hierbij is schade aan de galwegen de meest gevreesde complicatie. Gelukkig komt deze 
complicatie niet vaak voor (0.3-07%), maar deze zorgt wel voor veel morbiditeit en soms zelfs 
mortaliteit.1-9 Het niet juist interpreteren van de anatomie van de extra-hepatische galwegen 
wordt gezien als de belangrijkste oorzaak voor het optreden van deze complicatie. 10 De 
‘Critical view of safety’(CVS)- techniek is ontwikkeld om galwegletsel te voorkomen, door de 
kans op misidentificatie te minimaliseren.11 Pilotstudies hebben laten zien dat het gebruik 
van NIRF-cholangiografie de anatomie van de galwegen duidelijker maakt, en dat zo de CVS 
eerder bereikt kan worden. In hoofdstuk 2 wordt het studieprotocol voor een internationale 
multicenter gerandomiseerde studie gepresenteerd. Het doel van deze studie is om te 
evalueren of het gebruik van NIRF-cholangiografie leidt tot het eerder bereiken van de CVS. 
Bij het gebruik van NIRF-cholangiografie worden grote verschillen in het behaalde 
fluorescentiesignaal gevonden. Deze verschillen kunnen komen door verschillen in de 
achtergrondfluorescentie van de lever, de penetratiediepte van de gebruikte kleurstof en 
verschillende andere factoren.12 In hoofdstuk 3 worden de technieken die nu gebruikt 
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worden voor NIRF-cholangiografie met elkaar vergeleken. Factoren van invloed op de 
fluorescentie-intensiteit worden onderzocht in ex vivo experimenten, gecombineerd met 
de kennis uit de huidige literatuur. De volgende beïnvloedende factoren zijn gevonden: 
dosis, timing van de indocyanine groen (ICG)-toediening, toedieningsweg, afstand tussen 
de laparoscoop en de kleurstof, patiëntfactoren (zoals BMI), aanwezigheid van ontsteking, 
het gebruikte systeem en de software om de beelden te analyseren. In dit hoofdstuk 
wordt op basis van deze bevindingen een advies gegeven hoe NIRF-cholangiografie toe te 
passen. Zo moet er gestreefd worden naar een concentratie ICG in de gal tussen de 0.00195 
en 0.025mg/ml, moet de ICG zo vroeg mogelijk toegediend worden, moet de laparoscoop 
dicht bij het te beoordelen weefsel gehouden worden en dient het best beschikbare 
systeem gebruikt te worden. 
In hoofdstuk 4 worden twee nieuwe, preklinische fluorescente kleurstoffen vergeleken 
met een derde, eerder geteste preklinische fluorescente kleurstof. Deze derde stof, IRDye® 
800CW (LICOR Biotechnology, Lincoln, United States), was zeer veelbelovend in eerdere 
experimenten en leek zelfs beter dan het ICG dat men in de huidige praktijk gebruikt.13 
Echter, deze kleurstof is erg duur. De nieuwere kleurstoffen IRDye® 800BK en IRDye® 800NOS 
zijn een stuk goedkoper. Deze drie kleurstoffen worden met elkaar vergeleken in een studie 
met varkens, waarbij de arteria cystica direct zichtbaar was met alle drie de kleurstoffen. 
Met de twee nieuwere kleurstoffen verscheen de ductus cysticus later, maar net zo goed 
als met IRDye® 800CW. De nieuwere IRDye® 800BK en IRDye® 800NOS lijken daarom goede 
alternatieven te zijn voor IRDye® 800CW. 
In hoofdstuk 5 worden de gebruikte methodes voor objectivering van het fluores-
centiesignaal in de huidige literatuur geanalyseerd. We vonden dat de twee meest gebruikte 
softwareprogramma’s (Osirix en ImageJ) vergelijkbare resultaten geven. Een derde 
softwareprogramma dat soms gebruikt wordt is Photoshop. Dit programma geeft minder 
goed vergelijkbare resultaten. Verder worden er in de huidige literatuur verschillende 
formules gebruikt om de fluorescentie-intensiteit van het doelorgaan af te zetten tegen 
de fluorescentie-intensiteit van de omliggende weefsels. De gebruikte formules zijn met 
elkaar vergeleken, maar er kan geen eenduidig antwoord gegeven worden welke formule 
te gebruiken. Wel is het advies om zowel de fluorescentie-intensiteit van het doelorgaan als 
de fluorescentie-intensiteit van de achtergrond te rapporteren om zo verschillende studie-
uitkomsten met elkaar te kunnen vergelijken in de toekomst. 
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DEEL 2 NABIJ-INFRARODE FLUORESCENTIE BEELDVORMING BIJ 
COLORECTALE CHIRURGIE 
Twee belangrijke complicaties bij colorectale chirurgie zijn naadlekkage nadat er een 
anastomose is aangelegd, en ureterschade bij chirurgie in het kleine bekken. Helaas is de 
incidentie van naadlekkage hoog, 3-15% van colorectale operaties. 14-21 Dit is een ernstige 
complicatie omdat het de morbiditeit verhoogt, er vaak een heroperatie nodig is, en er ook 
kans op mortaliteit is 16, 20-22 Er zijn verschillende factoren van invloed op het voorkomen van 
naadlekkage bekend, waarvan de perfusie van de darmsegmenten die aan elkaar gemaakt 
worden een belangrijke is. 23-25 Zonder goede perfusie van de anastomose zal deze niet 
goed genezen. Met het gebruik van NIRF-beeldvorming kan deze perfusie in beeld worden 
gebracht tijdens de operatie. Derhalve is de verwachting dat het gebruik van NIRF-angiografie 
tijdens de operatie een deel van de naadlekkages kan voorkomen. In hoofdstuk 6 hebben 
we deze hypothese onderzocht door middel van een systematische review en vonden 
we dat het gebruik van NIRF-angiografie in colorectale chirurgie makkelijk toepasbaar en 
veilig is. Na NIRF-angiografie werd de plaats van doornemen van de darmen verplaatst 
in 10.8% van de patiënten. Er werd significant minder frequent naadlekkage gezien in de 
gepubliceerde literatuur wanneer NIRF-angiografie werd gebruikt. Met name een initieel fel 
fluorescent signaal lijkt een voorspeller voor goede genezing van de anastomose. 
In de studies geanalyseerd in hoofdstuk 6 werd de plaats van het doornemen van de 
darmen met name bepaald op basis van het subjectieve oordeel van de chirurg wanneer het 
signaal ‘fluorescent genoeg’ was. Er is geen duidelijke afkapwaarde wanneer het signaal fel 
genoeg is om zeker te zijn van voldoende perfusie, terwijl dit wel wenselijk is. In hoofdstuk 
7 hebben we daarom onderzocht of de intensiteit van het fluorescente signaal samenhangt 
met serologische markers voor naadlekkage en postoperatieve inflammatoire markers zoals 
CRP, I-FABP en calprotectine. In een pilotstudie met een heterogene groep van 30 patiënten 
konden wij geen relatie vinden tussen fluorescentie-intensiteit en deze inflammatoire 
markers. Er werd wel een hogere fluorescentie-intensiteit van de darm gemeten in relatie 
tot de intensiteit van de achtergrond bij patiënten die geen naadlekkage ontwikkelden. Ook 
de subjectieve score voor fluorescentie-intensiteit van de darm was hoger in de patiënten 
die geen naadlekkage ontwikkelden. 
Tijdens colorectale chirurgie kan de ureter zich erg dicht bij het operatiegebied bevinden 
en kan het moeilijk zijn om de ureter te onderscheiden van het andere omliggende weefsel. 
Toch is het herkennen van de locatie van de ureter de belangrijkste stap in het voorkomen 
van schade aan de ureter. Door gebruik te maken van een fluorescente kleurstof die wordt 
geklaard door de nieren kunnen de ureteren tijdens de operatie beter zichtbaar gemaakt 
worden. In hoofdstuk 8 werd het gebruik van methyleenblauw als fluorescente kleurstof 
om de ureter in beeld te brengen onderzocht in patiënten die electieve colorectale 
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chirurgie ondergingen. Deze kleurstof is vrij beschikbaar en goedkoop. Een nadeel is echter 
dat deze kleurstof fluorescent is op een andere golflengte dan het veelgebruikte ICG, 
waarop de meeste apparatuur is ontworpen. Er zijn dus andere filters en software nodig 
om fluorescentie imaging met methyleenblauw te doen dan bij gebruik van ICG. In deze 
studie werden 10 patiënten geïncludeerd en werden verschillende doses methyleenblauw 
uitgeprobeerd. In vijf van de tien patiënten kon de ureter worden geïdentificeerd met 
methyleenblauw. Dit waren de patiënten die de hoogste dosis kregen, namelijk 0.75 tot 
1mg/kg. In al deze vijf patiënten was de ureter in normaal (wit) licht ook zichtbaar. Vanwege 
deze teleurstellende resultaten lijkt het gebruik van methyleenblauw niet van toegevoegde 
waarde in de dagelijkse praktijk.
Een potente kleurstof met de excitatie en emissiegolflengte vergelijkbaar met die van ICG, 
die ook nog eens geklaard wordt door de nieren, zou ideaal zijn voor de beeldvorming 
van de ureters tijdens colorectale chirurgie. In hoofdstuk 9 en 10 worden twee nieuwe 
fluorescente kleurstoffen die aan deze eigenschappen voldoen, onderzocht. Dit zijn de 
preklinische dyes (IRDye® 800BK en IRDye® 800NOS) welke door hun excitatie en emissie 
rond de 800nm een veel grotere penetratiediepte hebben dan methyleenblauw met een 
excitatie en emissie net onder de 700nm. Deze nieuwe fluorescente kleurstoffen zijn getest 
in varkens en vergeleken met een eerder onderzochte preklinische stof: de IRDye® 800CW. 
Elk varken kreeg één van deze stoffen intraveneus toegediend. Alle stoffen toonden een fel 
fluorescent signaal waarbij de ureters in de varkens zeer goed zichtbaar waren. Van de drie 
stoffen was het IRDye® 800BK welke het beste signaal gaf, en deze fluorescente kleurstof 
is daarom verder onderzocht in hoofdstuk 10. Drie verschillende doses van IRDye® 
800BK, namelijk 3mg, 6mg en 12mg, werden toegediend in drie verschillende varkens. De 
resultaten verkregen met elk van de drie verschillende doses waren vergelijkbaar. Dezelfde 
kleurstof hebben we daarna nog gebruikt in geëxplanteerde humane en varkensureters 
om na te gaan of de penetratiediepte genoeg was om ook door de dikkere humane ureters 
de fluorescentie te kunnen zien. We observeerden dat dit mogelijk was, maar dat de 
aanwezigheid van vet op de ureter het fluorescente signaal wel duidelijk verminderde. 
DEEL 3 NABIJ-INFRARODE FLUORESCENTIE BEELDVORMING BIJ 
SCHILDKLIERCHIRURGIE 
Bij schildklierchirurgie is het belangrijk om schade aan de bijschildklieren te voorkomen. 
Ook hier is de belangrijkste factor in het voorkomen van iatrogene schade het identificeren 
van de anatomische structuur. Het is echter niet genoeg om enkel de bijschildklier te 
identificeren om schade aan de bijschildklier te voorkomen. Door manipulatie van de 
schildklier kan de bloedvoorziening naar de bijschildklier verminderd worden, waardoor de 
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functie van een gespaarde bijschildklier alsnog onvoldoende is. In hoofdstuk 11 evalueren 
we zowel het identificeren van de bijschildklier als het beoordelen van de perfusie na het 
verwijderen van de schildklier. In 30 (hemi-)thyroidectomieën werd NIRF-beeldvorming 
gebruikt. De techniek was veilig en makkelijk toe te passen. In 17 van de 30 operaties werd 
het gebruik van NIRF-beeldvorming als toegevoegde waarde gezien door de operateur, 
met name door het geven van extra zekerheid over de locatie van de bijschildklier en de 
resterende functie.
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Valorisation 
Every surgical procedure incorporates a potential risk for complications. As described in the 
introduction of this thesis, part of these complications is caused by misidentification of the 
anatomy. A technique which improves intra-operative visualization of the anatomy could 
help avoid such complications, thereby prevent morbidity and mortality and lower health 
care costs. Near infrared fluorescence (NIRF) imaging concerns an innovative technique that 
might improve the intraoperative distinction of vital anatomical structures. 
The aim of this thesis was to investigate a selection of the currently possible applications 
of NIRF imaging during surgery in order to prevent iatrogenic injury due to anatomical 
misrecognition. 
Relevance of scientific results in this thesis 
The use of the aforementioned technique (NIRF imaging) is aimed at preventing iatrogenic 
complications during surgery. Avoiding complications has multiple advantages. First, it 
prevents morbidity and, possibly, even mortality in patients. Second, complications are 
always accompanied with an increase in health care costs. As mentioned in the discussion 
of Chapter 6, the use of NIRF imaging is quite cheap, since indocyanine green costs only 
about 80 euros per vial, and for most applications, 1 vial can be used for multiple cases. 
The fluorescence modality is now incorporated in all new endoscopy systems and therefore 
does not result in additional costs. By preventing complications with a low-cost intervention, 
health care costs can be saved. Third, it is assumed that the use of NIRF imaging makes the 
surgical procedures easier. This means safer and faster, improving speed and outcome and 
thereby quality of care. 
The three parts of this thesis cover four complications that are attempted to be prevented.
The first complication is iatrogenic bile duct injury during laparoscopic cholecystectomy. In 
this case the use of NIRF imaging is applied for visualization of the cystic duct. We started 
a multicenter randomized controlled trial (Chapter 2) to investigate whether the use of 
NIRF imaging is actually as promising during elective laparoscopic cholecystectomies, 
as was suggested by earlier research. Next, in a systematic review combined with ex vivo 
experiments (Chapter 3) we found important factors to take into consideration while using 
the technique to obtain the best possible results. Also, a new fluorescent dye showed very 
promising images of the cystic duct, facilitating clear visualization of this structure during 
surgery (Chapter 4). 
The second investigated complication is anastomotic leakage in colorectal surgery. 
Sufficient perfusion of the bowel at the location of the anastomosis is essential for 
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anastomotic healing. By visualizing the bowel perfusion with NIRF imaging, it is expected 
that anastomotic leakage will occur less often. A systematic review was performed, indeed 
describing a lower anastomotic leak rate when using NIRF imaging (Chapter 6). Based 
on these results, the use of NIRF imaging to prevent anastomotic leakage is increasingly 
becoming standard practice.  Our experiments show a possible relation between subjective 
and measured fluorescence intensity of the bowel using NIRF imaging and anastomotic 
leakage (Chapter 7), further supporting its use in practice. 
The third complication we focused on is ureter damage in colorectal surgery. The use of 
NIRF imaging could facilitate visualization of the ureter. When the surgeon knows the exact 
location of the ureter, ureteral damage seems to be less likely. We showed that the ureter 
could be visualized using methylene blue as a fluorescent dye (Chapter 8), however, without 
added value compared to the naked eye. Novel dyes were tested in pigs and seemed more 
promising by providing a clear visualization of the ureters during surgery (Chapter 9 and 
10). 
In part four of the thesis, unwillingly parathyroid removal during thyroid surgery was the 
subject of investigation. Using NIRF imaging in thyroid surgery to identify the parathyroid 
glands provided more certainty about the location of the parathyroid glands (Chapter 11). 
Target population 
This thesis contributes to the patients requiring surgery, especially elective laparoscopic 
cholecystectomy, colorectal surgery or thyroid surgery. Based on the results of this thesis, 
other researchers and surgeons might be encouraged and inspired to further explore aspects 
of these applications, thereby improving these further and exploring other applications of 
the technique, helping patients undergoing other specific types of surgery. 
Innovation and future
At the start of this thesis, the use of NIRF imaging was merely used in research settings. 
The protocol of the RCT described in Chapter 1 is the first started RCT regarding the 
intraoperative use of NIRF imaging. This RCT is the first step to assess whether the technique 
should be used in standard practice and should be incorporated in guidelines. The RCT in 
itself also improved the cooperation between surgeons, industry and research facilities since 
all these parties are actively involved in the RCT. However, although the RCT is an important 
step in the application of NIRF imaging, it might be unfit to illustrate the benefit of reduction 
of a complication with low frequency. This is the case with both bile duct injury and ureteral 
injury. The way to go here is prospective registration of all procedures performed in an 
international multicenter database. Our group is part of the international community 
of fluorescence imaging that is at present taking such initiatives. This community is also 
evaluating by several Delphi rounds the present status of application of the NIRF technique 
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in any field that has been described so far. All these initiatives have in part been stimulated 
by the contribution of our group, by its research and by its active communication.   
The use of methylene blue as a fluorescent dye seemed not of added value in this thesis. 
The excitation and emission wavelength of MB is different compared to the more successful 
indocyanine green. To visualize these dyes, a fluorescence imaging system providing the 
right excitation wavelength and filtering the right emission wavelength are needed. Since 
the use of MB was somewhat disappointing in our experiments, these wavelengths are not 
incorporated in standard fluorescence imaging systems. This led to the development of 
new dyes on the same excitation and emission wavelength as indocyanine green, so that 
standard fluorescence imaging systems can be used. This shows that the results of research 
in NIRF imaging influences the actions of the industry and the products that are developed 
and made commercially available.  
During the progression of this thesis the use of NIRF imaging has become standard 
practice in several hospitals, mainly for the application of assessing perfusion during 
anastomotic bowel surgery. 
One of the problems in assessing perfusion of anastomotic surgery is the decision when 
the bowel is ‘fluorescent enough’. A start to answer this question was made in Chapter 7 
of this thesis, although further research in a large cohort is needed to set a cutoff value of 
the fluorescence intensity that is ideally intra-operatively measured. Other future point of 
improvement of this technique include standard quantification of the signal (of which we 
made a start by writing Chapter 5), but also better dyes, better equipment and standard 
overlay of white and fluorescent light images 
The application of NIRF imaging in thyroid surgery requires additional research to 
further assess the added value of the technique and improve the application. Because of 
the results produced in this thesis, one of the manufacturers of NIRF imaging systems is now 
re-evaluating their system to further improve the application of this technique in thyroid 
surgery. As soon as this system is available new research is required to re-assess the added 
value of this technique in thyroid surgery. 
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Dankwoord
Ontzettend veel mensen hebben mij door deze promotie-tijd heen getrokken, geduwd en 
gelukkig ook soms gewoon enthousiast langs de lijn geapplaudisseerd voor de successen. 
Professor Stassen, Laurents, ik wil jou ontzettend bedanken voor alles wat ik van jou heb 
mogen leren. Ik begon als WESP student, als een zenuwachtig meisje dat eigenlijk helemaal 
niet zo veel van onderzoek doen wist, en ook niet zo goed Engels kon. Met als resultaat 
heel veel ‘rode tekst’ in de protocollen die ik je toe stuurde. Gelukkig werden de teksten 
ook steeds minder rood, maar bleef jij wel het oog voor detail houden en is uiteindelijk 
elke komma in dit proefschrift weloverwogen geplaatst. Ik kon tijdens mijn promotie 
veranderen van dat zenuwachtige meisje naar een zelfverzekerde onderzoeker die met 
trots de resultaten presenteert op congressen; Waar jij dan ook zodra het maar enigszins 
kon halverwege in de zaal goedkeurend aan het knikken was bij wat ik zei. Ontzettend 
bedankt daarvoor!
Professor Bouvy, Nicole, als ik even het overzicht kwijt was, me onnodig zorgen maakte 
over dingen en gewoon even concrete afspraken en actieplannen nodig had was jij altijd 
daar. Met een oplossing. Jij hebt me geleerd dat er altijd een manier is om moeilijke dingen 
op te lossen, zelf danwel door de juiste persoon te zoeken die je daarbij kan helpen. Dat is 
een les die ik nooit zal vergeten. 
Dr Schols, Rutger, jij was eigenlijk vanaf het moment dat ik me begon te verdiepen in 
de fluorescentie imaging mijn grote voorbeeld in dit veld. Ik denk dat ik jouw proefschrift 
misschien wel vaker heb gelezen dan jijzelf. Bij jou kon ik terecht voor de kleine dingen ‘op 
welk knopje moest ik nu drukken?’ en de grotere als het reviseren van de manuscripten 
en dit proefschrift. Onze reis naar Miami voor het fluorescentie congres zal me altijd bij 
blijven, en dan met name ons kort maar krachtige bezoek aan de Kennedy space center, de 
tour langs de highlights van Miami, de biertjes en burgers en natuurlijk onze fantastische 
praatjes die we daar gaven op het congres. 
Fokko, officieel misschien niet in mijn promotieteam maar onofficieel ben jij dat eigenlijk 
wel een beetje. Jouw enthousiasme is ontzettend aanstekelijk. Na een kwartiertje met jou 
over het onderzoek praten kon ik zo weer 3 maanden door. Ik denk dat ik in de toekomst 
gewoon een paar projecten zal verzinnen waarbij jij nodig bent, alleen maar om weer met 
je samen te mogen werken. 
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Mahdi, onze samenwerking verliep niet altijd vloeiend, maar ik denk wel dat we daarmee 
allebei uiteindelijk een stuk meer uit het onderzoek hebben kunnen halen. Al die uren die 
wij samen besteed hebben aan het analyseren van de videobeelden en het meten van de 
target to background ratio hebben zich uitbetaald in een aantal mooie publicaties, praatjes 
op congressen, een deel van dit proefschrift en ik weet zeker dat ook jouw proefschrift ook 
spoedig zal volgen.  
Verder wil ik alle co-auteurs en iedereen die mee heeft geholpen aan de FALCON trial via 
deze weg bedanken. In het bijzonder Sander van Kuijk, wat fijn dat ik altijd bij jou terecht 
kon met mijn statistiek-vragen. Maar ook Jarno Melenhorst, Tim Lubbers en Sanne 
Engelen, Liza Mitalas en alle aiossen die de lap chols deden wil ik graag bedanken voor 
hun geduld op OK als ik weer eens hun patiënten had geïncludeerd in mijn studies. 
Audrey, roooooomy! Wij deelde een werkkamer, soms wat studenten, af en toe onderzoeks-
projecten en maar ook een afkeer voor veel dingen die voor andere de gewoonste zaak van 
de wereld waren. Dit maakte ons misschien soms wat gemeen, maar daar konden wij ook 
niets aan doen. Ik heb zo ontzettend veel lol met jou gehad, op het werk, op de fiets, in de 
zomer in het park, op congres en de korte vakanties die we daar soms aan vast plakte. Met 
jou waren zelfs vage congressen in the middle of nowhere van Tsjechië één groot feest. 
Sebastiaan, Steen, jouw foute-uur afspeellijst heeft me door de laatste loodjes van deze 
promotie heen getrokken. In combinatie met onze ochtend-koffie, lunch-koffie en middag-
koffie natuurlijk. Wald, Waldo, wat een feest is alles als jij er ook bij bent! (Behalve als we 30 
seconds spelen, dat doe ik nooit meer met of tegen jou). Ons zeilweekendje was een van de 
vele hoogtepunten tijdens deze tijd, maar ook de feestjes, jouw Daniel Arends imitaties, de 
avonturen op de wielrenfiets en op het trailrun-pad. Cathelijne, Cath (geen kat want katten 
zijn niet jouw ding). Ik heb nog spierpijn van het lachen, denk niet dat die ooit nog weg gaat. 
Jouw doorzettingsvermogen en enthousiasme zijn inspirerend en aanstekelijk. Rob, met 
jou fietsen heet niet voor niets ‘huilen met Rob’. Gelukkig breng je naast wat tranen vooral 
veel gezelligheid, mooie routes en ben jij een ontzettend goede organisator van lab-uitjes, 
sinterklaasfeestjes, wielertours op groot scherm kijken en eigenlijk zo’n beetje alle leuke 
dingen die er op het lab gebeurde. Met jullie vier zeilen was één van de leukste weekendjes 
weg die ik ooit heb gedaan. Maar ik zal ook mijn tafelvoetbal-skills nooit meer verliezen na 
al die uren training met jullie. 
Marissa, jij begon ongeveer tegelijkertijd met mij vanuit de semi stage als promovendus 
op het lab. ’s avonds of tijdens de koffie konden wij uren praten, roddelen en ons verbazen 
over onze nieuwe collega’s, METC, onze grote RCTs en de wereld van de chirurgen. Op de 
chirurgendagen deelde wij vanzelfsprekend een kamer met 8 mensen en probeerde we zo 
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het ‘mamma-team’ en de rest van de chirurgie-promovendi enigszins te verbinden. Romy, 
de hoeveelheid energie die jij hebt is ongekend. Ik bewonder jou enorm om de manier 
waarop jij zelf beslist wat je belangrijk vindt in het leven en er ook nog eens voor zorgt dat 
jij al die dingen gewoon allemaal tegelijk kan doen. 
Leontine, Kim, Bas, David, Martine, Yvonne, Frans en Jasper jullie waren er vanaf het 
begin van mijn promotie-onderzoek bij en ik ben ontzettend blij met jullie ontvangst in de 
groep. Ook het licht dwingende advies om een wielrenfiets te kopen, was misschien wel een 
van de beste adviezen in mijn leven. Ik wil jullie ontzettend bedanken voor de gezellige tijd 
op het lab, op de fiets in het prachtige heuvelland en tijdens de vrijdagmiddagborrels waar 
jullie toch wel een van de key-ingredients voor waren. 
Claire, Mirjam, Rianne, Merel, Cathy, jullie waren/zijn de échte lab-mensen. Met grote 
verbazing ontvingen jullie mij soms in het lab als ik af en toe een buisje voor Audrey moest 
afdraaien. Wat blijkbaar heel simpel is, maar waarbij ik dan meestal toch jullie hulp een 
beetje nodig had, waarvoor dank. 
Collega’s uit het Viecuri: Michael, Frans, Anne, Stan, Maarten, Freek, Maud, Martijn, 
Tim, Tom, Marlies, Rutger, Eliza, Alexandra, Mintsje, Melissa; in het jaar, of voor 
sommige enkele maanden dat ik met jullie samen heb mogen werken heb ik het enorm 
naar mijn zin gehad. Jullie hebben mij de eerste stapjes als dokter (niet doctor) helpen 
maken. Julie waren allemaal ontzettend fijne collega’s! Ook mijn nieuwe collega’s bij de 
KNO in het Zuyderland ontzettend bedanken voor de kansen die jullie mij geven om dit vak 
te ontdekken en de fijne nieuwe werkplek. 
Lieve angels, who the F*** is Els? En waarom staat ze in dit dankwoord? Geen idee. Jullie 
heb ik grotendeels pas na mijn fulltime promotie-tijd leren kennen, maar jullie hebben er 
wel voor gezorgd dat ik voldoende energie had voor de laatste loodjes van dit proefschrift. 
En jullie zorgen er natuurlijk voor dat ik nooit meer van de triatlon-verslaving af zal komen 
zolang jullie ook mee doen. Ik doe mijn uiterste best om jullie soort van bij te blijven houden. 
Lieve Malou, wat ben ik blij dat ik jou heb leren kennen. Het is super om iemand te hebben 
die over zo veel dingen hetzelfde denkt, dezelfde kledingsmaak heeft, maar dan net een 
ander figuur waardoor de leuke dingen die jou niet perfect staan mij vaak wel en andersom, 
even fanatiek is en gewoon snapt wat ik wil, wens en bedoel. Ik vind het ontzettend jammer 
dat je zo ver weg woont maar ben ook heel erg blij jij desondanks zo’n goede vriendin voor 
mij blijft. 
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Lieve Aline, wat mis ik ons borrel-plank en wijn diner op zondag af en toe, zoals wij dat 
deden in de studententijd. Ook mis ik soms jouw al dan niet mislukte baksels, tripjes naar 
Parijs, Disney en Milaan. Gelukkig heb ik daar af en toe gezellige telefoontjes, appjes en 
dates ergens tussen Den Haag en Maastricht voor terug gekregen en ben ik vooral heel blij 
voor jou dat alles voor zover gelukt is waar je op gehoopt had. 
Leslie, wat hou ik van de luie zondagmiddagen waarin we lekker uit lunchen gaan en door 
een stad wandelen. Nog even wachten en dan kunnen we met de kinderwagen met daarin 
jouw mooie kindje door die steden lopen. Anne, met jou lekker de natuur in op de fiets 
of met de hardloopschoenen is zo heerlijk ontspannend. Daarna kan ik alles weer aan. 
Kimberley, Hester en Marloes, wat ken ik jullie al lang zeg! We spreken elkaar niet heel 
vaak meer maar ik vind het altijd super gezellig om bij jullie te zijn.
Mijn schoonfamilie, Carroll, Marianne, wat fijn dat ik altijd bij jullie terecht kan en zo vaak 
van jullie kook-kunsten mag genieten.  
Paps, mams en Stefan, ookal kon ik soms niet goed uitleggen wat ik nou de hele dag 
deed. Jullie en (vooral paps) snapte wel goed dat dit proefschrift een keer af moest. Door 
jouw subtiele vragen ‘heb je al een datum?’ werd menig treinreis met een goed boek toch 
veranderd in een reis waarin op de laptop werd gewerkt aan een manuscript. Ook was hotel 
mamma altijd beschikbaar als ik weer eens een slaapplek nodig had voor congres of reis, of 
gewoon voor de gezelligheid. Ik hoop dat ik jullie trots maak met wat ik doe en dat jullie je 
realiseren dat jullie daar altijd, al is het soms op afstand, een steentje aan bij hebt gedragen. 
Lieve Casper, Cas, eigenlijk ben jij de reden dat ik überhaupt ben gaan nadenken over het 
doen van promotieonderzoek. Jouw enthousiasme en vastberadenheid over de toege-
voegde waarde van het doen van onderzoek heeft mij aan het denken gezet dat ik dat dan 
misschien ook wel wilde, en heeft ervoor gezorgd dat ik me vanaf het begin als een pitbull 
in deze promotieplek heb vastgebeten. Op de moeilijke tijden was jouw schouder er om 
even op uit te huilen, bij de kleine en grote successen was jij er om het glas te heffen. Die 
researchgate score van mij zal denk ik nooit hoger worden dan die van jou, but one can 
always dream… Ik hoop dat jij er altijd voor mij zou willen zijn als schouder om op uit te 
huilen en als liefste om het glas mee te heffen in goede tijden. Want samen met jou zijn de 
zware tijden minder zwaar en de goede tijden het best. 
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